meglumine antimoniate has been researched along with meglumine in 801 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 102 (12.73) | 18.7374 |
| 1990's | 160 (19.98) | 18.2507 |
| 2000's | 261 (32.58) | 29.6817 |
| 2010's | 263 (32.83) | 24.3611 |
| 2020's | 15 (1.87) | 2.80 |
| Authors | Studies |
|---|---|
| Barrios, AA; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V | 1 |
| Gradoni, L; Gramiccia, M; Orsini, S | 1 |
| Franke, ED; Grogl, M; Thomason, TN | 1 |
| Bigaignon, G; Cornu, G; Mattot, M; Ninane, J; Vermylen, C | 1 |
| da Costa, CA; Dias, M; Genaro, O; Lima, Ade O; Magalhaes, PA; Mayrink, W; Melo, MN; Michalick, MS; Nascimento, E; Toledo, VP | 1 |
| Abahussain, A; al-Gindan, Y; alKhawajah, A; Jain, S; Larbi, EB | 1 |
| Croft, SL; Frommel, D; Gebre-Hiwot, A; Tadesse, G | 1 |
| Castillo, R; Hernández-Quero, J; Jiménez, E; Medrano, FJ; Pineda, JA; Reyes, MJ; Rivero, A; Sánchez-Quijano, A; Velez, ID; Viciana, P | 1 |
| Berman, JD; Chapman, WL; Hanson, WL; Ksionski, G; Waits, VB | 1 |
| Ozsoylu, S | 2 |
| Bouchouareb, D; Moulin, B; Ollier, J; Olmer, M; Purgus, R | 1 |
| Arnold, P; Deplazes, P; Gessler, M; Skaggs, J | 1 |
| Enriquez, A; García Aguado, C; Gazapo, E; González Lahoz, JM; Laguna, F; Martínez, P; Puente, S | 1 |
| Anastassiadis, G; Asvesti, C; Kolokotronis, A; Zographakis, I | 1 |
| Berman, JD; Herwaldt, BL; Neva, FA | 1 |
| Jennings, FW | 1 |
| Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N | 1 |
| Marr, JJ; Martinez, S | 1 |
| Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R | 1 |
| Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Almeida, RP; Badaró, F; Badaró, R; Barral, A; Barral-Netto, M; Carvalho, EM; Falcoff, E; Falcoff, R; Pedral-Sampaio, D; Santos, SB | 1 |
| Chapman, WL; Hanson, WL; Lovelace, JK; Waits, VB | 1 |
| Gatta, F; Gradoni, L; Gramiccia, M; Lupardini, E; Orsini, S | 1 |
| Kürkçüoğlu, N; Tandoğdu, R | 1 |
| Ellis, WY; Jackson, JE; Lawyer, PG; Limmer, BL; Mebrahtu, YB; Panisko, DM; Reed, SG; Tally, JD; Were, JB | 1 |
| Dedet, JP | 1 |
| De Rivera, MV; Franke, ED; Kruger, JH; Lucas, CM; Tovar, AA; Wignall, FS | 1 |
| Goerttler, E; Krutmann, J; Rzany, B; Schöpf, E | 1 |
| Betti, F; Gradoni, L; Gramiccia, M | 1 |
| Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE | 2 |
| Hanson, WL; Klayman, DL; Lovelace, JK; Vennerstrom, JL; Waits, VB | 1 |
| Arana, BA; Arana, FE; Castillo, AL; de Mérida, AM; Navin, TR; Pozuelos, JL | 1 |
| Gradoni, L; Gramiccia, M; Iorio, MA; Orsini, S | 1 |
| Vion, B | 1 |
| Jackson, JE; Tally, JD; Tang, DB | 1 |
| Coutellier, P; Delgrange, B | 1 |
| Castellanos, PL; Castes, M; Convit, J; Martinez, A; Moros, Z; Rondon, AJ; Trujillo, D | 1 |
| Berenguer, J; Bernaldo de Quirós, JC; Bouza, E; Cercenado, E; García de la Fuente, A; Moreno, S | 1 |
| Casals, A; Clotet, B; Ribelles, N; Vallés, J | 1 |
| de Vásquez, AM; Johnson, CM; Narvaez, E; Paz, HM; Sáenz, RE | 1 |
| Chulay, JD; Fleckenstein, L; Smith, DH | 1 |
| Marsden, PD; Sampaio, JH; Sampaio, RN | 1 |
| Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA | 1 |
| Bloom, B; Castellanos, PL; Castes, M; Convit, J; Garcia, L; Pinardi, ME; Rondon, A; Ulrich, M | 1 |
| Chapman, WL; Hanson, WL; White, MR | 1 |
| Kumar, PV; Sadeghi, E; Torabi, S | 1 |
| Bonventre, PF; Nickol, AD | 2 |
| Dupic, Y; Goutner, C; Massip, P; Navarrot, P | 1 |
| Gradoni, L; Gramiccia, M; Mancianti, F; Maroli, M | 1 |
| Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP | 1 |
| Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
| Tsetentis, Y | 1 |
| Chong, H | 1 |
| Marsden, PD | 1 |
| Lambert, D; Mambre, B | 1 |
| De Caluwé, JP; Delcourt, A; Heimann, R; Lievens, P; Taelman, H; Trolin, C | 1 |
| Gradoni, L; Gramiccia, M; Mancianti, F; Pieri, S | 2 |
| de la Cruz Amorós, E; Lambruschini Ferri, N; Rodríguez Miguélez, JM; Torres Simón, JM | 1 |
| Hiçsönmez, G; Jama, H; Ozsoylu, S | 1 |
| Benderitter, T; Casanova, P; Nashkidachvili, L; Quilici, M | 1 |
| Arici, C; Bonaccorso, C; Gavazzeni, G; Rizzi, M | 1 |
| Cillari, E; Liew, FY; Lo Campo, P; Mansueto, S; Milano, S; Salerno, A | 1 |
| Castro Coto, A; Coto Chacón, F; Hidalgo Hidalgo, H; Solano Aguilar, E | 1 |
| Alvar, J; González-Lahoz, JM; Polo, RM; Verdejo, J | 1 |
| Dumon, H; Franck, J; Gambarelli, F | 1 |
| Desjeux, P; Le Pont, F; Mollinedo, S; Paredes, A; Ugarte, G | 1 |
| Alfred, C; Brandicourt, O; Gentilini, M; Mazier, D; Monjour, L; Nzuzi, KK; Ploton, I; Tselentis, Y; Vouldoukis, I | 1 |
| Belazzoug, S; Neal, RA | 1 |
| Aranzazu, N; Castellanos, PL; Convit, J; Pinardi, ME; Reyes, O; Ulrich, M | 1 |
| Berman, JD; Chapman, WL; Hanson, WL; Jackson, JE; Klein, RS; Lovelace, JK; Waits, VB | 1 |
| el-On, J; Kernbaum, S; Rubinstein, N; Schnur, LF | 1 |
| Costa, JM; Dorea, JG; Holzbecher, J; Marsden, PD; Ryan, DE | 1 |
| Mravak, S; Schulzke, I; Weber, B | 1 |
| Ayats, R; Cadafalch, J; Orta, C; Portus, M | 1 |
| Gutiérrez Rodero, F | 1 |
| Barrios, LA; Costa, JM; Cuba, CC; Marsden, PD; Netto, EM; Vexenat, CO | 1 |
| Davis, JS; De Alencar, JE; Evans, T; Naidu, TG; Pearson, RD; Wheeler, DA | 1 |
| Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC | 1 |
| de Souza, PE; Pimentel, PS; Senra, MS | 1 |
| Ben Rachid, MS; Ben Said, M | 1 |
| Adinolfi, LE; Bonventre, PF | 1 |
| Chapman, WL; Hanson, WL; Madindou, TJ | 1 |
| Adinolfi, LE; Bonventre, PF; Eppstein, DA; Vander Pas, M | 1 |
| Gutiérrez Rodero, F; Moya Jeromini, I; Ortiz de la Tabla Ducasse, V; Pozuelo González, A | 1 |
| Ben Salah, N; Katlama, C; Pichard, E; Régnier, B; Vachon, F | 1 |
| Andreoli, A; Bonora, G; Cambiè, M; Gargantini, G; Giaracuni, G; Manzoni, D; Perletti, L | 1 |
| Marsden, PD; Sampaio, RN; Veiga, JP; Wolff, ER | 1 |
| Steck, EA | 1 |
| Fisher, BK; Schewach-Millet, M; Semah, D | 1 |
| Matthews, PJ; Neal, RA | 1 |
| Heimgartner, E | 1 |
| Hidalgo, H; Solano, E; Zeledón, R | 1 |
| García de Miguel, MJ; García Hortelano, J; López-Herce Cid, J; Ramirez Balza, O; Vidal López, ML | 1 |
| Caravagno, C; Maturana, G; Miranda, C; Moyano, C; Osorio, G; Retamales, I; Ubilla, M | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Swartz, GM; Waits, VB | 1 |
| Ceyhan, M; Diker, S; Dilmen, U; Kinik, E; Yurdakök, M | 1 |
| Barreto, AC; Cuba, CC; Llanos Cuentas, EA; Marsden, PD | 1 |
| Armas, JA; Moreno, G; Rezzano, S; Scorza, JV | 1 |
| Berman, JD; Hanson, WL; Keenan, CM; Lamb, SR; Waits, VB | 1 |
| Alving, CR; Hanson, WL; Munnell, JF; Weldon, JS | 1 |
| Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Duvivier, A; Lefèbvre, P; Nemery, A | 1 |
| Kokkini, G; Liosis, G; Papaefstathiou, J; Vrionis, G | 1 |
| Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
| Chapman, WL; Davidson, DE; Hanson, WL; Hendricks, LD; Hockmeyer, WT; Waits, VB | 1 |
| Bódalo Herrero, A; Cambronero Galache, M; Casado Flores, J; Casquero Junquera, J; Courel Grijalba, A; Martínez Cortés, F | 1 |
| Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN | 1 |
| Hanson, WL | 1 |
| Avila, JL; Biondo, F; Convit, J; Monzón, H | 1 |
| Almagro, M; Cabrera Torres, A; De Pablos Gallego, JM; De Puerta, S; Esquivias, JJ; Gómez Morales, M; López Garrido, P | 1 |
| Aram, GN; Arya, LS; Fazal, MI; Goel, RG; Qureshi, MA; Singh, M | 1 |
| Carcassonne, Y; Imbert, C; Sainty, D; Sebahoun, G | 1 |
| Ahmad, E; Ghahramani, N; Javid, R; Malek Hosseini, SA; Nezakatgoo, N; Salahi, H | 1 |
| Berman, JD; Franke, ED; Gasser, RA; Grögl, M; Magill, AJ; Oster, CN | 1 |
| Moreira, ES; Petrillo-Peixoto, Mde L; Soares, RM | 1 |
| Buffet, P; Caumes, E; Gentilini, M | 1 |
| Berman, J; Grogl, M; Hernandez, N; Mejia, H; Soto, J | 1 |
| Hernández, DE; Martínez, C; Oliver, M; Planas, G | 1 |
| Aminjavaheri, M; Momeni, AZ | 2 |
| Bryceson, A; Desjeux, P; Gradoni, L | 1 |
| Belloli, C; Carli, S; Ceci, L; De Natale, G; Marcotrigiano, G; Montesissa, C; Ormas, P; Tassi, P | 1 |
| Cortés, E; Cucurull, E; de Otero, J; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| Barbosa, AC; Dorea, JG; Franco, MA; Rath, S | 1 |
| da Costa, JM; Monjour, L; Neogy, AB; Vouldoukis, I | 1 |
| Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
| Gaeta, GB; Gradoni, L; Maisto, A; Pellizzer, G; Scalone, A | 1 |
| Badaró, F; Badaró, R; Carvalho, JS; Ho, JL; Johnson, WD; Jones, TC; Nascimento, C; Reed, SG; Russo, D | 2 |
| González-Lahoz, JM; Laguna, F; Soriano, V | 1 |
| Ali, A; Berhe, N; Hailu, A; Yeneneh, H | 1 |
| Harto, A; Hilara, Y; Ledo, A; Miralles, ES; Moreno, R; Núñez, M | 1 |
| Alvar, J; Boggio, J; González, F; Molina, R; Nieto, J; Rodriguez, F; San Andrés, M; San Andrés, MD; Tesouro, M; Vitutia, M | 1 |
| Closa, JM; Font, A; Gines, C; Mascort, J | 1 |
| Albertini, M; Gari-Toussaint, M; Le Fichoux, Y; Léger, I; Manassero, J; Mariani, R; Marty, P; Tommasi, C | 1 |
| Betto, P; Davidson, RN; Giambenedetti, M; Gradoni, L; Orsini, S | 1 |
| Alvar, J; González-Lahoz, JM; Laguna, F; López-Vélez, R; Montilla, P; Soriano, V | 1 |
| Chamorro Jambrina, C; Estecha Foncea, MA; Mas Lodo, M; Molina Cantero, JM | 1 |
| Blanquer, J; Llombart, A; Mesejo, A; Núñez, C; Pérez, PL; Ruiz, F; Simó, M | 1 |
| Barthet, M; Berland, Y; Bernard, JC; Brunet, P; Dussol, B; Jouglard, J; Rodor, F; Sahel, J | 1 |
| Belloli, C; Carli, S; Ceci, L; De Natale, G; Madonna, M; Marcotrigiano, GO; Ormas, P; Tassi, P | 1 |
| Añez, N; Burguera, JL; Burguera, M; Lugo de Yarbuh, A; Petit de Peña, Y | 1 |
| Bustamante, SE; Corbett, CE; Duarte, MI | 1 |
| Evans, TG | 1 |
| Desmyttere, S; Hachimi-Idrissi, S; Otten, J | 1 |
| Jurado, R; Kindelan, JM; Sanchez-Guijo, P; Torre-Cisneros, J; Villanueva, JL | 1 |
| Edrissian, GH; Movahhed-Danesh, AM; Nadim, A; Soleimanzadeh, G | 1 |
| Alcindor, LG; Ayrault-Jarrier, M; Bekaert, ED; Dubois, DY; Kallel, R; Mebazza, A | 1 |
| Aragort de Rossell, R; de Jesús de Durán, R; Rodríguez, AM; Rossell, O | 1 |
| Castrillo, JM; de Górgolas, M; Fernández Guerrero, ML | 1 |
| Harhalakis, N; Lazanas, MC; Nikiforakis, E; Papandreou, S; Saroglou, G; Scandali, A; Tsekes, GA | 1 |
| Altieri, S; di Martino, L; Ferrara, M; Gaeta, GB; Gradoni, L; Gramiccia, M; Pempinello, R; Pizzuti, R; Scotti, S | 1 |
| Barbieri, CL; Cantos, G; Gorin, PA; Iacomini, M; Travassos, LR | 1 |
| Barrios, AA; Bruneton, J; Cavé, A; Fournet, A; Hocquemiller, R; Muñoz, V | 1 |
| de Lalla, F; Franzetti, M; Gradoni, L; Pellizzer, G; Stecca, C; Vespignani, M | 1 |
| Buffet, P; Deray, G; Grögl, M; Jacobs, C; Martinez, F | 1 |
| Arnold, P; Deplazes, P; Eckert, J; Lutz, H; Smith, NC | 1 |
| Bourantas, C; Chaliasos, N; Kritikou, E; Lapatsanis, P | 1 |
| Cortes, E; de Otero, J; Gasser, I; Ocaña, I; Pahissa, A; Ribera, E | 1 |
| Evans, TG; Hibbs, JB; Reed, SS | 1 |
| Alcázar, R; de la Torre, M; Peces, R | 1 |
| Alberola, J; Arboix, M; Esteban, M; Valladares, JE | 1 |
| Boix, V; Massa, B; Pérez-Mateo, M; Portilla, J; Torrús, D | 1 |
| Derouin, F; Farinotti, R; Gangneux, JP; Garin, YJ; Sulahian, A | 1 |
| Buffet, PA; Derouin, F; Garin, YJ; Nassar, N; Sulahian, A | 1 |
| Dumon, H; Gambarelli, F; Garnier, JM; Kaplanski, S; Piarroux, R; Unal, D | 1 |
| Furtado, T; Nogueira-Castañon, MC; Pereira, CA | 1 |
| Barroeta, S; Bonfante-Garrido, R; de Alejos, MA; Grimaldi Júnior, G; Meléndez, E; Momen, H; Torrealba, J; Valdivia, O | 1 |
| Abdo, MC; Anacleto, C; Fernandes, AP; Ferreira-Pinto, KC; Miranda-Vilela, AL; Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Escobar, MA; Saravia, NG; Weigle, KA | 1 |
| Ferreira, ME; Fournet, A; Fuentes, S; Hocquemiller, R; Nakayama, H; Rojas De Arias, A; Schinini, A; Torres De Ortiz, S | 1 |
| Asensio, C; Bravo, JA; Esteban, RJ; Osuna, A | 1 |
| Bertho, AL; Coutinho, SG; Da-Cruz, AM; De Luca, PM; McMahon-Pratt, D; Mendonça, SC; Oliveira, MP; Soong, L | 1 |
| Brandonisio, O; Ceci, L; Faliero, SM; Fasanella, A; Panunzio, M; Puccini, V | 1 |
| Caramello, P; Millesimo, M; Savoia, D; Zucca, M | 1 |
| Bai, M; Kastanioudakis, I; Kostoula, A; Skevas, A | 1 |
| Agudelo, S; Berman, J; Grogl, M; Hendrickx, E; Modabber, F; Puerta, J; Velez, I | 1 |
| Bouthelier Moreno, M; de Juan Martín, F; Fortuño Cebamanos, B; Gilaberte Calzada, Y; Justa Roldán, ML; Navarro Serrano, E; Sáez de Adana Pérez, E | 1 |
| Deniau, M; Dumon, H; Faraut-Gambarelli, F; Faugère, B; Giusiano, B; Marty, P; Michel, G; Piarroux, R | 1 |
| Derouin, F; Gangneux, JP; Garin, YJ; Sulahian, A | 2 |
| Abate, O; Buracco, P; Guglielmino, R; Morello, E | 1 |
| Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
| Alcázar, R; Benezet, J; De la Torre, M; Ortega-Carnicer, J | 1 |
| Slappendel, RJ; Teske, E | 1 |
| Camma, C; Cascio, A; Giordano, S; Gradoni, L; Gramiccia, M; Russo, R; Scalone, A; Scarlata, F; Titone, L | 1 |
| Chippaux, JP; Djidingar, D; Gragnic, G; Julvez, J; Meynard, D; Tchani, O | 1 |
| Gonçalves-Costa, SC; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Schubach, A | 2 |
| Alvarez, E; Canales, J; Davies, CR; Dye, C; Leon, E; Llanos-Cuentas, EA; Roncal, N; Sharp, SJ | 1 |
| Alberola, J; Arboix, M; Cristofol, C; Franquelo, C; Freixas, J; Valladares, JE | 1 |
| Isaza, DM; Mosca, W; Restrepo, M | 1 |
| Boehringer, C; Bonnefont, C; Bourdoiseau, G; Chabanne, L; Hoareau, E; Stolle, T | 1 |
| Berman, J; Fuya, P; Herrera, R; Soto, J | 1 |
| Ermak, TN; Filippov, PG; Gruzdev, BM; Kravchenko, AV | 1 |
| Disdier, P; Mary, C; Serratrice, J; Swiader, L; Weiller, PJ | 1 |
| Black, GF; Blackwell, JM; Braga, R; Ishikawa, EA; Kima, P; McMahon-Pratt, D; Quinnell, RJ; Shaw, JJ; Shaw, MA; Silveira, FT; Soong, L | 1 |
| Alberola, J; Arboix, M; Cristòfol, C; Franquelo, C; Gállego, M; Portús, M; Riera, C; Valladares, JE | 1 |
| Abahussein, A; al-Gindan, Y; Alkhawajah, AM; Jain, S; Larbi, E | 1 |
| McMurray, WJ; Rainey, PM; Roberts, WL | 1 |
| Aste, N; Biggio, P; Ferreli, C; Pau, M | 1 |
| Aktepe, N; Avci, S; Erel, O; Gurel, MS; Kocyigit, A; Seyrek, A; Vural, H | 1 |
| Ciaramella, P; Cortese, L; de Luna, R; Gradoni, L; Oliva, G; Orsini, S; Persechino, A; Scalone, A | 1 |
| Baghestani, S; Handjani, F; Kumar, PV; Sodeifi, M | 1 |
| García Salazar, MA; Jiménez Martín, MJ; López Martínez, J; Temprano Vázquez, S | 1 |
| Amusategui, I; Sainz, A; Tesouro, MA | 2 |
| Gama, V; Lucumi, A; Robledo, S; Saravia, NG | 1 |
| Abajo, P; Daudén, E; Martín, R | 1 |
| Berenguer, J; Cano, J; Fernández Alvarez, JM; Gimeno, M; Gonzalo Lafuente, JC; Vázquez-Piñeiro, T | 1 |
| Dumon, H; Garnier, JM; Minodier, P; Perrimond, H; Piarroux, R; Unal, D | 1 |
| Gilead, L; Horev, L; Jonas, F; Klaus, SN; Zlotogorski, A | 1 |
| Barbosa Santos, EG; Barroso, JA; Brito, CM; Conceição, NF; Marzochi, MC; Pacheco, RS | 1 |
| Anacleto, C; Moreira, ES; Petrillo-Peixoto, ML | 1 |
| Arana, FE; Castanys, S; Gamarro, F; Morello, A; Pérez-Victoria, JM; Repetto, Y | 1 |
| Ahmad, S; Rahim, F; Rehman, F; Zada, B | 1 |
| Fernandes, O; Mattos, M; Oliveira-Neto, MP; Pirmez, C; Souza, CS | 1 |
| Derouin, F; Dullin, M; Gangneux, JP; Garin, YJ; Sulahian, A | 1 |
| Agostoni, C; Dorigoni, N; Malfitano, A; Migliorini, D; Scaglia, M | 1 |
| Bitnun, A; Ephros, M; Shaked, P; Waldman, E; Zilberstein, D | 1 |
| Dumon, H; Faraut-Gambarelli, F; Garnier, JM; Gire, C; Minodier, P; Piarroux, R | 1 |
| Alunda, JM; Cuquerella, M; de la Fuente, C; Fernández-Pérez, FJ; Gómez, MT; Méndez, S | 1 |
| Aoun, K; Belkaid, M; Ben Ismail, R; Bouratbine, A; Bousnina, S; Harrat, Z; Maherzi, A | 1 |
| Robledo, SM; Saravia, NG; Valencia, AZ | 1 |
| Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A | 1 |
| Belloli, C; Bertini, S; Carli, S; Crescenzo, G; Mengozzi, G; Ormas, P; Zaghini, A | 1 |
| Alvar, J; Gómez-Rodrigo, J; Laguna, F; López-Vélez, R; Medrano, FJ; Pasquau, J; Picó, G; Pulido, F; Salas, A; Sanz, J; Torre-Cisneros, J; Torres, E | 1 |
| Carvalho, S; de Figueiredo, TL; Demicheli, C; Frézard, F; Lopes, JC; Sinesterra, RD | 1 |
| Aisa, MJ; Alberola, J; Arboix, M; Carrió, J; Castillejo, S; Fisa, R; Gállego, M; Ribas, N; Riera, C; Valladares, JE | 1 |
| Atienza Fernández, F; Castelló Viguer, MT; Cuesta Estellés, G; Echánove Errazti, I; Esteban Esteban, E; Ridocci Soriano, F | 1 |
| Krause, G; Kroeger, A | 1 |
| Khalid, M; Mujtaba, G | 1 |
| Ardehali, S; Handjani, F; Panjehshahin, MR; Salmanpour, R; Tabatabaee, HR; Tabei, SZ; Zerehsaz, F | 1 |
| García-Bolao, I; Segura, I | 1 |
| Alsina, J; Bover, J; Gil-Vernet, S; Grinyó, JM; Hueso, M; Rufí, G; Serón, D | 1 |
| Corzo, JE; de la Rosa, R; Delgado, J; González-Moreno, MP; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Davidson, RN | 1 |
| Greiner, M; Moritz, A; Steuber, S | 1 |
| Greiner, M; Moritz, A; Schirrmann, I; Steuber, S | 1 |
| Holzmuller, P; Lemesre, JL; Sereno, D | 1 |
| Blackwell, JM; Cabrera, M; Castes, M; Convit, J; Shaw, MA; Trujillo, D | 1 |
| Andrade-Narvaez, FJ; Canto-Lara, SB; Damian-Centeno, AG; Vargas-Gonzalez, A | 1 |
| González Lahoz, J; Laguna, F; Valencia, ME | 1 |
| Demicheli, C; Frézard, F; Michalick, MS; Soares, CF | 1 |
| Arboix, M; Carrió, J; de Colmenares, M; Gállego, M; Portús, M; Riera, C | 1 |
| Barreto, SM; Krettli, AU; Lima e Costa, MF; Passos, VM; Romanha, AJ; Volpini, AC | 1 |
| Hantson, P; Haufroid, V; Lambert, M; Luyasu, S | 1 |
| Hepburn, NC | 1 |
| Márquez, M; Rivero, A; Santos, J | 1 |
| Alarcón, A; Alvar, J; Bernabeu-Wittel, M; Cordero, E; Prados, D; Regordán, C; Villanueva, JL | 1 |
| Ahmadiani, A; Azar, A; Ebtekar, M; Ghazanfari, T; Hassan, ZM; Naderi, G | 1 |
| Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B | 1 |
| Costa, MA; Demicheli, C; Ferreira, CS; Frézard, F | 1 |
| Derouin, F; Gangneux, JP; Garin, YJ; Meneceur, P; Pannier-Stockman, C; Sulahian, A | 1 |
| Aquino, RB; Barbosa, TC; Ferreira, E; Fonseca, G; Lambert, JS; Lucena, S; Nogueira, SA | 1 |
| Banzet, S | 1 |
| Alberola, J; Arboix, M; Castillejo, S; Ferrer, L; Fisa, R; Gallego, M; Iniesta, L; Portús, M; Riera, C; Roura, X; Solano-Gallego, L; Valladares, JE | 1 |
| Afonso, LC; Costa , CA; Genaro, O; Gollob, KJ; Mayrink, W; Oliveira, MA; Pinto, JA; Toledo, VP | 1 |
| Añez, N; Cazorla, D; Sánchez de Mirt, A; Yépez, J | 1 |
| Bakirtaç, A; Kara, C; Kuyucu, N; Teziç, T | 1 |
| Panadés, MJ; Porcel, JM; Rubio, M; Sacristán, O | 1 |
| Develoux, M; Huerre, M; Ndiaye, B; Thierno, DM | 1 |
| Carrió, J; Gállego, M; Portús, M; Riera, C | 1 |
| Dordain, ML; Rapp, C; Simon, F | 1 |
| Cuba Cuba, CA; Howard, MK; Miles, MA; Ogunkolade, W | 1 |
| Monzani, AS; Salomón, OD; Sosa Estani, S; Studer, C | 1 |
| Delgado, G; Moreno, A; Patarroyo, ME; Puentes, F | 1 |
| Abebe, Y; Abraham, Y; Berhe, N; Breivik, K; Hailu, A; Tadesse, Y | 1 |
| Alvarez, E; Arevalo, I; Llanos-Cuentas, A; Matlashewski, G; Meng, TC; Miller, R; Najar, E; Ward, B | 1 |
| Guerra, MV; Macêdo, VO; Paes, MG; Romero, GA | 1 |
| Anacleto, C; Andrade, AF; Ferreira, AV; Gazola, KC; Michalick, MS; Moreira, ES | 1 |
| Bevilaqua, CM; Costa, DC; Prata, JR; Rocha, MF; Sidrim, JJ; Simões-Mattos, L; Teixeira, MJ | 1 |
| Fretzayas, A; Karpathios, T; Kitsiou, S; Mathioudakis, J; Moustaki, M | 1 |
| Arana, B; Diaz, A; Rizzo, N | 1 |
| Armijos, RX; Weigel, MM | 1 |
| Fiekers, JF | 1 |
| Benítez, MD; de La Rosa, M; Martín, J; Miranda, C; Morillas, F; Navarro, JM | 1 |
| Añez, N; Gonzalez, N; Guevara, P; Premoli-de-Percoco, G; Ramirez, JL | 1 |
| Guerin, JM; Leibinger, F; Masmoudi, R; Mofredj, A | 1 |
| Bagán, JV; Jiménez, Y; Milián, MA; Pérez, A; Scully, C | 1 |
| De Souza, AA; Ishikawa, EA; Lainson, R; Silveira, FT | 1 |
| Miekeley, N; Mortari, SR; Schubach, AO | 1 |
| Aste, N; Biggio, P; Pau, M | 1 |
| da Costa, CA; Genaro, O; Machado-Pinto, J; Marques, MJ; Mayrink, W; Modabber, F; Pinto, J | 1 |
| Kafetzis, DA; Maltezou, HC | 1 |
| Carrió, J; Portús, M | 1 |
| Basha, M; Bregu, H; Davachi, F; Lita, G; Sulcebe, G | 1 |
| Benjelloune, A; Berraho, A; Charif Chefchaouni, M; El Lyacoubi, M; Lamrani, R | 1 |
| Antinori, S; Cascio, A; Colomba, C; Orobello, M; Paterson, D; Titone, L | 1 |
| Calza, L; Chiodo, F; di Bari, MA; Manfredi, R | 1 |
| Castillo, JA; Gracia, MJ; Guarga, JL; Lucientes, J; Moreno, J; Peribáñez, MA | 1 |
| Alchorne, MM; Macedo, FS; Ogawa, MM; Tomimori-Yamashita, J | 1 |
| Aminjavaheri, M; Momeni, AZ; Reiszadae, MR | 1 |
| Alavi, A; Esfandiarpour, I | 1 |
| Abebe, Y; Abraham, Y; Ali, A; Berhe, N; Hailu, A; Mengistu, G; Tsige, K | 1 |
| Handjani, F; Nouhpisheh, MK; Salmanpour, R | 1 |
| Bulut, V; Gur, S; Gurel, MS; Kocyigit, A; Ulukanligil, M | 1 |
| Abolhassani, M; Alimohammadian, MH; Darabi, H; Kariminia, A | 1 |
| Belhadj, S; Chaker, E; Dedet, JP; Hammami, M; Kallel, K; Pratlong, F | 1 |
| Faghihi, G; Tavakoli-kia, R | 1 |
| Costa Val, AP; Demicheli, C; Frézard, F; Melo, MN; Michalick, MS; Rocha, OG; Schettini, DA; Souza, LF | 2 |
| Gianotti, R; Rigoni, C; Veraldi, S | 1 |
| Badaró, R; Bittencourt, A; Follador, I; Nunes, VL; Silva, N; Straatmann, A | 1 |
| Almeida Catanho, MT; Amorim, LF; Bernardo-Filho, M; Brandao, KC; Cavalcanti Jales, RL; de Brito Tiago, GG; Gomes, ML; Holanda Leite, RC; Jales-Junior, LH; Lopes de Brito, LM; Xavier Holanda, CM | 1 |
| Báfica, A; Barral, A; Freitas, LA; Nascimento, EG; Oliveira, F | 1 |
| Garnier, JM; Horelt, A; Minodier, P; Retornaz, K | 1 |
| Bogenrieder, T; Landthaler, M; Lehn, N; Stolz, W | 1 |
| Alvarez, N; Le Baut, G; Le Pape, P; Robert, JM; Robledo, S; Velez, ID | 1 |
| Flores M, RM; Macêdo, Vde O; Noronha, EF; Romero, GA | 1 |
| Ali, IH; Ben Abdallah, N; Ben Maïz, H; Ben Moussa, F; Ben Salem, L; Cherif, L; el Younsi, F; Khiari, K; Maazoun, I; Turki, S | 1 |
| Abdo, MC; Anacleto, C; Fernandes, AP; Ferreira, AV; Moreira, ES; Murta, SM; Romanha, AJ | 1 |
| Enk, CD; Gardlo, K; Hochberg, M; Ingber, A; Ruzicka, T | 1 |
| Bhutto, AM; Hashiguchi, Y; Nonaka, S; Soomro, RA | 1 |
| Cordova, X; Sorci, JJ; Usatine, RP | 1 |
| Barão, SC; Giorgio, S | 1 |
| Alvar, J; Clotet, B; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Prados, D; Ribera, E; Sirera, G; Sust, M; Torre-Cisneros, J; Videla, S | 1 |
| Bernal, LJ; Cerón, JJ; Martínez-Subiela, S | 1 |
| Amini Harandi, A; Asilian, A; Faghihi, G; Momeni, A; Sadeghinia, A | 1 |
| Arruda, D; Foss, NT; Motta, AC; Souza, CS | 1 |
| NOGUER MORE, S | 1 |
| BOIX BARRIOS, J | 1 |
| BAPTISTA, L; BELLIBONI, N; CASTRO, RM | 1 |
| BERNARD, R; GIRAUD, P; VINCENT, P | 1 |
| FLOCH, H | 1 |
| CORNEJO, A | 2 |
| MATOS, J; VELASCO, JA | 1 |
| CARVALHO, O | 1 |
| PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S | 1 |
| CAMBI, P | 1 |
| Bari, I; Ejaz, A; Iftikhar, N | 1 |
| Darie, H; Debord, T; Gros, P; Imbert, P; Rapp, C; Roué, R; Simon, F | 1 |
| da Silva, JB; de Melo, AL; Demicheli, C; Falcão, CA; Frézard, F; Ochoa, R; Rossi-Bergmann, B; Sinisterra, RD | 1 |
| Gradoni, L; Gramiccia, M; Scalone, A | 2 |
| ESCHER, D; LAHAM, E | 1 |
| DURAND, P | 1 |
| BRETTE, R; CORNUT, P; COUDERT, J; MONNET, P | 1 |
| BOULARD, C; MASSONNAT, J; PORTIER, A | 1 |
| RIPA, F; TONDI, IV | 1 |
| Cardenas, GA; Cohen, C; Gonzalez-Serva, A | 1 |
| Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P | 1 |
| Garnier, JM; Minodier, P; Retornaz, K; Robert, S | 1 |
| Isaac-Márquez, AP; Lezama-Dávila, CM | 1 |
| Lamothe, J | 2 |
| Asilian, A; Faghihi, G; Momeni, A; Sadeghinia, A | 1 |
| Armijos, RX; Calvopiña, M; Mancheno, M; Rodriguez, R; Weigel, MM | 1 |
| Asilian, A; Iraji, F; Momeni, AZ; Shahtalebi, MA; Vali, A | 1 |
| di Martino, L; Di Muccio, T; Gradoni, L; Gramiccia, M; Occorsio, P; Scalone, A | 1 |
| Colomba, C; Frasca Polara, V; Salsa, L; Scarlata, F; Titone, L | 1 |
| Aste, N; Atzori, L; Ferreli, C; Pistis, P; Zucca, M | 1 |
| Allahverdiyev, AM; Culha, G; Durdu, M; Memisoglu, HR; Uzun, S | 1 |
| Amari, L; Belhaj, S; Ben Chaabene, T; Goubontini, A; Kilani, B | 1 |
| Querido, J | 1 |
| Asilian, A; Enshaeieh, Sh; Faghihi, G; Shariati, F; Sharif, A; Siadat, AH | 1 |
| Diaz-Bertrana, MC; Durall, I; Franch, J; Lafuente, P; Munilla, A; Pastor, J; Torrent, E | 1 |
| Saravia, NG; Walker, J | 1 |
| de Carvalho, EM; de Farias Guerra, MV; de la Glória Orge Orge, M; de Oliveira Macêdo, V; Paes, MG; Romero, GA | 1 |
| Delis, D; Kafetzis, DA; Liapi, G; Mavrikou, M; Stabouli, S; Velissariou, IM | 1 |
| Cardoso, JE; de Oliveira-Silva, F; Fernandes, AP; Ferreira, LA; Gonçalves, GS; Maciel, FC; Rabello, A; Souza, RC | 1 |
| Alvarez, N; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F | 1 |
| Gómez, A; Henao, HH; Osorio, Y; Saravia, NG; Travi, B | 1 |
| Bouassida, S; Boudaya, S; Maalej, N; Masmoudi, A; Mseddi, M; Souissi, A; Turki, H; Zahaf, A | 1 |
| Andersen, EM; Berman, JD; Colina, O; Cruz-Saldarriaga, M; Echevarria, J; Llanos-Cuentas, A; Luz-Cjuno, M; Miranda-Verastegui, C | 1 |
| Barral, A; Boaventura, V; Campos, LF; Costa, JM; da Cruz Junior, AC; da Rocha, AV; de Oliveira, CI; Noronha, A; Novais, FO; Oliveira, JG | 1 |
| Arango, G; Jaramillo, LM; Muñoz, D; Osorio, E; Restrepo, A; Robledo, S; Vélez, I | 1 |
| Serarslan, G; Söğüt, S; Yilmaz, HR | 1 |
| Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M | 1 |
| Aceña, MC; Castillo, JA; Gascón, M; Gómez-Ochoa, P; Miana-Mena, FJ | 1 |
| Cruz, I; Flores, MD; López-Vélez, R; Mateo, M | 1 |
| Berman, J; Soto, J; Toledo, J; Vega, J | 1 |
| Arévalo, I; Llanos-Cuentas, A; Matlashewski, G; Miranda-Verástegui, C; Ward, BJ | 1 |
| Aguar, MC; Díaz-Gómez, JR; Lapuebla, X; Rovira, RE | 1 |
| Guarneri, C; Guarneri, F | 1 |
| Bernardo Filho, M; Catanho, MT; Holanda, CM; Leite, RC; Souza, GM | 1 |
| Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
| Aste, G; Boari, A; Di Tommaso, M; Steiner, JM; Williams, DA | 1 |
| De-Carvalho, RR; Miekeley, N; Miranda, ES; Paumgartten, FJ | 1 |
| Badaro, R; Correia, TM; David, JR; de Freitas, LA; Lobo, IM; Nakatani, M; Netto, E; Oliveira, MI; Soares, MB | 1 |
| Ahmed, I; Ahmed, P; Altaf, C; Anwar, M; Ashraf, T | 1 |
| Affronti, M; Di Rosa, S; Malta, R; Renda, M; Rini, GB; Rubino, ME; Trifirò, G; Vassallo, L | 1 |
| Affronti, M; Di Rosa, S; Malta, R; Peralta, S; Renda, M; Rini, GB; Savalli, F; Scardavi, M; Trifiró, G | 1 |
| Cascio, A; Giordano, S; Mancuso, G; Scarlata, F; Titone, L | 1 |
| Aquino, D; Barral, A; Barral-Netto, M; Brodskyn, C; Caldas, A; Costa, J; Favali, C; van Weyenbergh, J; Vinhas, V | 1 |
| Dzhokhtaberidze, TG; Khochava, MA; Lomtadze, ML; Shalamberidze, IA; Shilakadze, MA | 1 |
| Moosavi, Z; Nakhli, A; Rassaii, S | 1 |
| Aquino, D; Barral, A; Barral-Netto, M; Caldas, AJ; Costa, J; Silva, AA | 1 |
| Bouassida, S; Kitar, A; Masmoudi, A; Rebai, M; Turki, H; Zahaf, A | 1 |
| Cavalli, R; Cremonesi, R; Galloni, C; Veraldi, S | 1 |
| Atabek, ME; Pirgon, O; Unal, E | 1 |
| Aşçioglu, O; Canoz, O; Doganay, M; Ferahbaş, A; Mistik, S; Utaş, S; Yaman, O | 1 |
| Abdi, K; Darabi, M; Ghareghozloo, B; Kariminia, A; Solgi, G | 1 |
| de Oliveira, FB; Demicheli, C; Dzamitika, SA; Falcão, CA; Frézard, F; Garnier-Suillerot, A; Marbeuf, C; Rossi-Bergmann, B | 1 |
| Demicheli, C; Frézard, F; Melo, MN; Michalick, MS; Ribeiro, RR; Rocha, OG; Schettini, DA | 1 |
| Boudaya, S; Maalej, N; Masmoudi, A; Turki, H; Zahaf, A | 1 |
| Boucher, P; Hadighi, R; Hajjaran, H; Khamesipour, A; Mohebali, M; Ouellette, M | 1 |
| Ouellette, M; Rojas, R; Saravia, NG; Valderrama, L; Valderrama, M; Varona, MX | 1 |
| Boumis, E; Chinello, P; Della Rocca, C; Paglia, MG; Petrosillo, N; Proietti, MF | 1 |
| Djossou, F; Ibanez, C; Le Bras, M; Longy-Boursier, M; Malvy, D; Vatan, R | 1 |
| Katsambas, A; Kontochristopoulos, G; Papakonstantinou, AM; Petropoulou, H; Stavropoulos, PG | 1 |
| Nilforoushzadeh, MA; Sadeghian, G | 1 |
| da Silva, JB; Demicheli, C; Ferreira, LA; Frézard, F; Martins, PS; Melo, AL; Ochoa, R; Pimenta, AM; Sinisterra, RD | 1 |
| Buffet, PA; Darie, H; Freitag, S; Gounod, N; Le Guern, AS; Therby, A; Van Der Vliet, D | 1 |
| Ansari, N; Jaffray, F; Nilfrousihzadeh, MA; Reiszadeh, MR | 1 |
| de Castro Pimenta, AM; Demicheli, C; dos Santos Ferreira, C; Frézard, F | 1 |
| Abtahi, N; Razmavar, MR; Salmanpour, R | 1 |
| Bermúdez, H; Boelaert, M; Chappuis, F; Desjeux, P; Dujardin, JC; Garcia, L; Rojas, E | 1 |
| Bonello, FL; de Lima, VM; Feitosa, MM; Ikeda-Garcia, FA; Lopes, RS; Marques, FJ; Morinishi, CK; Perri, SH; Zanette, MF | 1 |
| Carvalho, SF; Costa, RT; De Almeida Silva, L; Nascimento, E; Prata, A; Rodrigues, V; Romero, HD | 1 |
| Gómez-Rodríguez, F; Gómez-Soto, F; Molina-Ruano, FJ; Puerto-Alonso, JL | 1 |
| Grimaldi, GJ; Oliveira-Neto, MP; Porrozzi, R; Teva, A | 1 |
| Cortes, S; João, A; Pereira, MA; Santos-Gomes, GM | 1 |
| Costa, M; Ferrer, L; Martorell, S; Miranda, S; Ramis, A | 1 |
| Ciarlini, PC; Feitosa, MM; Ikeda-Garcia, FA; Lima, VM; Lopes, RS; Marques, FJ; Perri, SH | 1 |
| Shajari, G; Taghaviardakani, A; Talaei, R; Talari, SA; Vakili, Z | 1 |
| Dowlati, Y; Eskandari, SE; Firooz, A; Ghoorchi, MH; Gorouhi, F; Hooshmand, B; Khamesipour, A; Khatami, A; Nassiri-Kashani, M; Rashighi-Firoozabadi, M | 1 |
| Barro-Traoré, F; Goumbri-Lompo, O; Niamba, P; Soudré, RT; Traoré, A | 1 |
| Cruz, A; Herwaldt, BL; Palacios, R; Rainey, PM; Saravia, NG; Stagni, G; Trujillo, R | 1 |
| Kumar, PV; Mousavi, A; Rizvi, MM; Sadeghi, E; Sadeghipour, A; Soleimanpour, H; Tabatabaei, AH; Vasei, M | 1 |
| Soto, J; Soto, P | 1 |
| Cadena, H; Tabares, CJ; Travi, BL | 1 |
| Mumtaz, N; Rahman, SB; ul Bari, A | 1 |
| Iraji, F; Nilfroushzadeh, MA; Sadeghian, G | 1 |
| Barroso, PA; Calvopina, M; Hashiguchi, Y; Kato, H; Korenaga, M; Marco, JD | 1 |
| Derakhshan, R; Haftbaradaran, E; Jaffary, F; Moradi, S; Nilforoushzadeh, MA | 1 |
| Bouvresse, S; Crickx, B; Descamps, V; Devillière, M; Mahé, E; Marinho, E; Matichard, E; Soria, A | 1 |
| Adaui, V; Arevalo, J; Chappuis, F; De Doncker, S; Dujardin, JC; Lazo, M; Llanos-Cuentas, A; Loayza-Muro, R; Maurer, A; Miranda-Verástegui, C; Ramirez, L; Tulliano, G; Zimic, M | 1 |
| Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
| Arevalo, I; Llanos-Cuentas, A; Matlashewski, G; Pollack, H; Quispe, A; Spaeth, G; Tulliano, G | 1 |
| Brooker, S; Chappuis, F; Kabatereine, N; Kolaczinski, JH; Onapa, A; Reithinger, R; Worku, DT | 1 |
| Gravino, AE; Manna, L; Pavone, LM; Picillo, E; Reale, S; Vitale, F | 1 |
| Fontes, CJ; Hueb, M; Nery, AF; Rodrigues, AM | 1 |
| Alvarez, E; Bryceson, A; Campos, P; Chang, E; Cruz, M; Echevarria, J; Llanos-Cuentas, A; Rosales, E; Seas, C | 1 |
| Frutuoso, MS; Pompeu, MM; Silva, TM; Sólon, FR; Sousa, AQ; Teixeira, MJ | 1 |
| Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL | 1 |
| Akhoundi, B; Fotouhi, A; Hooshmand, B; Kabir, MJ; Mohebali, M; Nadim, A; Rahnema, A; Razaghian, AR; Zarei, Z | 1 |
| Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G | 1 |
| Dabiri, SH; Esfandiarpour, I; Yousefi, K | 1 |
| Layegh, P; Moghiman, T; Pezeshkpoor, F; Shakeri, MT; Vosugh, EM; Yazdanpanah, MJ | 1 |
| Azeredo-Coutinho, RB; Callahan, H; Max, G; Mendonça, SC; Portal, AC | 1 |
| Avallone, L; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Mastellone, V; Pelagalli, A; Piantedosi, D | 1 |
| Dabiri, SH; Esfandiarpour, I | 1 |
| Bahia, AP; da Silva, JB; de Melo, AL; Demicheli, C; Frézard, F; Le Moyec, L; Martins, PS; Pimenta, AM; Salerno, M | 1 |
| Bottini, S; Lunardon, L; Persico, MC; Veraldi, S | 1 |
| Akrout, F; Ayadi, N; Bouassida, S; Boudaya, S; Khabir, A; Masmoudi, A; Meziou, TJ; Sallemi, T; Turki, H; Zahaf, A | 1 |
| Abraham, D; Cajal, SP; Juarez, M; Krolewiecki, AJ; Matsumoto, T; Mimori, T; Romero, HD; Taranto, NJ | 1 |
| Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A | 1 |
| de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
| Amaral, FM; Aragão-Filho, WC; Costa, GC; Frazão, JB; Guerra, RN; Maciel, MC; Nascimento, FR; Patrício, FJ; Pereira, PV; Pereira, WS; Rebêlo, JM; Ribeiro, MN; Silva, LA; Sousa, SM | 1 |
| Ameur, HB; Amor, SB; Becher, SB; Fitouri, Z; Matoussi, N | 1 |
| Baron, AR; Del Pilar Mahecha, M; Dueñes, B; Montaña, R; Montero, LM; Reithinger, R; Sanchez, BF; Vega, JC | 1 |
| Baena, V; Cañavate, C; Cruz, I; Gilaberte, M; Pujol, RM; Yébenes, M | 1 |
| Cavailler, P; Chappuis, F; Couffignal, S; Loutan, L; Mueller, Y; Nguimfack, A; Rwakimari, JB | 1 |
| Amato Neto, V; Amato, VS; Graf, ME; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
| Dahdah, MJ; Ghosn, S; Kibbi, AG | 1 |
| Balderrama, M; Berman, JD; Rea, J; Soto, J; Soto, P; Toledo, J; Valda, L | 1 |
| Carrió, J; García, E; Miñarro, M; Pérez, P; Portus, M; Pujals, G; Suñé-Negre, JM; Tico, JR | 1 |
| Alonso, C; Castilla, J; Fuertes, MA; Nguewa, PA; Pérez, JM | 1 |
| Campos Neto, A; da Costa, RT; Dias, ES; França, JC; Fujiwara, RT; Mayrink, W; Miret, J; Nascimento, E; Reed, S; Sampaio, W; Vale, A; Vieira, E | 1 |
| Akkaya, VB; Basak, PY; Ceyhan, AM; Erturan, I; Yildirim, M | 1 |
| Belaabidia, B; El Biaz, S; Essaadouni, L; Hamdaoui, A; Zahlane, M | 1 |
| Akrout, F; Ayadi, N; Bouassida, S; Boudawara, T; Bouzid, L; Khabir, A; Masmoudi, A; Meziou, TJ; Turki, H; Zahaf, A | 1 |
| Compagnoni, F; Franceschi, A; Mancianti, F | 1 |
| Elfekih, N; Ezzine, N; Fazaa, B; Hajlaoui, K; Kamoun, MR; Kastalli, S; Loueslati, MH; Zeglaoui, F | 1 |
| Cabral, LM; Castro, HC; Dias, LR; Dornelas, CB; Juliano, VN; Rodrigues, CR; Santos, TC; Villardi, M | 1 |
| Alves, CF; Demicheli, C; Frézard, F; Melo, FA; Melo, MN; Michalick, MS; Moura, EP; Pimentel, VM; Ribeiro, RR; Sampaio, WM; Schettini, DA; Silva, SM; Tafuri, WL | 1 |
| Hussain, I; Janjua, SA; Munir, A | 1 |
| Ayres, DC; Giorgio, S; Pinto, LA | 1 |
| Ashkan, MM; Rahim, KM | 1 |
| Boechat, N; Carvalho, AS; Costa, JC; Duarte, SL; Mendonça, JS; Morais-Teixeira, Ed; Rabello, A | 1 |
| De Majo, M; Lo Giudice, S; Masucci, M; Pennisi, MG; Reale, S; Vitale, F | 1 |
| de Paula-Coelho, VN; Muniz-Junqueira, MI | 1 |
| Galindo-Sevilla, N; Mancilla-Ramirez, J; Martinez-Rojano, H; Quiñonez-Diaz, L | 1 |
| Foglia Manzillo, V; Gradoni, L; Guglielmino, R; Oliva, G; Pagano, A; Restucci, B | 1 |
| Caligiorne, RB; de Assis, TS; Rabello, A; Romero, GA | 1 |
| Alborzi, A; Fakhar, M; Hatam, GR; Kadivar, MR; Motazedian, MH; Pouladfar, GR | 1 |
| Jaffary, F; Mahzoni, P; Nilforoushzadeh, MA; Sadeghian, G; Shirani-Bidabad, L; Ziaei, H | 1 |
| Achour Barchiche, N; Madiou, M | 1 |
| Coraspe, V; Delgado, O; Franco-Paredes, C; Navarro, P; Rivas, MA; Rodriguez-Morales, AJ; Silva, S | 1 |
| Amaral, VF; Canto-Cavalheiro, MM; Charret, KS; da Silva, EF; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
| Aragão, EB; Arruda, GA; Daher, EF; Evangelista, LF; Galeano, NM; Lima, RS; Mota, RM; Oliveira, RA; Silva Júnior, GB; Silva, SL | 1 |
| Baron, AR; Dueñes, B; Mahecha, Mdel P; Montaña, R; Montero, LM; Reithinger, R; Sanchez, BF; Vega, JC | 1 |
| Badri, T; Ben Brahim, M; Ben Jannet, S; Chouk, S; Daghfous, R; El Aïdli, S; Fenniche, S; Marrrak, H; Mlika, BR; Mokhtar, I | 1 |
| Sadeghi, M; Sadeghian, G; Ziaei, H | 1 |
| Díaz, E; Machuca, C; Padrón-Nieves, M; Ponte Sucre, A; Romero, A | 1 |
| Brito, ME; Luna, CF; Medeiros, AC; Pereira, VR; Reis, LC; Silva, CJ; Souza, MA | 1 |
| Layegh, P; Moghiman, T; Naviafar, P; Pezeshkpoor, F; Soruri, AH | 1 |
| Bianciardi, P; Mateo, M; Maynard, L; Miró, G; Vischer, C | 1 |
| Ansari, N; Firouz, A; Jaffary, F; Nilforoushan, Z; Nilforoushzadeh, MA; Siadat, AH | 1 |
| Mahmoudi, M; Nilforoushzadeh, MA; Saberi, S; Shirani-Bidabadi, L; Siadat, AH; Zolfaghari-Baghbaderani, A | 1 |
| Arnedo-Pena, A; Bellido-Blasco, JB; Herrero-Carot, C; Romeo-García, MA | 1 |
| Barral, AM; de Almeida, HL; Diehl, ES; Fleury, RN; Ura, S | 1 |
| Aitourhoui, M; Belgnaoui, FZ; Bouhllab, J; Elguelbazouri, N; Hassam, B; Marcil, T; Qasmi, S; Senouci, K | 1 |
| Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M | 1 |
| Chang, KP; Dutta, S; Kolli, BK; Muñoz, DL; Muskus, C; Robledo, SM; Varela M, RE | 1 |
| Avallone, L; Cestaro, A; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Pelagalli, A; Piantedosi, D | 1 |
| Bertazzolo, W; Dell'Orco, M; Paccioretti, F | 1 |
| Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L | 1 |
| Ejaz, A; Ul Bari, A | 1 |
| García-Lázaro, M; Natera, C; Rivero, A; Villar, C | 1 |
| Kubota, LT; Santos, VS; Santos, Wde J; Tarley, CR | 1 |
| Brustoloni, YM; Cônsolo, CE; Melnikov, P; Zanoni, LZ | 1 |
| Buffet, PA; Caumes, E; Jauréguiberry, S; Jeddi, F; Mazier, D; Thellier, M | 1 |
| Alborzi, A; Shahian, M | 1 |
| Bacellar, O; Carvalho, EM; Guimarães, LH; Lago, EL; Machado, PR; Morgan, DJ; Schriefer, A | 1 |
| Boutaleb-Charki, S; Díaz, JG; Guitierrez-Sánchez, R; Huertas, O; Marín, C; Pérez-Cordon, G; Rosales, MJ; Sánchez-Moreno, M | 1 |
| Bóia, MN; Brustoloni, YM; Cunha, RV; Dorval, ME; Fernandes, TD; Oliveira, AL | 1 |
| Firdous, R; Ranja, K; Yasinzai, M | 1 |
| Buffet, PA; Bullani, R; de Vallière, S; Gillmore, JD; Greub, G; Joneberg, JE; Mary, C; Rotman, S; Tarr, PE | 1 |
| El Fékih, N; Fazaa, B; Kamoun, MR; Khaled, S; Kharfi, M; Sliti, N; Trabelsi, S | 1 |
| Daher, EF; Fonseca, PP; Gerhard, ES; Leitão, TM; Silva Júnior, GB | 1 |
| Feily, A; Namazi, MR; Yaghoobi, R | 1 |
| Aresu, L; Bianciardi, P; Brovida, C; Castagnaro, M; Cavicchioli, L; Giroud, L; Valente, M; Vischer, C | 1 |
| Figueroa, RA; Miranda, MC; Prager, M; Zea, DF | 1 |
| Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Teva, A; Vieira, F | 1 |
| Dorta, ML; Miguel, DC; Pelli de Oliveira, MA; Pereira, LI; Ribeiro-Dias, F; Uliana, SR; Yokoyama-Yasunaka, JK; Zauli-Nascimento, RC | 1 |
| Del Giudice, P; Dereure, J; Hakimi, S; Le Quellec, A; Rivière, S | 1 |
| Alves, EV; Arruda, VO; de Azevedo, AP; Lima, MI; Monteiro, SG; Pereira, SR | 1 |
| Caldas, ED; Neves, DB; Sampaio, RN | 1 |
| Amri, F; Aoun, K; Ben Alaya, N; Bouratbine, A; Chouihi, E; Mary, C; Raies, A | 1 |
| Demicheli, C; Ferreira, WA; Frézard, F; Le Moyec, L; Martins, PS; Neto, RL; Ribeiro, RR; Rocha, OG | 1 |
| Battikh, R; Belhadj, R; Berraies, N; Gargouri, S; Haloues, M; Harzallah, K; Hmida, J; Jemli, B; Manaa, J | 1 |
| Arik Yilmaz, E; Tanir, G; Taylan Ozkan, A; Tuygun, N | 1 |
| Bagherani, N; Maraghi, S; Rafiei, A; Yaghoobi, R | 1 |
| Bianciardi, P; Cañavate, C; Cruz, I; Miró, G; Mortarino, M; Oliva, G; Vischer, C | 1 |
| Alvar, J; Balasegaram, M; Boelaert, M; Lynen, L; Meheus, F; van Griensven, J | 1 |
| Abbehusen, M; de Jesus, RS; Goto, Y; Guderian, J; Howard, RF; Nakatani, M; Netto, EM; Pedral-Sampaio, G; Reed, SG; Trigo, J | 1 |
| Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB | 1 |
| Benslama, A; Charra, B; Ezzouine, H; Motaouakkil, S | 1 |
| Brahn, E; Craft, N; Pegues, DA; Yao, Q | 1 |
| García Esteban, C; García-Bermejo, I; Guillén Martín, S; La Orden Izquierdo, E; Prieto Tato, LM; Ramos Amador, JT; Salcedo Lobato, E | 1 |
| Azeredo-Coutinho, RB; Baptista, C; Conceição-Silva, F; de Almeida Marzochi, MC; de Camargo Ferreira E Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; de Souza Coutinho, R; Fernandes Pimentel, MI; Pereira Quintella, L; Roberto Mortari, S; Rosandiski Lyra, M; Soares Moreira, J; Valete-Rosalino, CM | 1 |
| Ezzine Sebai, N; Fazaa, B; Kamoun, MR; Khaled, A; Kharfi, M; Mrabet, N; Zeglaoui, F | 1 |
| Isaac-Márquez, AP; Lezama-Dávila, CM; McChesney, JD; Nanayakara, NP; Satoskar, AR | 1 |
| Baba, M; Bal, N; Durdu, M; Eryilmaz, A; Yiğit, F | 1 |
| Adaui, V; Arévalo, J; Cupolillo, E; Dujardin, JC; Ribeiro-Alves, M; Romero, GA; Torres, DC | 1 |
| Cavassini, M; Cometta, A; Foguena, AK; Greub, G; Schroeder, D | 1 |
| Brustoloni, YM; Cônsolo, LZ; Cunha, RV; Dorval, ME; Oliveira, AL; Oshiro, ET | 1 |
| Aflatoonian, MR; Dowlati, Y; Fekri, AR; Khamesipour, A; Mahboudi, F; Modabber, F; Nadim, A; Sharifi, I | 1 |
| Araujo-Melo, MH; Araújo-Silva, M; Carmo, CN; Conceição-Silva, F; Meneses, AM; Moreira, JS; Oliveira, RV; Pimentel, MI; Salgueiro, MM; Schubach, AO; Valete-Rosalino, CM | 1 |
| Bardagí, M; Ferrer, L; Ravera, I; Roura, X; Torres, M; Zanna, G | 1 |
| García, C; García, RG; Kampeerapappun, P; López, M; López-Jaramillo, P; Rincón, MY; Silva, SY; Smith, DJ; Smith, E; Vélez, ID | 1 |
| Ben Osman, A; Chaker, E; El Euch, D; Ishak, F; Kort, R; Mokni, M; Zaraa, I | 1 |
| Abbas, MM; Masood, S; Mumtaz, MJ; Rashid, BN; Tabassum, S; Ullah Rao, MS | 1 |
| Aghaie, H; Heshmatkhah, A; Shamsi Meymandi, S; Zandi, S | 1 |
| López, L; Mestra, L; Rodríguez, E; Rojas, C; Sánchez, X; Vélez, I | 1 |
| Cedeño, DL; Jones, MA; Muñoz, DL; Robledo, SM; Taylor, VM; Vélez, ID | 1 |
| Alves, FP; Ashman, JA; Beckmann, AM; Bogatzki, LY; Campos-Neto, A; Coler, RN; Cowgill, KD; Fernandes, DF; Kahn, SJ; Nascimento, E; Piazza, FM; Pine, SO; Reed, SG; Vieira, EP | 1 |
| Guerra-Giraldez, C; Mortara, RA; Price, HP; Ramos, CS; Smith, DF; Uliana, SR; Yokoyama-Yasunaka, JK | 1 |
| Hajiabdolbaghi, M; Hajjaran, H; Hashemian, H; Jafari, S; Mohebali, M | 1 |
| Nilforoushzadeh, MA; Sadeghian, G; Shirani-Bidabadi, L; Ziaei, H | 1 |
| Alexandrino-de-Oliveira, P; da Cunha, RV; Da-Costa, Fd; Da-Cruz, AM; Dorval, ME; Paniago, AM; Pereira, GR; Santos-Oliveira, JR | 1 |
| Foto, E; Gradoni, L; Kuneshka, L; Petrela, R; Zavalani, F | 1 |
| Balasegaram, M; Hailu, A; Hailu, W; Hurissa, Z; Omollo, R; Tafes, H; Weldegebreal, T; Yifru, S | 1 |
| Boughamoura, L; Bouguila, J; Chabchoub, I; Essoussi, AS; Mlika, A; Moncef, Y; Saghrouni, F | 1 |
| Arasteh, M; Babakoohi, S; Firooz, A; Kashani, MN; Nilforoushzadeh, MA; Sadr, B | 1 |
| Amarti, A; Harmouche, T; Iguermia, S; Mernissi, FZ; Mikou, O | 1 |
| Demicheli, C; Frézard, F | 1 |
| Craft, N; Da-Cruz, AM; de Oliveira, MP; de Oliveira-Neto, MP; Maretti-Mira, AC; Pirmez, C | 1 |
| Butsashvili, M; Chubabria, G; Kajaia, M; Kamkamidze, G; Kokaia, N; McNutt, LA; Morse, DL; Zenaishvili, O | 1 |
| Achour, I; Chakroun, A; Charfeddine, I; Ghorbel, A; Hammami, B; Mnejja, M; Turki, H | 1 |
| Di Mauro, D; Petrillo, G; Viglianesi, A | 1 |
| Chrusciak Talhari, C; Chrusciak-Talhari, A; da Silva, RM; de Oliveira Penna, G; Dietze, R; Gadelha Yamashita, EP; Lima Machado, PR; Talhari, S | 1 |
| Abderrahim, E; Bacha, MM; Bahloul, A; Ben Abdallah, T; Ben Maïz, H; Chaouech, D; Cherif, M; Khaled, S; Kheder, A; Ounissi, M; Rajhi, H; Trabelsi, S; Turki, S; Znaidi, N | 1 |
| Dobakhti, F; Khalili, G; Khaze, V; Mahmoudzadeh-Niknam, H; Partovi, F | 1 |
| Layegh, P; Rahsepar, AA; Rahsepar, S | 1 |
| Alcântara, L; Carvalho, EM; Glesby, MJ; Guimarães, LH; Machado, PR; Morgan, DJ; Newlove, T | 1 |
| Descalzo, MA; Fraile, C; Gálvez, R; Miró, G; Molina, R | 1 |
| Ayadi, N; Béji, M; Bouomrani, S; Farah, A | 1 |
| Giudice, E; Passantino, A | 1 |
| Habibi, S; Handjani, F; Hatam, GH; Motazedian, MH; Pourmohammadi, B; Sarkari, B | 1 |
| Dabiri, S; Javadi, A; Nadji, M; Shamsi Meymandi, M; Shamsi Meymandi, S | 1 |
| Delgado, G; Granados, D; Mariño, A; Plaza, D; Sánchez, Y | 1 |
| Costa, MA; da Veiga-Júnior, VF; de Souza Lima, MM; Dias-Filho, BP; dos Santos, AO; Nakamura, CV; Ueda-Nakamura, T | 1 |
| Cuzzi, T; de Camargo Ferreira e Vasconcellos, E; de Fátima Madeira, M; de Matos Salgueiro, M; de Oliveira Schubach, A; Lambert Passos, SR; Mouta-Confort, E; Quintella, LP; Valete-Rosalino, CM | 1 |
| Borborema, SE; de Andrade, HF; do Nascimento, N; Osso, JA; Schwendener, RA | 1 |
| Barati, M; Fasihi Harandi, M; Hakimi Parizi, M; Khamesipour, A; Nakhaee, N; Nosratabadi, J; Sharifi, I; Shokri, A | 1 |
| Karoui, S; Osman, AB; Zaraa, I | 1 |
| Amaral, V; Campos, MC; Canto-Cavalheiro, MM; Charret, KS; Dos Reis, C; Echevarria, A; Leon, LL; Rodrigues, RF | 1 |
| Harms, G; Reiter-Owona, I; Richter, J; Scherbaum, H; Stich, A | 1 |
| Friedrich, K; Grimaldi, G; Marchevsky, RS; Miekeley, N; Paumgartten, FJ; Porrozzi, R; Vieira, FA | 1 |
| Korkmaz, M; Özbel, Y; Şakru, N; Töz, SÖ | 1 |
| de Souza, W; Godinho, JL; Rodrigues, JC; Silva, R; Simas-Rodrigues, C; Ürmenyi, TP | 1 |
| Garcerant, D; Gore Saravia, N; Miranda, MC; Montero, LM; Muvdi Arenas, S; Nicholls, RS; Osorio, L; Pérez, M; Prager, M; Rodríguez-Barraquer, I; Rojas, MX; Rubiano, LC | 1 |
| Amato, ME; De Palo, P; Greco, B; Lubas, G; Paradies, P; Sasanelli, M | 1 |
| Alvi, RU; Masood, S; Naveed, S | 1 |
| Aït-Oudhia, K; Dedet, JP; Gazanion, E; Lachaud, L; Oury, B; Pratlong, F; Sereno, D | 1 |
| Amorim, IF; Azevedo, EG; da Silva, SM; Demicheli, C; Frézard, F; Gontijo, NF; Melo, MN; Michalick, MS; Ribeiro, RR; Tafuri, WL | 1 |
| Abebe, Z; Dassoni, F; Morrone, A; Naafs, B | 1 |
| Case, AJ; Davis, GD; Hamid, H; Nadir, M; Robert, LL; Safi, N | 1 |
| Castillo, H; Diaz-Toro, Y; Fernández, O; Ovalle, C; Perez, M; Saravia, NG; Valderrama, L; Valderrama, M | 1 |
| Assareh, A; Azarian, B; Hadighi, R; Hajjaran, H; Mohebali, M; Vaziri, B | 1 |
| Forouzannia, SK; Pourrajab, F; Tabatabaee, SA | 1 |
| López, L; Robayo, M; Vargas, M; Vélez, ID | 1 |
| Baker, NC; Blanco, V; Craft, N; Garcerant, D; Martinez, J; Rubiano, L | 1 |
| Albuquerque, C; Campino, L; Cardoso, L; Dias, I; Machado, J; Pires, MA; Requicha, J; Sargo, T; Viegas, C | 1 |
| Andrade, LC; Daher, EF; Junior, GB; Libório, AB; Lima, CG; Martins, AM; Mota, RM; Oliveira, RA; Sanches, TR; Seguro, AC | 1 |
| Azeredo-Coutinho, RB; Baptista, C; de Oliveira, Rde V; Madeira, Mde F; Moreira, JS; Pimentel, MI; Salgueiro, Mde M; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM; Vasconcellos, Ede C | 1 |
| de Saldanha, RR; Martins-Papa, MC; Muniz-Junqueira, MI; Sampaio, RN | 1 |
| Esfandiarpour, I; Farajzadeh, S; Fathabadi, EA; Heshmatkhah, A; Rahnama, Z | 1 |
| Civitella, C; Guglielmini, C; Luciani, A; Sconza, S | 1 |
| Aguado-Lobo, M; Borbujo, J; Espinosa-Lara, P; García-Donoso, C; Martínez-Sánchez, D; Moreno-Torres, A; Romero-Maté, A; Tardío, JC | 1 |
| Donard, OF; Gleyzes, C; Grosso, O; Plau, B; Séby, F | 1 |
| Aguado, M; Borbujo, J; Córdoba, S; Gandolfo Cano, M; Huerta-Brogera, M; Martínez-Morán, C; Romero, A | 1 |
| Calla-Magariños, J; Fernández, C; Freysdottir, J; Giménez, A; Quispe, T; Troye-Blomberg, M | 1 |
| Dastgheib, L; Mirashe, Z; Naseri, M | 1 |
| Duffey, GB; Horton, LE; Paniz Mondolfi, AE; Perez-Alvarez, A; Reyes Jaimes, O; Tirado, M; Zerpa, O | 1 |
| Brelaz-de-Castro, MC; da Rocha, LF; de Almeida, AF; de Assis-Souza, M; de Oliveira, AP; Pereira, VR | 1 |
| Abreu, KL; Alves, MP; Daher, EF; Franco, LF; Jacinto, CN; Júnior, GB; Montenegro, BR; Oliveira, MJ; Rocha, NA; Sampaio, AM; Vieira, AP | 1 |
| Chakravarty, J; Sundar, S | 1 |
| Molinet, FJ; Noronha, EF; Romero, GA | 1 |
| Alborzi, A; Ghadimi Moghadam, A; Pouladfar, G; Pourabbas, B; Rezaee, Z | 1 |
| Cupolillo, E; Dávila, AM; Ribeiro-Alves, M; Romero, GA; Torres, DC | 1 |
| Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B | 1 |
| Behnaz, F; Golshan, Z; Mohammadzadeh, M | 1 |
| Emami, S; Momeni, A; Navaei, A; Rafienia, M; Rasoolian, M | 1 |
| Frézard, F; Salaün, P | 1 |
| Chatzis, MK; Kasabalis, D; Petanides, T; Saridomichelakis, MN; Steiner, JM; Suchodolski, JS; Xenoulis, PG | 2 |
| Cuervo, P; Marín-Villa, M; Muskus, CE; Peláez, RG | 1 |
| Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N | 1 |
| Antoniou, M; Christodoulou, V; Koutala, E; Mazeris, A; Messaritakis, I; Papadogiorgaki, S; Vlahou, A | 1 |
| Dowlati, Y; Firooz, A; Khamesipour, A; Khatami, A; Mehryan, P; Rahshenas, M; Talaee, R; Tehrani, S | 1 |
| Blum, JA; Hatz, C; Mosimann, V; Neumayr, A | 1 |
| Adibpour, N; Eskandari, A; Hashemitabar, M; Khademvatan, S; Rahim, F; Rezaee, S | 1 |
| Amorim, FM; Barbosa-Filho, JM; Caldas, JP; Leite, JA; Néris, PL; Oliveira, MR; Rodrigues, LC; Rodrigues, YK; Rodrigues-Mascarenhas, S | 1 |
| Andrade, HF; Borborema, SE; Nascimento, Nd; Osso, JA | 1 |
| Calvopiña, M; Hashiguchi, Y; Martinez, L | 1 |
| Abedkhojasteh, H; Hadighi, R; Hajjaran, H; Heidari, M; Kazemi-Rad, E; Khadem-Erfan, MB; Khamesipour, A; Mohebali, M; Raoofian, R; Rezaie, S; Saffari, M | 1 |
| Blanco, VM; Gómez, MA; Koren, R; Márquez, R; Navas, A; Rojas, LJ; Saravia, NG; Vargas, DA; Zilberstein, D | 1 |
| Botella Estrada, R; Escutia Muñoz, B; Torres Garcia, Y | 1 |
| Bento, DB; Dal-Pizzol, F; de Andrade, VM; de Souza, B; Dias, RO; Leffa, DD; Moreno, SE; Petronilho, F; Romão, PR; Steckert, AV | 1 |
| Giordano, A; Ibba, F; Meazzi, S; Paltrinieri, S; Rossi, G | 1 |
| Campos, PP; Demicheli, C; Dias Corrêa-Junior, J; Frézard, F; Kato, KC; Morais-Teixeira, E; Rabello, A; Reis, PG; Salaün, P; Silva-Barcellos, NM | 1 |
| Lenvers, P; Marty, P; Peyron, F | 1 |
| Mesquita, JT; Reimão, JQ; Tempone, AG | 1 |
| Barnadas, MA; Català, A; Muñoz, C; Puig, L | 1 |
| Batista, MA; Castro, RA; Ferreira, FM; Frézard, F; Moura, SA; Rezende, SA; Rossi, FM; Silveira-Lemos, D | 1 |
| Borges-Costa, J; Campino, L; Filipe, P; Lopes, L; Soares-Almeida, L; Vasconcelos, P | 1 |
| Jazayeri, SB; Shahlaee, A | 1 |
| Arboleda, M; Díaz, A; Jaramillo, L; Ortiz, D | 1 |
| Ghazizadeh, F; Jaafari, MR; Jabini, R; Karimi, G; Khamesipour, A; Vahdati Hasani, F | 1 |
| Aoun, K; Bouratbine, A | 1 |
| Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN | 1 |
| Chicharro, C; Lombardo, G; Lupo, T; Pennisi, MG; Solano-Gallego, L | 1 |
| Abbasi, A; Bavarsad, N; Fallah, M; Feizi, E; Jaafari, MR; Kalat, SA; Khamesipour, A; Khashayarmanesh, Z; Neghabi, K | 1 |
| Andrade, AP; Demicheli, C; Fernandes, FR; Ferreira, WA; Frézard, F; Islam, A | 1 |
| Ansari, S; Behnam, B; Mohebali, M; Sayyahfar, S | 1 |
| Diaz-Toro, Y; Fernández, OL; Gomez, MA; Muvdi, S; Ovalle, C; Rodríguez, I; Saravia, NG; Valderrama, L | 1 |
| Khamesipour, A; Khatami, A; Mortazavi, H; Soori, T; Vasheghani-Farahani, A | 1 |
| Attarwala, S; Saleem, M; Talat, H | 1 |
| Aoun, K; Badri, T; Ben Abda, I; Benmously-Mlika, R; Bouratbine, A; Chelbi, H; Fenniche, S; Hammami-Ghorbel, H; Mokhtar, I | 1 |
| Aoun, K; Benikhlef, R; Bouratbine, A; Faraut, F; Harrat, Z; Jeddi, F; Marty, P; Mary, C; Piarroux, R; Pomares, C; Pratlong, F | 1 |
| López Aventín, D; Martín-Ezquerra, G; Pujol, RM; Villar García, J | 1 |
| Azevedo, EG; da Silva, SM; de Oliveira E Castro, RA; de Souza, LE; Demicheli, C; Ferreira, AA; Ferreira, CS; Frézard, F; Rezende, SA; Ribeiro, RR | 1 |
| Barrio, A; Basombrío, MA; Cardozo, RM; Cimino, RO; de Raspi, EM; García Bustos, MF; Parada, LA; Parodi, C; Prieto, GG; Soto, J; Uncos, DA; Yeo, M | 1 |
| Coelho, DR; Miranda, ES; Paumgartten, FJ; Saint'Pierre, TD | 1 |
| Alves, MP; Daher, EF; Henn, GA; Martins, AM; Meneses, GC; Montenegro, BL; Oliveira, MJ; Rocha, HA; Sampaio, AM; Silva, GB | 1 |
| Fernández-Crehuet, P; Ruiz-Villaverde, R | 1 |
| Almeida, LP; Cantanhêde, LF; Castelo Branco, PV; Pereira, SR; Soares, RE | 1 |
| Berry, A; Charafeddine, K; Ghosn, N; Habib, RH; Issa, G; Khalifeh, H; Khalifeh, I; Rady, A; Saroufim, M | 1 |
| Kutlubay, Z; Polat, E | 1 |
| Baba, N; Boui, M; Frikh, R; Hjira, N; Lamsyah, H; Marcil, T; Oumakhir, S | 1 |
| Caro-Gutiérrez, D; Gamo Villegas, R; López-Estebaranz, JL; Pampín Franco, A; Pinedo, F | 1 |
| Barrio, A; Basombrio, MA; Beckar, J; Garcia Bustos, MF; Moreno, S; Parodi, C | 1 |
| Confort, EM; da Costa, DC; da Silva, AF; Madeira, Mde F; Martins, AC; Moreira, JS; Palmeiro, MR; Quintella, LP; Schubach, Ade O; Silva, Fda C; Valete-Rosalino, CM | 1 |
| Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-Martínez, R; Orte-Aldea, C; Whyte-Orozco, J | 1 |
| Coelho, DR; De-Carvalho, RR; Paumgartten, FJ; Rocha, RC; Saint'Pierre, TD | 1 |
| Alsina Gibert, M; Estrach, T; Fuertes, I; Giavedoni, P; Iranzo, P | 1 |
| Calvi, SA; da Silva, LD; de Abreu, MM; de Assis Golim, M; de Campos Soares, ÂM; Fortaleza, CM; Gatto, M; Simão, JC; Tasca, KI | 1 |
| Bhattacharjee, H; Charret, KS; Mandal, G; Mandal, S; Mukhopadhyay, R; Papadopoulou, B; Sharma, M | 1 |
| Baptista, C; Conceição-Silva, F; Leon, LL; Madeira, Mde F; Miranda, Lde F; Schubach, Ade O | 1 |
| El Benaye, J; El Haouri, M; Miloudi, M | 1 |
| Baños, I; Chicharro, C; Cuervas-Mons, V; García-Domínguez, J; Martinez-Ruiz, R; Múñez, E; Ramos, A; Suarez-Massa, D | 1 |
| de Arias, AR; Lima, AP; Maldonado, M; Pandolfi, E; Schinini, A; Serna, ME; Torres, S | 1 |
| Bertho, ÁL; Cunha, CF; Da-Cruz, AM; Ferraz, R; Gomes-Silva, A; Lyra, MR; Mendonça, SC; Pimentel, MI; Schubach, AO; Valete-Rosalino, CM | 1 |
| Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S | 1 |
| Aksoy, M; Özbilgin, A; Sürücü, HA; Turan, E; Yeşilova, Y | 1 |
| Aoun, K; Harrat, Z; Laamrani El Idrissi, A; Marty, P | 1 |
| Cardona-Arias, JA; López-Carvajal, L; Vélez, ID | 1 |
| Cerrone, A; Corso, R; Galiero, G; Gravino, AE; Manna, L; Muzj, P | 1 |
| Fernández, OL; Gonzalez-Fajardo, L; McMahon-Pratt, D; Saravia, NG | 1 |
| Barati, DA; Bojd, MS; Hemmati, M; Karamian, M; Salehabadi, A | 1 |
| Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Metin Timur, Ö; Mungan, M; Öz, N; Tanır, G; Yılmaz, N | 1 |
| Aksoy, M; Ardic, N; Oghumu, S; Satoskar, AR; Surucu, HA; Yesilova, A; Yesilova, Y | 1 |
| Ishkhanian, S; Shanehsaz, SM | 1 |
| de Barros, NB; de Figueiredo Nicolete, LD; Ferreira, Ados S; Macedo, SR; Nicolete, R | 1 |
| Chahed, J; Chouchène, C; Ksia, A; Mekki, M; Nouri, A | 1 |
| Azzabi, S; Boukhris, I; Cherif, E; Kechaou, I | 1 |
| Ahmadi, F; Bahrami, S; Esmaeilzadeh, S; Zarei, M | 1 |
| Aguiar, MG; de Morais-Teixeira, E; Ferreira, LA; Rabello, A; Soares de Souza Lima, B | 1 |
| El kartouti, A; Elbenaye, J; Miloudi, M | 1 |
| Aksakal, M; Serarslan, G | 1 |
| Çakalağaoğlu, F; Demirdal, T; El, S; Kaptan, F; Örmen, B; Özkan Çayıröz, P; Sezak, N; Türker, N; Ural, S; Vardar, İ | 1 |
| Araújo, EJ; Conchon-Costa, I; da Silva, SS; Fanti, JR; Felipe, I; Kawakami, NY; Miranda, MM; Mizokami, SS; Panis, C; Pavanelli, WR; Sforcin, JM; Teixeira, FH; Verri, WA; Watanabe, MA | 1 |
| Hatam, G; Moein, M; Taghavi-Moghadam, R; Zarshenas, MM | 1 |
| Khamesipour, A; Mohammadi, AM; Nateghi Rostami, M; Seyyedan Jasbi, E | 1 |
| Ezatpour, B; Kheirandish, F; Mahmoudvand, H; Rashidipour, M; Saedi Dezaki, E; Sharifi, I | 1 |
| Abbas, O; Alam, E; Khalifeh, I; Moukarbel, R | 1 |
| Araujo, VC; Arruda, CC; Carollo, CA; Kadri, MC; Matos, Mde F; Monteiro, PE; Oshiro, ET; Queiroz, DP; Rizk, YS; Rodrigues, PO | 1 |
| Bertho, AL; Cunha, CF; Da-Cruz, AM; Ferraz, R; Lyra, MR; Pimentel, MI; Schubach, AO | 1 |
| Abdolahi Khabisi, S; Davami, MH; Ghatee, MA; Naraki, T; Sarkari, B | 1 |
| Aït-Oudhia, K; Benbetka, S; Benikhlef, R; Eddaikra, N; Harrat, Z; Kherachi Djenad, I; Moulti-Mati, F; Oury, B; Sereno, D | 1 |
| Aristides, SM; Fernandes, AC; Lonardoni, MV; Pedroso, RB; Silveira, TG; Venazzi, EA; Zanzarini, PD | 1 |
| Hashemzadeh, S; Khoddami, M; Layegh, P; Rajabi, O | 1 |
| Azorin, D; Noguera-Morel, L; Xirotagaros, G | 1 |
| Altet, L; Di Filippo, L; Martínez-Orellana, P; Montserrat, S; Ordeix, L; Planellas, M; Roura, X; Solano-Gallego, L | 1 |
| Aristides, SM; de Mello, TF; Demarchi, IG; Donatti, L; Fernandes, AC; Lonardoni, MV; Pedroso, RB; Silveira, TG; Venazzi, EA | 1 |
| Andrade Junior, HF; Borborema, SE; Nascimento, Nd; Osso Junior, JA | 1 |
| Acedo-Sánchez, C; Corpas-López, V; Díaz-Sáez, V; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F | 1 |
| Brasileiro, A; García-Martinez, P; Giménez-Arnau, AM; Martín-Ezquerra, G; Pujol, RM | 1 |
| Albuquerque, DR; Cruz, AF; de Lacerda, JC; Ferreira Aguiar, MC; Leite, CF; Resende, RG | 1 |
| Bedoya, A; Cruz-Barrera, ML; Daza, CD; Echeverry, MC; Lopez, MC; Mariño, ML; Perez-Franco, JE; Robayo, ML; Saavedra, CH | 1 |
| Alonso, S; Laamrani El Idrissi, A; Najdi, A; Nejjari, C; Picado, A; Sicuri, E; Tachfouti, N | 1 |
| Andrade, MS; Corrêa-Júnior, JD; Demicheli, C; Fernandes, FR; Ferreira, LA; Frézard, F; Lanza, JS; Magalhães-Paniago, R; Melo, MN; Vilela, JM | 1 |
| Castanys, S; Corpas-López, V; Gamarro, F; García-Hernandez, R; Gómez Pérez, V; Martín-Sanchez, J; Tomás, AM | 1 |
| Hajaliloo, E; Hajjaran, H; Kazemi-Rad, E; Khadem-Erfan, MB; Mohebali, M; Oshaghi, MA; Raoofian, R; Reisi Nafchi, H | 1 |
| Behdani, R; Mazloum Farsi Baf, M; Sasannejad, P; Zabolinejad, N | 1 |
| Akhdari, N; Amal, S; Hocar, O; Ouadi, Z; Tassi, N | 1 |
| Alcántara, G; Checa, R; Chicharro, C; Cruz, I; de Quadros, LP; Gálvez, R; Hernández, L; Jiménez, MÁ; Mateo, M; Miró, G; Montoya, A | 1 |
| Cota, G; Rabello, A; Senna, MC; Silva, RE; Toledo, A | 1 |
| Arias-Santiago, S; Blasco-Morente, G; Martínez-López, A; Pérez-López, I | 1 |
| Corpas-López, V; Díaz-Sáez, V; Gijón-Robles, P; López-Viota, J; López-Viota, M; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Mancilla, MJ; Morillas-Márquez, F; Navarro Moll, MC | 1 |
| Barbosa, JF; Caligiorne, RB; de Figueiredo, SM; Lyon, S | 1 |
| Alborch, L; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L | 1 |
| Guo, Q; Liao, Q; Miao, R; Shu, M; Wan, C; Wang, Z; Wen, Y; Zhu, Y | 1 |
| Cerón, JJ; Escribano, D; Kocaturk, M; Martínez-Subiela, S; Pardo-Marín, L; Torrecillas, A; Tvarijonaviciute, A; Yilmaz, Z | 1 |
| Alborzi, A; Attar, A; Falahi, F; Jafarpour, Z; Kadivar, MR; Karimi, A; Pouladfar, G | 1 |
| Barud, HS; Borges, VM; Celes, FS; de Oliveira, CI; Khouri, R; Ribeiro, SJ; Trovatti, E; Van Weyenbergh, J | 1 |
| Omidian, E; Radmanesh, M | 1 |
| Carvalho de Castro, E; de Araújo-Melo, MH; de Oliveira Schubach, A; de Vasconcellos Carvalhaes Oliveira, R; do Nascimento Brahim Paes, LR; Jardim Duarte, CC; Oliveira Bezerra, DC; Oliveira de Barcelos, R; Pereira Bom Braga, F; Ramos Ferreira Terceiro, B; Salgado de Sousa Torraca, T; Valete-Rosalino, CM | 1 |
| Handjani, F; Hatam, GR; Mohammadpour, I; Motazedian, MH | 2 |
| Abamor, ES; Allahverdiyev, AM; Bagirova, M; Rafailovich, M | 1 |
| Cerón, JJ; Garcia-Martinez, JD; Martínez-Subiela, S; Pardo-Marín, L; Pastor, J; Segarra, S; Tvarijonaviciute, A | 1 |
| Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J | 1 |
| Abbasi, I; Aguirre, C; Calvopina, M; Castillo, A; Cevallos, W; Warburg, A | 1 |
| Marcoval, J; Penín, RM | 1 |
| Alcolea, V; Díaz, M; Espuelas, S; Gutiérrez-Sánchez, R; Marín, C; Martín-Escolano, R; Martín-Montes, Á; Moreno, E; Pérez-Silanes, S; Plano, D; Sánchez-Moreno, M; Sanmartín, C | 1 |
| Damrose, E; Fernandes, AM; Silva, L | 1 |
| Castro, MDM; Cossio, A; Osorio, L; Velasco, C | 1 |
| Bartlett, AH; Berger, BA; Castro, MDM; Cossio, A; Pho, MT; Prada, S; Saravia, NG | 1 |
| Adinehbeigi, K; Bahrami, S; Razi Jalali, MH; Shahriari, A | 1 |
| Romanha, AJ; Romero, I; Soares, MJ; Steindel, M; Téllez, J | 1 |
| Ayatollahi, J; Bafghi, AF; Shahcheraghi, SH | 1 |
| Godarzi, H; Heiran, A; Saki, N | 1 |
| Antônio, LF; Bedoya-Pacheco, SJ; Fagundes, A; Lyra, MR; Madeira, MF; Marzochi, MCA; Mouta-Confort, E; Passos, SRL; Pimentel, MIF; Ribeiro, MN; Saheki, MN; Salgueiro, MM; Santos, GPLD; Schubach, AO; Valete-Rosalino, CM; Vasconcellos, ÉCFE | 1 |
| Kazuma, FJ; Membrive, NA; Reinhold-Castro, KR; Silveira, TGV; Teixeira, JJV; Teodoro, U | 1 |
| Alves, FP; Amaral, TA; Costa, CHN; Costa, DL; de Almeida, RP; de Carvalho, AL; de Carvalho, SFG; de Melo, EV; Leite, RD; Lima, SS; Rabello, A; Rode, J; Romero, GAS; Sousa, AQ | 1 |
| Anversa, L; Batista, LR; Cuba, MB; Dias da Silva, VJ; Martins, TY; Nogueira Nascentes, GA; Ramirez, LE; Richini Pereira, VB; Ruiz, LDS; Salles Tiburcio, MG | 1 |
| García, M; Monzote, L; Satyal, P; Scull, R; Setzer, WN | 1 |
| Burchmore, R; Ceron, JJ; Escribano, D; Horvatic, A; Kocaturk, M; Martinez-Subiela, S; Mrljak, V; Pardo-Marin, L; Yilmaz, Z | 1 |
| Brito, NC; Cota, GF; Rabello, A | 1 |
| da Silva Pacheco, R; de Fatima Madeira, M; de Oliveira Schubach, A; Fernandes Pimentel, MI; Gagini, T; Maria Valete-Rosalino, C | 1 |
| Calvopiña, M; Cevallos, W; Flores, J; Loor, R; Padilla, J; Paredes, Y; Puebla, E | 1 |
| Alexandre-Pires, G; Alves-Azevedo, R; de Jesus, J; Ligeiro, D; Lopes-Ventura, S; Pereira da Fonseca, I; Pereira, MA; Rafael-Fernandes, M; Rodrigues, A; Santos, M; Santos-Gomes, G; Santos-Mateus, D; Tomás, AM; Valério-Bolas, A | 1 |
| Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Baneth, G; Marí-Martorell, D; Martínez-Orellana, P; Montserrat-Sangrà, S; Ordeix, L; Solano-Gallego, L | 1 |
| Antônio, LF; Brahim, LR; Costa, ADD; Dias, CMG; Duque, MCO; Lyra, MR; Marzochi, MCA; Paes, LEC; Pimentel, MIF; Schubach, AO; Valete-Rosalino, CM; Vieira, IF | 1 |
| Cedeño, DL; Fernandez, M; Jones, MA; Murillo, J; Ocampo-Cardona, R; Ríos-Vásquez, LA; Robledo, SM; Velez, ID | 1 |
| Carvalho, JP; Cota, E; Cota, G; Moreira, HSA; Rabello, A; Ramalho, DB; Senna, MCR; Silva, RED | 1 |
| Bruno, O; Denis, S; Ihcene, KD; Khatima, AO; Naouel, E; Razika, B; Sofiane, B; Zoubir, H | 1 |
| Aydın Teke, T; Gayretli Aydın, ZG; Kaman, A; Metin, Ö; Mungan, M; Öz, FN; Tanır, G | 1 |
| Cordeiro-da-Silva, A; Dantas-Torres, F; Miró, G; Travi, BL | 1 |
| Azevedo, EG; Caliari, MMV; Castro, RS; de Amorim, IFG; Demicheli, C; Frezard, FJG; Michalick, MSM; Mosser, DM; Pereira, RA; Pinheiro, LJ; Pinto, AJW; Silva, SM; Tafuri, WL | 1 |
| Cardona-Arias, JA; López-Carvajal, L; Tamayo-Plata, MP; Vélez, ID | 1 |
| Acedo-Sánchez, C; Corpas-López, V; Díaz-Sáez, V; Martín-Sánchez, J; Merino-Espinosa, G; Morillas-Márquez, F; Navarro-Moll, MC | 1 |
| Abbas, D; Masoud, D; Moein, D; Saeed, M | 1 |
| Bordignon, J; Conchon Costa, I; Costa, IN; da Silva, SS; Fanti, JR; Felipe, I; Mizokami, SS; Pavanelli, WR; Verri, WA | 1 |
| Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Pardo-Marín, L; Segarra, S | 1 |
| Carneiro de Freitas, JC; Macedo Rondon, FC; Maia de Morais, S; Pereira Mendes, FN; Pinto Vieira, ÍG; Vieira-Araújo, FM | 1 |
| Bernal, LJ; Cantos-Barreda, A; Cerón, JJ; Escribano, D; Martínez-Subiela, S; Tecles, F | 1 |
| Çavuş, İ; Ertabaklar, H; Kaya, T; Özbilgin, A; Yıldırım, A | 1 |
| Clavijo, A; Gavilan, C; González de Dios, J; Moral, L; Ramos, JM; Salvador, T | 1 |
| Bamorovat, M; Derakhshanfar, A; Keyhani, AR; Khosravi, A; Mosallanejad, SS; Salari, Z; Sharifi, I; Tavakkoli, H | 1 |
| Borborema, SET; de Andrade Junior, HF; do Nascimento, N; Osso Junior, JA; Tempone, AG | 1 |
| Almeida, TC; da Silva, ATP; da Silva, GN; Perasoli, FB; Rezende, SA; Silva, DF; Silva, SC | 1 |
| Avelar, DM; Cota, G; Moreira, HSA; Pedras, MJ; Rabello, A; Ramalho, DB; Saraiva, L; Senna, MCR; Silva, RED | 1 |
| Carbone, DCB; Carvalho, CME; Cônsolo, FZ; Muller, KTC; Reis, VQD; Sanches, SC; Silva, MC; Zanoni, LZG | 1 |
| Alves, J; Barreiros, H; Bonito, F; Costin, A | 1 |
| Bartoloni, A; Bartolozzi, D; Corsi, P; Di Muccio, T; Gramiccia, M; Spinicci, M; Trotta, M; Zammarchi, L | 1 |
| Abbasi Shaye, Z; Ghanizadeh, S; Layegh, P; Salehi, M; Zabolinejad, N | 1 |
| Braz, LMA; Celeste, BJ; Goto, H; Lindoso, JAL; Oyafuso, LKM; Ramos-Sanchez, EM; Reis, LC; Yamashiro-Kanashiro, EH | 1 |
| Bonacci, S; Britti, D; Bruno, F; Castelli, G; Cosco, D; Fresta, M; Paolino, D; Procopio, A; Puleio, R; Vitale, F | 1 |
| Clevenbergh, P; Mervillie, K; Mostmans, Y; Richert, B; Van Gysel, J; Vanden Nest, H | 1 |
| Alvarez, F; Arana, B; Boni, M; Echevarria, J; Jiménez, A; Llanos-Cuentas, A; López, L; Méndez, C; Quintero, J; Ramos, AP; Rode, J; Tabares, Y; Valencia, B; Vélez, I | 1 |
| Alahdin, S; Almani, PGN; Babaei, Z; Bamorovat, M; Keyhani, A; Mohseni, F; Mostafavi, M; Nave, HH; Oliaee, RT; Salarkia, E; Sarlak, M; Sharifi, F; Sharifi, I; Tavakoly, R | 1 |
| Aflatoonian, MR; Bahrami, M; Eskandari, SE; Fekri, A; Firooz, A; Ghoorchi, M; Javadi, A; Khamesipour, A; Khatami, A; Sharifi, I | 1 |
| Aounallah, A; Belajouza, C; Denguezli, M; Lahouel, M; Manaa, L; Mkhinini, H; Salah, NB | 1 |
| Afshari, F; Eskandari, S; Firooz, A; Jaafari, M; Javadi, A; Khamesipour, A; Mohammadi, A; Mortazavi, H; Tasbihi, M | 1 |
| Bacellar, O; Carvalho, EM; Fraga, D; Guimarães, LH; Lago, E; Lago, J; Lago, T; Silva, YJ; Werneck, GL | 1 |
| Carvalho, AG; Carvalho, CDP; Carvalho, RDP; Dias, JVL; Luz, JGG; Pires, HHR | 1 |
| Darchini-Maragheh, E; Derakhshan, Z; Mashayekhi Goyonlo, V | 1 |
| Amato, VS; Cota, G; França, AO; Francesconi, F; Hueb, M; Lyra, MR; Oliveira, LFA; Oliveira, RVC; Pimentel, MIF; Pompilio, MA; Rodrigues, BC; Sampaio, RNR; Schubach, AO; Silva, RE; Souza, RM; Valete, CM | 1 |
39 review(s) available for meglumine antimoniate and meglumine
| Article | Year |
|---|---|
Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
Topics: Adult; Allopurinol; Animals; Antimony; Antiprotozoal Agents; Graft Rejection; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Methylprednisolone; Muromonab-CD3; Organometallic Compounds | 1992 |
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Mechlorethamine; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine | 1991 |
Cutaneous leishmaniasis in French Guiana: a review.
Topics: Animals; Antiprotozoal Agents; Disease Reservoirs; French Guiana; Humans; Insect Vectors; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae | 1990 |
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
Mucosal leishmaniasis ("espundia" Escomel, 1911).
Topics: Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
[Treatment of cutaneous leishmaniasis].
Topics: Antiprotozoal Agents; Humans; Hyperthermia, Induced; Immunotherapy; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
[Visceral kala-azar of Spanish origin. Apropos of a case].
Topics: Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1988 |
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
[Kala-azar. Presentation of 7 cases and review of the literature].
Topics: Antimony; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Chemotherapy and the immune response in protozoal infections.
Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibody Formation; Antimalarials; Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Immunity, Cellular; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Protozoan Infections | 1981 |
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Leishmaniasis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines; Vaccination | 1993 |
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Drug Carriers; Drug Resistance; Follow-Up Studies; HIV-1; Humans; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
[Treatment of infantile visceral leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Resistance; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome | 1999 |
Visceral leishmaniasis in clinical practice.
Topics: AIDS-Related Opportunistic Infections; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
Cutaneous leishmaniasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Life Cycle Stages; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence; Skin | 2000 |
[Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Substance Abuse, Intravenous | 2000 |
Chemotherapy of cutaneous leishmaniasis: a review.
Topics: Antifungal Agents; Antimony; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Ointments; Organometallic Compounds; Phosphorylcholine | 2001 |
Visceral leishmaniasis in paediatrics.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Child; Disease Vectors; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence | 2002 |
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2003 |
[Cutaneous leishmaniasis].
Topics: Amphotericin B; Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Controlled Clinical Trials as Topic; Diagnosis, Differential; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Photochemotherapy; Time Factors | 2003 |
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases].
Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
[Visceral leishmaniasis: new drugs].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2003 |
[Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients].
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Child; Clinical Trials as Topic; Drug Utilization; Humans; Immunocompetence; Italy; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome | 2004 |
[Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cluster Analysis; Disease Outbreaks; Female; Humans; Infant; Italy; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Morbidity; Organometallic Compounds; Retrospective Studies | 2004 |
[Current situation and future of antileishmanial therapy in Colombia].
Topics: Antimony; Antiprotozoal Agents; Colombia; Forecasting; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Developing Countries; Endemic Diseases; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine | 2008 |
Anticancer compounds as leishmanicidal drugs: challenges in chemotherapy and future perspectives.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antiprotozoal Agents; Apoptosis; Humans; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Organoplatinum Compounds; Oxyquinoline; Phospholipids; Topoisomerase II Inhibitors | 2008 |
Combination therapy for visceral leishmaniasis.
Topics: Amphotericin B; Antiprotozoal Agents; Asia; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Europe; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Safety; South Africa | 2010 |
New delivery strategies for the old pentavalent antimonial drugs.
Topics: Administration, Oral; Administration, Topical; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Delivery Systems; Humans; Leishmaniasis; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2010 |
Intermediate/borderline disseminated cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Child; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2013 |
Leishmaniasis: an update of current pharmacotherapy.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome | 2013 |
Cutaneous leishmaniasis in North Africa: a review.
Topics: Africa, Northern; Animals; Antiprotozoal Agents; Climate; Disease Outbreaks; Disease Reservoirs; Endemic Diseases; Humans; Incidence; Insect Vectors; Leishmania infantum; Leishmania major; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Rodentia; Virulence; Zoonoses | 2014 |
Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials.
Topics: Confidence Intervals; Controlled Clinical Trials as Topic; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Treatment Outcome | 2015 |
Cutaneous Leishmaniasis of the Eyelids: A Case Series with Molecular Identification and Literature Review.
Topics: Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Cytological Techniques; Eyelid Diseases; Eyelids; Female; Humans; Infant; Injections, Intramuscular; Iran; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Microbiological Techniques; Microscopy; Organometallic Compounds; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Lip leishmaniasis: a case series with molecular identification and literature review.
Topics: Adult; Aged; Animals; Child; Child, Preschool; Diagnosis, Differential; Female; Humans; Iran; Leishmania infantum; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Treatment Outcome | 2017 |
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cryotherapy; Databases, Factual; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2017 |
Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Molecular Diagnostic Techniques; Organometallic Compounds; Phosphorylcholine; Point-of-Care Systems; Serologic Tests | 2018 |
94 trial(s) available for meglumine antimoniate and meglumine
| Article | Year |
|---|---|
Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.
Topics: Adolescent; Adult; Aged; Animals; Brazil; Child; Child, Preschool; Female; Humans; Immunotherapy, Active; Leishmania; Leishmania guyanensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Protozoan Vaccines | 1992 |
Allopurinol in the treatment of American cutaneous leishmaniasis.
Topics: Allopurinol; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Allopurinol in the treatment of American cutaneous leishmaniasis.
Topics: Adolescent; Adult; Allopurinol; Antimony; Antiprotozoal Agents; Child, Preschool; Developing Countries; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Follow-Up Studies; Guatemala; Hot Temperature; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Personnel; Organometallic Compounds; Radio Waves; Randomized Controlled Trials as Topic; Sorbitol | 1990 |
Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy.
Topics: Adult; Antigens, Protozoan; BCG Vaccine; Clinical Trials as Topic; Female; Humans; Immunity, Cellular; Immunotherapy; Leishmaniasis; Leukocytes; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Tests | 1989 |
Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antibodies; Antigens, Protozoan; Antiprotozoal Agents; Child; Clinical Trials as Topic; Female; Humans; Immunotherapy; Leishmania mexicana; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Random Allocation; Skin Tests; Sorbitol; Vaccination | 1987 |
Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
Topics: Adolescent; Algeria; Antimony; Antiprotozoal Agents; Child; Clinical Trials as Topic; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin | 1995 |
Treatment of recurrent cutaneous Leishmaniasis.
Topics: Adolescent; Adult; Aged; Allopurinol; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome | 1995 |
Treatment of Mediterranean visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Europe; Humans; Infant; Leishmaniasis, Visceral; Liposomes; Mediterranean Islands; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1995 |
Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Combined Modality Therapy; Dog Diseases; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Lymphocytes; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Tests; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Neutropenia; Organometallic Compounds; Superinfection; Treatment Outcome | 1994 |
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Health Care Costs; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Neutropenia; Organometallic Compounds; Pilot Projects; Recombinant Proteins; Severity of Illness Index | 1994 |
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Allopurinol; Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Data Interpretation, Statistical; Female; Follow-Up Studies; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Organometallic Compounds; Recurrence; Retrospective Studies; Time Factors | 1996 |
Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial.
Topics: Adult; Allopurinol; Antimetabolites; Antimony; Antiprotozoal Agents; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Failure | 1997 |
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Treatment of American cutaneous leishmaniasis: a comparison between low dosage (5 mg/kg/day) and high dosage (20 mg/kg/day) antimony regimens.
Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
A low-dose antimony treatment in 159 patients with American cutaneous leishmaniasis: extensive follow-up studies (up to 10 years).
Topics: Adolescent; Adult; Age Factors; Animals; Antiprotozoal Agents; Brazil; Child; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mucous Membrane; Organometallic Compounds; Recurrence; Treatment Failure | 1997 |
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Topics: Antiprotozoal Agents; Benzethonium; Double-Blind Method; Drug Therapy, Combination; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin | 1998 |
Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.
Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 1997 |
Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Spain; Treatment Outcome | 1999 |
Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 1999 |
A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran.
Topics: Administration, Topical; Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Plant Extracts; Treatment Outcome | 1999 |
Clinical follow-up examination after treatment of canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 1998 |
Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Europe; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies | 2000 |
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Female; Humans; Imiquimod; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2001 |
Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunotherapy, Active; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |
Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
Topics: Adolescent; Adult; Allopurinol; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2002 |
Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adolescent; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Ketoconazole; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2001 |
Antimonial therapy induces circulating proinflammatory cytokines in patients with cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Cytokines; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
Topics: Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin; Treatment Outcome | 2003 |
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Treatment Outcome | 2003 |
Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.
Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Female; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
Topics: Adult; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2004 |
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
Topics: Administration, Topical; Adolescent; Adult; Animals; Antiprotozoal Agents; Benzethonium; Double-Blind Method; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Urea | 2004 |
Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiprotozoal Agents; Case-Control Studies; Child; Child, Preschool; Double-Blind Method; Female; Humans; Injections, Intralesional; Injections, Subcutaneous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Sulfate | 2004 |
Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Carbon Dioxide; Child; Female; Humans; Laser Therapy; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2004 |
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Female; Humans; Infusions, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Peru; Treatment Outcome | 2005 |
Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antiprotozoal Agents; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imiquimod; Infant; Injections, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Peru | 2005 |
Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Cytokines; Female; Hot Temperature; Humans; Interferon-gamma; Interleukin-10; Interleukin-5; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Female; Humans; Injections, Intralesional; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Ointments; Organometallic Compounds; Paromomycin; Treatment Outcome | 2005 |
Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
Topics: Adolescent; Adult; Aging; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2006 |
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
Topics: Adult; Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2006 |
Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Agents; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Treatment Outcome | 2006 |
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Combined Modality Therapy; Cryotherapy; Humans; Injections, Intralesional; Iran; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
Characterization of circulating lymphocyte subpopulations in canine leishmaniasis throughout treatment with antimonials and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmaniasis, Cutaneous; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors | 2007 |
Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Animals; Antimony; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Single-Blind Method; Treatment Outcome | 2006 |
Miltefosine in cutaneous leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Hot Temperature; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiofrequency Therapy | 2007 |
Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Drug Therapy, Combination; Honey; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Treatment Outcome | 2007 |
Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Animals; Antiprotozoal Agents; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Imiquimod; Injections, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pilot Projects; Treatment Outcome | 2007 |
Parenteral aminosidine is not effective for Peruvian mucocutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Humans; Infusions, Parenteral; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Nasal Mucosa; Organometallic Compounds; Paromomycin | 2007 |
Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Female; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Zoonoses | 2007 |
Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adult; Antiprotozoal Agents; Azithromycin; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2007 |
A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Topics: Administration, Oral; Adult; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Argentina; Azithromycin; Endemic Diseases; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2007 |
Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Bolivia; Child; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Time Factors; Treatment Outcome | 2008 |
Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
Topics: Adolescent; Adult; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome | 2008 |
Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmaniasis; Meglumine; Meglumine Antimoniate; Metronidazole; Organometallic Compounds; Spiramycin; Treatment Outcome | 2008 |
Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Cryotherapy; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2009 |
A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Omeprazole; Organometallic Compounds; Treatment Outcome; Young Adult | 2008 |
Effects of therapy on haemostasis in dogs infected with Leishmania infantum, Ehrlichia canis, or both combined.
Topics: Allopurinol; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dog Diseases; Dogs; Doxycycline; Drug Combinations; Ehrlichia canis; Ehrlichiosis; Enzyme Inhibitors; Female; Hemostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Treatment Outcome | 2009 |
Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreas | 2009 |
Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Endemic Diseases; Humans; Insect Bites and Stings; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pakistan; Psychodidae; Young Adult | 2009 |
Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2009 |
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.
Topics: Animals; Antiprotozoal Agents; Brazil; Dogs; Immunotherapy; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.
Topics: Administration, Topical; Adolescent; Adult; Colombia; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nitric Oxide; Organometallic Compounds; Treatment Outcome; Young Adult | 2010 |
Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Injections, Intralesional; Laser Therapy; Lasers, Gas; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Time Factors; Treatment Outcome; Young Adult | 2011 |
Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.
Topics: Adult; Antiprotozoal Agents; Capsules; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Phosphorylcholine; Young Adult | 2010 |
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Protozoan; Antibody Formation; Antigens, Protozoan; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polyproteins; Protozoan Vaccines; Recombinant Proteins; Young Adult | 2010 |
Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: comparison of conventional technique with mesotherapy gun.
Topics: Acute Disease; Adolescent; Adult; Child; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesotherapy; Organometallic Compounds; Pain; Treatment Outcome; Young Adult | 2010 |
Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Treatment Outcome; Young Adult | 2011 |
Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.
Topics: Adolescent; Adult; Age Factors; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Medication Adherence; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2011 |
Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis.
Topics: Adolescent; Adult; Anthelmintics; Antiprotozoal Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helminthiasis; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2011 |
Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.
Topics: Administration, Oral; Antiprotozoal Agents; Child; Child, Preschool; Colombia; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Treatment Failure | 2012 |
Monitoring the reverse to normal of clinico-pathological findings and the disease free interval time using four different treatment protocols for canine leishmaniosis in an endemic area.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Endemic Diseases; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors | 2012 |
Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.
Topics: Adolescent; Adult; Afghan Campaign 2001-; Aged; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Hyperthermia, Induced; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.
Topics: Adult; Aged; Antiprotozoal Agents; Chi-Square Distribution; Colombia; Drug Administration Schedule; Female; Health Facilities; Humans; Hyperthermia, Induced; Injections, Intramuscular; Kaplan-Meier Estimate; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Facilities; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome | 2012 |
Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
Topics: Administration, Oral; Adult; Allopurinol; Anti-Bacterial Agents; Antimetabolites; Antiprotozoal Agents; Azithromycin; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2012 |
Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Antiprotozoal Agents; Bandages; Child; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Young Adult | 2013 |
[Miltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis].
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Comparative Effectiveness Research; Female; Humans; Injury Severity Score; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nasopharynx; Organometallic Compounds; Phosphorylcholine; Young Adult | 2014 |
Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Retrospective Studies | 2015 |
A comparative study between the efficacy of oral cimetidine and low-dose systemic meglumine antimoniate (MA) with a standard dose of systemic MA in the treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Adolescent; Adult; Antiprotozoal Agents; Child; Cimetidine; Double-Blind Method; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome; Young Adult | 2015 |
Topical liposomal azithromycin in the treatment of acute cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Cutaneous; Adolescent; Adult; Antiprotozoal Agents; Azithromycin; Child; Drug Administration Schedule; Female; Humans; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Young Adult | 2016 |
Effectiveness of Short-Course Meglumine Antimoniate (Glucantime®) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran.
Topics: Child, Preschool; Cohort Studies; Drug Administration Schedule; Humans; Iran; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Retrospective Studies | 2017 |
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.
Topics: Brazil; Dose-Response Relationship, Drug; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2017 |
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult | 2017 |
Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Monocyclic Sesquiterpenes; Organometallic Compounds; Parasite Load; Sesquiterpenes; Treatment Outcome | 2018 |
Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult | 2018 |
A phase II multicenter randomized study to evaluate the safety and efficacy of combining thermotherapy and a short course of miltefosine for the treatment of uncomplicated cutaneous leishmaniasis in the New World.
Topics: Adult; Antiprotozoal Agents; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Treatment Outcome | 2022 |
Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial.
Topics: Antiprotozoal Agents; Humans; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2022 |
Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pilot Projects; Treatment Outcome | 2022 |
Efficacy of intralesional meglumine antimoniate in the treatment of canine tegumentary leishmaniasis: A Randomized controlled trial.
Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saline Solution; Ulcer | 2023 |
A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.
Topics: Antiprotozoal Agents; Brazil; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2023 |
668 other study(ies) available for meglumine antimoniate and meglumine
| Article | Year |
|---|---|
Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Naphthoquinones; Organometallic Compounds; Plant Extracts | 1992 |
Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
Topics: Animals; Antiprotozoal Agents; Disease Reservoirs; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Female; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1992 |
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Visceral and cutaneous leishmaniasis in an European paediatric population.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1992 |
Subacute toxicity of pentavalent antimony compounds in rats.
Topics: Alkaline Phosphatase; Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Bilirubin; Blood Cell Count; Blood Urea Nitrogen; Creatinine; Dose-Response Relationship, Drug; Female; Hemoglobins; Kidney; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats; Weight Gain | 1992 |
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania donovani; Leukemia, Monocytic, Acute; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine; Species Specificity; Tumor Cells, Cultured | 1992 |
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; Female; HIV-1; Hospitals, University; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Retrospective Studies; Spain; Treatment Outcome | 1992 |
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cholesterol Esters; Cricetinae; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Treatment of visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
[Parasitological and immunological progress control during and after chemotherapy of canine leishmaniasis].
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania donovani; Leishmaniasis, Visceral; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
[Visceral leishmaniasis: a study of 15 cases].
Topics: Age Factors; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Serologic Tests; Sex Factors; Spain | 1992 |
Oriental sore: a case report.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Lip Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1992 |
Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO).
Topics: Animals; Antimony; Antimony Sodium Gluconate; Drug Synergism; Drug Therapy, Combination; Eflornithine; Female; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Succimer; Tartrates; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome | 1991 |
In vitro activity of meglumine antimoniate, a pentavalent antimonial drug, on Leishmania promastigotes.
Topics: Animals; Antimony; Antiprotozoal Agents; In Vitro Techniques; Leishmania; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors | 1991 |
Tumor necrosis factor (cachectin) in human visceral leishmaniasis.
Topics: Acute Disease; Antimony; Antiprotozoal Agents; Cells, Cultured; Combined Modality Therapy; Female; Humans; Interferon-gamma; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Development of Leishmania (Viannia) panamensis lesions and relationship of numbers of amastigotes to lesion area on antimony-treated and untreated hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1991 |
Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
Topics: Animals; Antiprotozoal Agents; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pyrazoles; Pyrimidines; Structure-Activity Relationship | 1991 |
Interferon gamma therapy for cutaneous leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Interferon-gamma; Leishmania tropica; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins | 1990 |
Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.
Topics: Adenosine; Animals; Antimony Sodium Gluconate; Drug Resistance; Eflornithine; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1990 |
Diffuse cutaneous leishmaniasis acquired in Peru.
Topics: Adult; Antimony; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Skin | 1990 |
[Cutaneous leishmaniasis: treatment with cryotherapy and intramuscular injections of meglumine antimonate (glucantime)].
Topics: Adult; Combined Modality Therapy; Cryosurgery; Female; Humans; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Otitis Externa; Sorbitol | 1990 |
Fatal visceral disease caused by a dermotropic Leishmania in a patient with human immunodeficiency virus infection.
Topics: Adult; Animals; Antiprotozoal Agents; HIV Infections; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1990 |
Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate.
Topics: Adolescent; Adult; Aged; Antimony; Biopsy; Child; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intravenous; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Neutron Activation Analysis; Organometallic Compounds; Random Allocation; Skin; Sorbitol | 1990 |
Berberine derivatives as antileishmanial drugs.
Topics: Animals; Antiprotozoal Agents; Berberine; Berberine Alkaloids; Body Weight; Cricetinae; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Skin | 1990 |
In vivo effect of eflornithine (DFMO) and some related compounds on Leishmania infantum preliminary communication.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Eflornithine; Leishmania donovani; Leishmaniasis, Visceral; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1989 |
[Cutaneous leishmaniasis].
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1989 |
An in vitro micromethod for drug sensitivity testing of Leishmania.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors | 1989 |
[Kala-azar. Apropos of a case report in a Belgian woman].
Topics: Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1989 |
Retention of antimony in hair during leishmaniasis treatment.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Administration Schedule; Hair; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1989 |
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Opportunistic Infections; Organometallic Compounds; Serologic Tests; Spain; Trypanocidal Agents | 1989 |
[Visceral leishmaniasis with benign course in a patient infected with human immunodeficiency virus].
Topics: Acquired Immunodeficiency Syndrome; Adult; Allopurinol; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis | 1989 |
[Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
Topics: Adult; Antimony Sodium Gluconate; Drug Evaluation; Female; Gluconates; Humans; Immunologic Techniques; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Sorbitol | 1987 |
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Pentavalent antimonial treatment in mucosal leishmaniasis.
Topics: Antimony; Drug Administration Schedule; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nifurtimox; Nitrofurans; Organometallic Compounds | 1985 |
Recurrences of tegumentary leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence | 1985 |
Chemotherapy of experimental visceral leishmaniasis in the opossum.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Body Weight; Female; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Opossums; Organ Size; Organometallic Compounds; Sorbitol; Spleen | 1989 |
Kala azar with disseminated dermal leishmaniasis.
Topics: Adolescent; Antiprotozoal Agents; Biopsy; Child; Female; Humans; Iran; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Sorbitol | 1989 |
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.
Topics: Animals; Antigens, Protozoan; Antimony; Immune Tolerance; Interleukin-2; Leishmania donovani; Leishmaniasis, Visceral; Lymphocyte Activation; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds; Spleen; T-Lymphocytes, Regulatory | 1985 |
[Kala-azar in pregnant women].
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Infectious | 1986 |
Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Insect Vectors; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus | 1987 |
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
[Glucantime and allopurinol in the treatment of persistent infantile visceral leishmaniasis].
Topics: Allopurinol; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunologic Tests; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Severe leucopenia during treatment of visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmaniasis, Visceral; Leukocyte Count; Leukopenia; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
Glomerulonephritis in dogs with canine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Complement C3; Dog Diseases; Dogs; Glomerulonephritis; Immunoglobulin G; Kidney; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
Visceral leishmaniasis in a patient with human immunodeficiency virus.
Topics: Adult; AIDS-Related Complex; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Italy; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1988 |
Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily.
Topics: Adult; Aged; Female; Freezing; Humans; Interleukin-1; Interleukin-2; Leishmaniasis, Visceral; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phytohemagglutinins; Tissue Preservation | 1988 |
[Leishmaniasis of the genital organs].
Topics: Adult; Aged; Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Penile Diseases; Penile Neoplasms | 1987 |
Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
Topics: Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sorbitol | 1988 |
[Sensitivity of Leishmania spp. to antimony derivatives. Use of mouse peritoneal macrophages].
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Leishmania; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peritoneal Cavity; Sorbitol | 1987 |
Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected].
Topics: Animals; Antiprotozoal Agents; Bolivia; Cricetinae; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin | 1987 |
[Culture systems for production of promastigote and amastigote forms of Leishmania. Application to serological diagnosis and therapeutic trials].
Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Culture Media; Fluorescent Antibody Technique; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Serologic Tests; Time Factors | 1986 |
The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis.
Topics: Humans; Immunotherapy; Leishmania mexicana; Leishmaniasis; Leprosy; Meglumine; Meglumine Antimoniate; Mycobacterium leprae; Organometallic Compounds; Vaccination | 1986 |
Activity of purine analogs against Leishmania donovani in vivo.
Topics: Administration, Oral; Allopurinol; Animals; Cricetinae; Formycins; Guanosine; Injections, Intramuscular; Inosine; Leishmania donovani; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Saimiri; Spleen | 1987 |
In vitro and in vivo anti-leishmanial activity of chlorpromazine alone and combined with N-meglumine antimonate.
Topics: Animals; Antiprotozoal Agents; Chlorpromazine; Drug Therapy, Combination; Leishmania; Leishmaniasis; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Organometallic Compounds; Sorbitol; Spleen | 1986 |
Antimony accumulation in hair during treatment of leishmaniasis.
Topics: Antimony; Brazil; Hair; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Neutron Activation Analysis; Organometallic Compounds; Retrospective Studies; Sorbitol | 1987 |
[Kala-azar with marked ferritinemia in a German school child].
Topics: Anemia, Hypochromic; Child; Ferritins; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1987 |
[Visceral leishmaniasis mimicking histiocytic marrow reticulosis].
Topics: Adult; Antimony; Bone Marrow; Diagnosis, Differential; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Lymphatic Diseases; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1986 |
[Agranulocytosis caused by glucantime in the treatment of kala-azar].
Topics: Agranulocytosis; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Intralesional glucantime in Leishmania braziliensis braziliensis infections.
Topics: Adult; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
Humoral factors during South American visceral leishmaniasis.
Topics: Adolescent; Adult; Antibodies; Antigen-Antibody Complex; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Complement Fixation Tests; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1986 |
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
[Visceral leishmaniasis in Santarem/PA: general aspects of the control, serological survey in dogs and treatment of the human cases].
Topics: Adolescent; Adult; Animals; Brazil; Child; Child, Preschool; Dog Diseases; Dogs; Humans; Infant; Insect Control; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Psychodidae | 1985 |
[Value of the ELISA IgG and IgM test in the diagnosis and post-therapeutic monitoring of kala-azar].
Topics: Antimony; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rheumatoid Factor | 1985 |
Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1).
Topics: Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis, Visceral; Lymphokines; Macrophage Activation; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Piperidines; Thioglycolates | 1985 |
Chemotherapy of visceral leishmaniasis (Leishmania donovani) in the squirrel monkey (Saimiri sciureus).
Topics: Animals; Antimony; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saimiri | 1985 |
Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Antimony; Antiprotozoal Agents; Combined Modality Therapy; Cricetinae; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds | 1985 |
[Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
Topics: Adult; Agranulocytosis; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Immunosuppression associated with visceral leishmaniasis of hamsters.
Topics: Animals; Antigens, Protozoan; Antimony; Cricetinae; Immune Tolerance; Leishmania; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 1985 |
[Toxicity of Glucantime. A case].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
[Description of a case of visceral leishmaniasis. Epidemiologic, diagnostic and therapeutic considerations].
Topics: Antimony; Child, Preschool; Humans; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1985 |
Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Gluconates; Humans; Kidney Diseases; Kidney Tubules; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1983 |
Leishmaniasis recidivans treated with sodium stibogluconate.
Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence | 1981 |
In vivo antileishmanial properties of pentavalent antimonial compounds.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Gluconates; Leishmania; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred Strains; Organometallic Compounds | 1982 |
[Cutaneous leishmaniasis in patients returning from the tropics].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Benzenesulfonates; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sulfamethoxazole; Travel; Tropical Climate | 1984 |
[Successful intralesional treatment of leishmaniasis caused by Leishmania brasiliensis panamensis using glucantime].
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1984 |
[Visceral leishmaniasis (kala-azar): 1st case observed in Chile].
Topics: Adult; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1984 |
Liposomes in leishmaniasis: effects of parasite virulence on treatment of experimental leishmaniasis in hamsters.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Leishmania; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Virulence | 1984 |
[The hyperglycemic effect of N-methylglucamine antimonate (glucantime)].
Topics: Animals; Antimony; Blood Glucose; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Hyperglycemia; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 1984 |
Clinical characteristics of human Leishmania braziliensis braziliensis infections.
Topics: Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mucous Membrane; Organometallic Compounds | 1984 |
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors | 1984 |
Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
Topics: Administration, Oral; Animals; Antibiotics, Antineoplastic; Antimony; Bilirubin; Bone Marrow; Cricetinae; Drug Evaluation, Preclinical; Formycins; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 1983 |
Liposomal chemotherapy in visceral leishmaniasis: an ultrastructural study of an intracellular pathway.
Topics: Animals; Antimony; Cricetinae; Kupffer Cells; Leishmania; Leishmaniasis, Visceral; Liposomes; Lysosomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Phagocytosis; Spleen | 1983 |
Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
Topics: Animals; Antimony; Antiprotozoal Agents; Aotus trivirgatus; Cebidae; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Monkey Diseases; Organometallic Compounds | 1983 |
[A case of visceral leishmaniasis].
Topics: Aged; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Cold agglutinin syndrome and hemophagocytosis in systemic leishmaniasis.
Topics: Anemia, Hemolytic, Autoimmune; Antimony; Bone Marrow Cells; Child, Preschool; Histiocytes; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phagocytosis | 1984 |
Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1984 |
Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters.
Topics: Animals; Antimony; Cricetinae; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1983 |
[Kala-azar in childhood. 20 year review].
Topics: Adolescent; Age Factors; Aniline Compounds; Antimony; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Factors; Spain; Stilbenes | 1983 |
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis.
Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol | 1980 |
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol | 1982 |
[Kala-azar and autoimmune hemolytic anemia. Apropos of a fatally developing case caused by hepatotoxicity from N-methylglucamine antimonate].
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimony; Chemical and Drug Induced Liver Injury; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1982 |
Kala-azar in Afghanistan.
Topics: Afghanistan; Antimony; Antiprotozoal Agents; Child, Preschool; Female; Hepatomegaly; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1982 |
[Adult Mediterranean visceral leishmaniasis: report of 12 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Antimony; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1980 |
A case report of Kala-Azar in a kidney transplant patient.
Topics: Adult; Allopurinol; Antiprotozoal Agents; Follow-Up Studies; Humans; Immunosuppression Therapy; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Splenectomy; Splenomegaly; Time Factors | 1995 |
Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
Topics: Adult; Amylases; Antimony Sodium Gluconate; Antiprotozoal Agents; District of Columbia; Humans; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Peru; Prospective Studies | 1994 |
Glucantime susceptibility of Leishmania promastigotes under variable growth conditions.
Topics: Animals; Antimony; Antiprotozoal Agents; Biopterins; Cell Division; Culture Media; Fatty Acids; Folic Acid; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Oleic Acid; Oleic Acids; Organometallic Compounds; Species Specificity | 1995 |
Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antineoplastic Agents; Antiprotozoal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins; Rectal Diseases | 1995 |
Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Interactions; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Models, Biological; Organometallic Compounds; Paromomycin | 1995 |
[Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Enzyme Tests; Female; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence | 1995 |
Antimony oxidation states in antileishmanial drugs.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Stability; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction | 1995 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
Mediterranean visceral leishmaniasis in pregnancy.
Topics: Adult; Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Serologic Tests | 1994 |
Misdiagnosis of pancreatitis in patients receiving treatment with pentavalent antimonial agents.
Topics: Diagnostic Errors; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Prospective Studies | 1994 |
Relapse in Ethiopian visceral leishmaniasis (VL) patients after therapy with pentavalent antimonials: a ten year observation.
Topics: Adolescent; Adult; Age Factors; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; Follow-Up Studies; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sex Factors; Treatment Outcome | 1994 |
Mucocutaneous leishmaniasis and HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Time Factors; Treatment Outcome | 1994 |
Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
Topics: Animals; Antimony; Antiprotozoal Agents; Disseminated Intravascular Coagulation; Dog Diseases; Dogs; Female; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1994 |
[Childhood visceral leishmaniasis in the Alpes-Maritimes from 1985 to 1992].
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 1994 |
Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice.
Topics: Amphotericin B; Animals; Cricetinae; HIV Infections; Humans; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Spleen; Tissue Distribution | 1993 |
Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Female; HIV Infections; Humans; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects | 1994 |
[Syncope and electrocardiographic changes associated to treatment with meglumine antimoniate].
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Female; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Syncope | 1994 |
[Visceral leishmaniasis and multiple organ failure].
Topics: Adolescent; Animals; Bone Marrow; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Multiple Organ Failure; Organometallic Compounds | 1993 |
[Acute pancreatitis during treatment with meglumine antimoniate (Glucantime)].
Topics: Acute Disease; Adult; Animals; Antiprotozoal Agents; Female; Humans; Immune Tolerance; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1994 |
Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog.
Topics: Animals; Antimony; Biological Availability; Dogs; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds | 1994 |
Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Tissue Distribution | 1994 |
Regression of diffuse intralobular liver fibrosis associated with visceral leishmaniasis.
Topics: Adolescent; Animals; Antigens, Protozoan; Brazil; Hepatomegaly; Humans; Immunohistochemistry; Kupffer Cells; Leishmania infantum; Leishmaniasis, Visceral; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Splenomegaly | 1993 |
[Visceral leishmaniasis: a possible diagnosis in Belgium].
Topics: Antimony; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Infant; Leishmaniasis, Visceral; Leukemia; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Epidemiological aspects of kala-azar in Meshkin-Shahr, Iran: human infection.
Topics: Adolescent; Adult; Agglutination Tests; Ambulatory Care; Antiprotozoal Agents; Bone Marrow Examination; Child; Child, Preschool; Female; Fluorescent Antibody Technique; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Iran; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Population Surveillance | 1993 |
Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Apolipoproteins; C-Reactive Protein; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1993 |
Thermotherapy v. antimonials: what happens after the healing of cutaneous leishmaniasis lesions?
Topics: Animals; Antiprotozoal Agents; Disease Susceptibility; Female; Hyperthermia, Induced; Immunologic Memory; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Organometallic Compounds; Recurrence | 1993 |
Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; HIV-1; Humans; Interferon-gamma; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1993 |
Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dosage Forms; Female; Humans; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1993 |
The epidemiology and surveillance of visceral leishmaniasis in the Campania region of Italy. The value of zymodeme typing.
Topics: Adolescent; Adult; Allopurinol; Animals; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Isoenzymes; Italy; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Population Surveillance; Seasons; Skin Tests | 1993 |
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
Topics: Animals; Antimony; Antiprotozoal Agents; Carbohydrate Sequence; Cricetinae; Drug Carriers; Lectins, C-Type; Leishmania; Leishmaniasis; Macrophages; Mannans; Mannose; Mannose Receptor; Mannose-Binding Lectins; Meglumine; Meglumine Antimoniate; Mice; Molecular Sequence Data; Organometallic Compounds; Receptors, Cell Surface; Receptors, Immunologic; Saccharomyces cerevisiae | 1993 |
2-substituted quinoline alkaloids as potential antileishmanial drugs.
Topics: Alkaloids; Animals; Antiprotozoal Agents; Female; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Quinolines | 1993 |
Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
Topics: Acute Disease; Adult; Antimony; Antiprotozoal Agents; Female; Ghana; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1993 |
Tolerance and pharmacokinetics of antimony in a patient with renal failure.
Topics: Antiprotozoal Agents; Female; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Renal Insufficiency | 1995 |
Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites.
Topics: Animals; Antibodies, Helminth; Antibodies, Protozoan; Antiprotozoal Agents; Dirofilaria immitis; Dirofilariasis; Dog Diseases; Dogs; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Toxoplasmosis, Animal | 1995 |
A 7-month-old girl with fever and bleeding.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dicloxacillin; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases | 1996 |
Treatment of kala azar.
Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1996 |
Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide.
Topics: Animals; Antiprotozoal Agents; Body Weight; Disease Progression; Injections, Intraperitoneal; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitric Oxide; Organometallic Compounds; Species Specificity | 1996 |
Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Antitubercular Agents; Humans; Kidney Failure, Chronic; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Remission Induction; Renal Dialysis; Tuberculosis, Renal | 1996 |
Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs.
Topics: Animals; Antimony; Antiprotozoal Agents; Biological Availability; Dog Diseases; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1996 |
Meglumine antimoniate-induced pancreatitis.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antimony; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 1996 |
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Carriers; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 1996 |
Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver Diseases, Parasitic; Lung Diseases, Parasitic; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitology; Paromomycin; Splenic Diseases | 1996 |
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
Topics: Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunity, Cellular; Infant; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Recurrence | 1996 |
Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antimony; Antiprotozoal Agents; Fatal Outcome; HIV Antibodies; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1996 |
Disseminated American cutaneous leishmaniasis.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Azure Stains; Biopsy; Child; Cricetinae; Culture Media; Cytodiagnosis; Drug Administration Schedule; Drug Resistance; Female; Histiocytes; Humans; Injections, Intradermal; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests; Skin Ulcer; Venezuela | 1996 |
Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenates; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA, Protozoan; Drug Resistance; Drug Resistance, Multiple; Gene Dosage; Genes, Protozoan; Leishmania; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxides; Puromycin; Sequence Homology, Nucleic Acid; Vinblastine | 1996 |
Concurrent mucosal leishmaniasis and pulmonary tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Contraindications; Drug Therapy, Combination; Humans; Immunity, Cellular; Isoniazid; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pyrazinamide; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1996 |
In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Female; Injections, Subcutaneous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Plant Extracts; Plants, Medicinal | 1996 |
Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
Topics: Antiprotozoal Agents; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Opportunistic Infections; Organometallic Compounds | 1996 |
T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Topics: Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-2; Interleukin-4; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes | 1996 |
Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs.
Topics: Animals; Antiprotozoal Agents; Cytotoxicity, Immunologic; Dogs; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Monocytes; Neutrophils; Organometallic Compounds; Phagocytosis; Respiratory Burst | 1996 |
Evaluation of the immune response in visceral leishmaniasis.
Topics: Agglutination Tests; Animals; Antiprotozoal Agents; Clinical Laboratory Techniques; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Fluorescent Antibody Technique, Indirect; Humans; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Sensitivity and Specificity; T-Lymphocytes | 1996 |
Old-world leishmaniasis of the auricle.
Topics: Adult; Antimony; Antiprotozoal Agents; Ear Diseases; Ear, External; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
[Postkala-azar dermal leishmaniasis].
Topics: Animals; Antiprotozoal Agents; Child; Humans; Leishmania donovani; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Polymerase Chain Reaction | 1997 |
Activity of IFN-gamma in experimental Leishmania infantum murine visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Administration Schedule; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Liver; Lung; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Recombinant Proteins; Spleen | 1997 |
Osteomyelitis and arthrosynovitis associated with Leishmania donovani infection in a dog.
Topics: Animals; Antiprotozoal Agents; Diarrhea; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteomyelitis; Pain; Radiography; Radius; Synovial Fluid; Synovitis; Tibia; Ulna | 1997 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Pentavalent antimonial-induced torsade de pointes.
Topics: Aged; Anti-Arrhythmia Agents; Antimony; Antiprotozoal Agents; Electrocardiography; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Torsades de Pointes | 1997 |
Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.
Topics: Adolescent; Adult; Age Distribution; Aged; Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Sex Distribution; Sicily | 1997 |
[Visceral leishmaniasis in Niger: six new parasitologically confirmed cases].
Topics: Adult; Antiprotozoal Agents; Bone Marrow; Fatal Outcome; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Niger; Organometallic Compounds; Prevalence | 1997 |
Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Spleen | 1997 |
Cutaneous leishmaniasis in the Peruvian Andes: factors associated with variability in clinical symptoms, response to treatment, and parasite isolation rate.
Topics: Adolescent; Adult; Age Factors; Aged; Animals; Antiprotozoal Agents; Arm; Child; Disease Transmission, Infectious; Female; Head; Host-Parasite Interactions; Humans; Immunity, Active; Insect Control; Leg; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Multivariate Analysis; Occupational Diseases; Organometallic Compounds; Peru; Psychodidae | 1997 |
Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Carriers; Injections, Intramuscular; Injections, Subcutaneous; Leishmaniasis; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
Immunoblot analysis of Leishmania panamensis antigens in sera of patients with American cutaneous leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Blotting, Western; Colombia; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Molecular Weight; Organometallic Compounds; Sensitivity and Specificity | 1997 |
Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs.
Topics: Animals; Antibodies, Protozoan; Antibody Formation; Antiprotozoal Agents; B-Lymphocytes; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Immunity, Cellular; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; T-Lymphocytes | 1997 |
[The first case of visceral leishmaniasis in a patient with HIV infection in Russia].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Biopsy; Bone Marrow; HIV-1; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1997 |
Pseudo-acute transformation of an idiopathic myelofibrosis due to kala-azar.
Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primary Myelofibrosis | 1998 |
T cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia.
Topics: Adult; Animals; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Cell Division; Female; Humans; Interferon-gamma; Leishmania; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines; Species Specificity; T-Lymphocytes | 1998 |
Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
Topics: Analysis of Variance; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Administration Schedule; Injections, Subcutaneous; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds | 1998 |
Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime).
Topics: Antiprotozoal Agents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Models, Molecular; Organometallic Compounds; Osmolar Concentration | 1998 |
Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1998 |
Effects of antimonial therapy on serum zinc, copper and iron concentrations in patients with cutaneous Leishmaniasis in Turkey.
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Copper; Humans; Iron; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trace Elements; Turkey; Zinc | 1998 |
Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Outcome | 1998 |
Post-kala-azar dermal leishmaniasis.
Topics: Antiprotozoal Agents; Biopsy, Needle; Child, Preschool; Humans; Iran; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1998 |
[Torsade de pointes secondary to treatment with pentavalent antimonial drugs].
Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes | 1998 |
Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors | 1998 |
Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
Topics: Allopurinol; Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Serum Albumin; Serum Globulins; Time Factors | 1998 |
Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
Topics: Animals; Antiprotozoal Agents; Camptothecin; DNA Topoisomerases, Type I; DNA, Protozoan; Humans; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins | 1998 |
Follicular mucinosis associated with cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Biopsy, Needle; Disease-Free Survival; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Mucinosis, Follicular; Organometallic Compounds | 1998 |
Visceral leishmaniasis: a lingual presentation in a patient with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimony; Antiprotozoal Agents; Didanosine; HIV Infections; Humans; Laryngitis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Tongue Diseases; Zidovudine | 1998 |
Pediatric visceral leishmaniasis in southern France.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Failure; Treatment Outcome | 1998 |
South American cutaneous leishmaniasis: report of ten cases in Israeli travelers.
Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Headache; Humans; Israel; Leg Ulcer; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Muscle Weakness; Muscular Diseases; Organometallic Compounds; Pain; Retrospective Studies; Skin; South America; Travel; Weight Loss | 1998 |
N-methylglucamine antimonate (SbV+): intralesional canine tegumentary leishmaniasis therapy.
Topics: Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dogs; Female; Immunity, Cellular; Injections, Intralesional; Isoenzymes; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1998 |
Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
Topics: Animals; Antimony; Antiprotozoal Agents; DNA, Protozoan; Humans; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Open Reading Frames; Organometallic Compounds; Species Specificity | 1998 |
Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica.
Topics: Animals; Antiprotozoal Agents; Buthionine Sulfoximine; Chlorambucil; Drug Resistance; Leishmania tropica; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sulfhydryl Compounds | 1998 |
Visceral leishmaniasis in District Dir, NWFP.
Topics: Abdomen; Anemia; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Hypergammaglobulinemia; Leishmania donovani; Leishmaniasis, Visceral; Leukopenia; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Splenomegaly; Thrombocytopenia; Weight Loss | 1998 |
Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Biopsy; DNA, Protozoan; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin | 1998 |
Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum.
Topics: Animals; Drug Synergism; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Spleen; Trypanocidal Agents | 1999 |
Genital ulcer in an AIDS patient with disseminated leishmaniasis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Foot Ulcer; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Penile Diseases; Ulcer | 1998 |
Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenites; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
Value of Western blotting in the clinical follow-up of canine leishmaniasis.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Blotting, Western; Disease Progression; Dog Diseases; Dogs; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sensitivity and Specificity; Treatment Outcome | 1999 |
[Confirmation of the presence of Leishmania infantum MON-80 in Tunisia].
Topics: Animals; Antiprotozoal Agents; Blood Transfusion; Child, Preschool; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tunisia | 1999 |
Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment.
Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma].
Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms | 1998 |
Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs.
Topics: Amebicides; Animals; Antimony; Antiprotozoal Agents; Area Under Curve; Chromatography, Liquid; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluorometry; Half-Life; Injections, Subcutaneous; Least-Squares Analysis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Spectrophotometry, Atomic | 1999 |
Physico-chemical characterization of meglumine antimoniate.
Topics: Antiprotozoal Agents; Hydrogen-Ion Concentration; Leishmaniasis; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Potentiometry | 1999 |
Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Blood; Blotting, Western; Dog Diseases; Dogs; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin | 1999 |
[Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
Topics: Aged; Antimony; Antiprotozoal Agents; Electrocardiography; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes | 1999 |
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
Topics: Administration, Topical; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antiprotozoal Agents; Benzethonium; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Treatment Failure; Wound Healing | 1999 |
Meglumine antimoniate, amiodarone and torsades de pointes: a case report.
Topics: Aged; Amiodarone; Antiprotozoal Agents; Electrocardiography; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission, Spontaneous; Torsades de Pointes | 1999 |
The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Topics: Aged; Allopurinol; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Ketoconazole; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1999 |
High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
Topics: Adult; Amylases; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Creatinine; Female; HIV Infections; HIV-1; Humans; Leishmania infantum; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Recurrence; Retrospective Studies; Vomiting | 1999 |
PCR follow-up examination after treatment of canine leishmaniosis (CaL).
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Follow-Up Studies; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Species Specificity | 1998 |
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Cell Line; Drug Resistance; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mutation; Organometallic Compounds; Pentamidine | 2000 |
Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; BCG Vaccine; Cell Division; Combined Modality Therapy; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-5; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lymphocyte Activation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mycobacterium bovis; Organometallic Compounds; Protozoan Vaccines; T-Lymphocytes, Helper-Inducer; Th1 Cells; Tuberculin | 2000 |
Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico.
Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mexico; Middle Aged; Organometallic Compounds; Treatment Outcome | 1999 |
[Nephrotic syndrome and acute pancreatitis related to glucantime administration].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis | 2000 |
Novel methods for the encapsulation of meglumine antimoniate into liposomes.
Topics: Analysis of Variance; Animals; Antiprotozoal Agents; Cricetinae; Dehydration; Drug Compounding; Leishmania donovani; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds | 2000 |
Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Culture Media; Dogs; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2000 |
American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment.
Topics: Adolescent; Adult; Age Distribution; Analysis of Variance; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Cohort Studies; Evaluation Studies as Topic; Female; Humans; Incidence; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Sensitivity and Specificity; Sex Distribution; Skin Tests | 2000 |
Antimony excretion in a patient with renal impairment during meglumine antimoniate therapy.
Topics: Antimony; Antiprotozoal Agents; Creatinine; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Oliguria; Organometallic Compounds; Renal Insufficiency; Shock, Septic | 2000 |
Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice.
Topics: Adjuvants, Immunologic; Animals; Antiprotozoal Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Garlic; Interferon-gamma; Interleukin-10; Interleukin-2; Interleukin-4; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phytotherapy; Plants, Medicinal; Th1 Cells; Th2 Cells | 2000 |
A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate.
Topics: Administration, Topical; Antiprotozoal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Plant Extracts; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome | 2000 |
Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate.
Topics: Antimony; Glutathione; Hydrogen-Ion Concentration; Kinetics; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Temperature | 2001 |
Assessment of Leishmania promastigote growth in vitro by means of nucleoside hydrolase activity determination.
Topics: Animals; Antiprotozoal Agents; Culture Media; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; N-Glycosyl Hydrolases; Organometallic Compounds; Parasitic Sensitivity Tests; Ribose | 2001 |
Visceral leishmaniasis in a Brazilian child infected perinatally with human immunodeficiency virus.
Topics: Antiprotozoal Agents; Brazil; Female; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2001 |
[Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana].
Topics: Antiprotozoal Agents; Bedding and Linens; Clothing; French Guiana; Humans; Insect Repellents; Insecticides; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pentamidine; Recurrence; Skin; Trees | 2000 |
Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antibody Specificity; Antiprotozoal Agents; Dog Diseases; Dogs; Endemic Diseases; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Leishmania infantum; Leishmaniasis, Visceral; Longitudinal Studies; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Seroepidemiologic Studies; Spain | 2001 |
Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.
Topics: Adult; Animals; Antigens, Protozoan; Antimony; Antiprotozoal Agents; Cytokines; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Vaccines | 2001 |
[Effect of intralesional treatment with emetine hydrochloride on Leishmania (Viannia) braziliensis in hamsters].
Topics: Animals; Antiprotozoal Agents; Cicatrix; Cricetinae; Cytoplasm; Disease Reservoirs; Drug Evaluation, Preclinical; Emetine; Immunoenzyme Techniques; Injections, Intralesional; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Microscopy, Electron; Organometallic Compounds; Vacuoles | 2001 |
Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate.
Topics: Acute Disease; Allopurinol; Antiprotozoal Agents; Child, Preschool; Humans; Ketoconazole; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2001 |
[A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Tongue Diseases; Treatment Outcome | 2001 |
[Infiltrated cutaneous leishmaniasis and sporotrichosis caused by Leishmania major. First Senegalese case].
Topics: Adult; Animals; Diagnosis, Differential; Female; Humans; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Senegal; Sporotrichosis | 2001 |
In vitro activity of pentavalent antimony derivatives on promastigotes and intracellular amastigotes of Leishmania infantum strains from humans and dogs in Spain.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Dogs; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 2001 |
[N-methyl glucamine antimoniate or Glucantime].
Topics: Antiprotozoal Agents; Drug Interactions; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Selection; Treatment Outcome | 2000 |
Immunological selection for Leishmania (Viannia) braziliensis antigens.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Biomarkers; Blotting, Western; Case-Control Studies; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2001 |
[Epidemic outbreak of tegumentary leishmaniasis in Puerto Esperanza, Misiones, 1998].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antiprotozoal Agents; Argentina; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Incidence; Infant; Intradermal Tests; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Psychodidae | 2001 |
Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Flow Cytometry; Humans; Leishmania guyanensis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Propidium; Sensitivity and Specificity | 2001 |
Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study.
Topics: Adolescent; Adult; Ambulatory Care; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cross Infection; Ethiopia; Female; Hospitalization; Humans; Infant; Infant, Newborn; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rural Population; Treatment Outcome; Urban Population | 2001 |
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
Topics: Adolescent; Adult; Animals; Antiprotozoal Agents; Child; Female; Follow-Up Studies; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prognosis | 2001 |
Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
Topics: Animals; Antimony; Antiprotozoal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cricetinae; Disease Models, Animal; Drug Resistance; Glycosphingolipids; Lectins; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Time Factors | 2001 |
Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus).
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Naphthalenes; Organ Size; Organometallic Compounds; Random Allocation; Spleen; Terbinafine; Treatment Outcome; Trypanocidal Agents; Zoonoses | 2002 |
Splenic granulomatous lesions in immunocompetent pediatric patients with visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Granuloma; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Splenic Diseases; Treatment Outcome | 2001 |
The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador.
Topics: Adolescent; Adult; Antiprotozoal Agents; Data Interpretation, Statistical; Ecuador; Female; Health Knowledge, Attitudes, Practice; Humans; Leishmaniasis, Cutaneous; Male; Medicine, Traditional; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rural Population; Socioeconomic Factors | 2001 |
The contributions of plasma membrane Na+-Ca2+-exchange and the Ca2+-ATPase to the regulation of cytosolic calcium ([Ca2+]i) in a clonal pituitary cell line (AtT-20) of mouse corticotropes.
Topics: Animals; Calcium-Transporting ATPases; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Line; Cell Membrane; Clone Cells; Enzyme Inhibitors; Fura-2; Hydroquinones; Image Processing, Computer-Assisted; Ionomycin; Lithium; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Organophosphates; Pituitary Gland; Potassium Chloride; Signal Transduction; Sodium-Calcium Exchanger; Tetraethylammonium; Thapsigargin | 2001 |
[Isolated laringeal leishmaniasis and bone marrow culture (reply)].
Topics: Adult; Animals; Antiprotozoal Agents; Biopsy; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Humans; Laryngeal Diseases; Larynx; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
PCR detection of specific Leishmania-DNA in patients with periodontal disease.
Topics: Adult; Animals; Antiprotozoal Agents; Chronic Disease; DNA, Protozoan; Female; Gingiva; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Monocytes; Organometallic Compounds; Periodontitis; Polymerase Chain Reaction; Radiography; Venezuela | 2002 |
Visceral leishmaniasis with pericarditis in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Candidiasis; HIV Infections; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pericarditis | 2002 |
Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; Hepatitis C; Humans; Injections, Intravenous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Mouth Mucosa; Organometallic Compounds; Palate, Hard | 2002 |
An outbreak of cutaneous leishmaniasis among soldiers in Belém, Pará State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Disease Outbreaks; Female; Humans; Insect Vectors; Isoenzymes; Leishmania; Leishmaniasis, Cutaneous; Male; Mefloquine; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Protozoan Proteins; Psychodidae; Trees | 2002 |
Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Chromatography, Ion Exchange; Gas Chromatography-Mass Spectrometry; Hair; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |
Leishmaniasis of the prepuce.
Topics: Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Penile Diseases | 2002 |
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests | 2002 |
Pediatric visceral leishmaniasis in Albania.
Topics: Agglutination Tests; Albania; Antiprotozoal Agents; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sensitivity and Specificity | 2002 |
[Cutaneous leishmaniasis of the lid].
Topics: Adult; Biopsy, Needle; Diagnosis, Differential; Eyelid Diseases; Female; Humans; Inflammation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Nutrition Disorders; Organometallic Compounds; Recurrence; Retrospective Studies; Sicily; Treatment Outcome | 2002 |
American cutaneous leishmaniasis as a rare imported disease in Europe: a case report favourably treated with antimonial derivatives.
Topics: Adolescent; Antiprotozoal Agents; Brazil; Diagnosis, Differential; Humans; Italy; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Travel | 2001 |
Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cell Division; Diptera; Dog Diseases; Dogs; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Immunotherapy; Leishmania infantum; Leishmaniasis, Visceral; Lymphocyte Subsets; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
Unusual location of cutaneous leishmaniasis on the hallux in a Brazilian patient.
Topics: Aged; Animals; Antiprotozoal Agents; Female; Hallux; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiography | 2002 |
Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bradycardia; Child; Electrocardiography; Ethiopia; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2001 |
Expansion of gammadelta T Cells in patients infected with cutaneous leishmaniasis with and without glucantime therapy.
Topics: Adult; Aged; Antiprotozoal Agents; Case-Control Studies; Female; Flow Cytometry; Humans; Leishmaniasis, Cutaneous; Lymphocyte Activation; Lymphocyte Count; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; T-Lymphocyte Subsets | 2002 |
Human cutaneous leishmaniasis due to Leishmania infantum in the Sidi Bourouis focus (Northern Tunisia): epidemiological study and isoenzymatic characterization of the parasites.
Topics: Aged; Animals; Cells, Cultured; Child, Preschool; Female; Humans; Isoenzymes; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tunisia | 2003 |
Distribution of liposome-encapsulated antimony in dogs.
Topics: Animals; Antiprotozoal Agents; Biological Availability; Chemistry, Pharmaceutical; Dog Diseases; Dogs; Freeze Drying; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
Leishmaniasis of the lip.
Topics: Aged; Antiprotozoal Agents; Azure Stains; Humans; Leishmaniasis, Cutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2002 |
Post-kala-azar dermal leishmaniasis associated with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2002 |
Effects of the glucantime on the kinetic of biodistribution of radiopharmaceuticals in Wistar rats.
Topics: Animals; Antiprotozoal Agents; Drug Interactions; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Medronate; Tissue Distribution | 2002 |
American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.
Topics: Administration, Oral; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentoxifylline; Tumor Necrosis Factor-alpha | 2003 |
Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Equipment Design; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2003 |
Inhibition of parasite protein kinase C by new antileishmanial imidazolidin-2-one compounds.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Enzyme Inhibitors; Fibroblasts; Humans; Imidazoles; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Protein Kinase C; Spleen; Structure-Activity Relationship | 2002 |
High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals: a comparative approach using historical controls.
Topics: Antiprotozoal Agents; Arsenic; Cadmium; Case-Control Studies; Chi-Square Distribution; Drug Contamination; Female; Humans; Hydrogen-Ion Concentration; Lead; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metals, Heavy; Organometallic Compounds; Osmolar Concentration; Statistics, Nonparametric | 2003 |
[Obstructive acute renal failure revealing visceral leishmaniasis in a diabetic patient].
Topics: Acute Kidney Injury; Adult; Antibodies, Protozoan; Antiprotozoal Agents; Diabetes Mellitus, Type 1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed | 2003 |
Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.
Topics: Amino Acid Sequence; Animals; ATP-Binding Cassette Transporters; Base Sequence; Cell Line; Cells, Cultured; Drug Resistance; Electrophoresis, Gel, Pulsed-Field; Gene Amplification; Gene Expression Regulation; Genes, Protozoan; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Membrane Glycoproteins; Molecular Sequence Data; Organometallic Compounds; Protozoan Proteins; Restriction Mapping; Sequence Alignment; Transfection | 2003 |
Detection of new endemic areas of cutaneous leishmaniasis in Pakistan: a 6-year study.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Child, Preschool; Endemic Diseases; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pakistan | 2003 |
Back from the Peace Corps--with skin lesions from South America.
Topics: Adult; Animals; Antiprotozoal Agents; Diagnosis, Differential; Ecuador; Female; Government Agencies; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome | 2003 |
Efficacy of 8-bromoguanosine against murine cutaneous leishmaniasis induced with Leishmania amazonensis.
Topics: Alanine Transaminase; Animals; Female; Guanosine; Hematologic Tests; Injections, Intraperitoneal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Organometallic Compounds; Skin Ulcer; Trypanocidal Agents; Urea | 2003 |
The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Combined Modality Therapy; Cryotherapy; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2003 |
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompromised Host; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2003 |
[Parenteral glucantime therapy of bouton d'orient, with esthetic results superior to intralesional therapy].
Topics: Antimony; Esthetics; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1952 |
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 1952 |
[Case of sporotrichosis treated with N-methylglucamine antimoniate].
Topics: Antimony; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sporotrichosis | 1952 |
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1954 |
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis].
Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Leishmaniasis mucocutaneous americana; our experience in its treatment with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Two cases of kala-azar treated with glucantime].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1958 |
[8 cases of kala-azar cured with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1962 |
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid.
Topics: Antiprotozoal Agents; Arm; Cryotherapy; Female; Fingers; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pakistan; Paronychia; Sporotrichosis | 2003 |
[Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate].
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Djibouti; Drug Resistance; France; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds | 2003 |
Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; beta-Cyclodextrins; Chemical Phenomena; Chemistry, Physical; Cyclodextrins; Injections, Intraperitoneal; Intestinal Absorption; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 2004 |
Visceral leishmaniasis treatment, Italy.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Combinations; Drug Therapy; Humans; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2003 |
[Treatment of cutaneous leishmaniasis by antimoniate of N-methyl glucamine; 15 personal observations].
Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1950 |
[Treatment of kala-azar by glucantime].
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1950 |
[Distomatosis with abnormal symptomatology or complicated by infectious graft on prior heart disease? Value of an intradermo-reaction with fluke antigen; failure of glucantime; cure of the septicemic states by chloromycetin].
Topics: Chloramphenicol; Heart Diseases; Humans; Liver Diseases, Parasitic; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trematoda | 1950 |
[Polyneuritic complications after treatment of kala-azar in the adult with 2168 R.P].
Topics: Adult; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Neuritis; Organometallic Compounds; Polyneuropathies | 1951 |
[Use of glucantime in infantile kala-azar].
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1951 |
[American cutaneo-mucous leishmaniasis; glucantime therapy; preliminary note].
Topics: Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; United States | 1951 |
Multiple leg ulcers in a traveler.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Azure Stains; Biopsy; Humans; Leg Ulcer; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Travel | 2004 |
Detection of pathogenic bacteria in skin lesions of patients with chiclero's ulcer. Reluctant response to antimonial treatment.
Topics: Antiprotozoal Agents; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Ulcer | 2003 |
Use of meglumine antimoniate in canine leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Humans; Infant; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2004 |
[Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy].
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Female; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Recurrence | 2004 |
Leishmaniasis of the lip in a patient with Down's syndrome.
Topics: Animals; Antiprotozoal Agents; Diagnosis, Differential; Down Syndrome; Female; Humans; Injections, Intramuscular; Leishmania infantum; Leishmaniasis, Visceral; Lip Diseases; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2004 |
Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Cryosurgery; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Turkey | 2004 |
[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Follow-Up Studies; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors | 2004 |
Emergency initiative to reduce leishmaniasis in Afghanistan.
Topics: Afghanistan; Antimony Sodium Gluconate; Antiprotozoal Agents; Bedding and Linens; Emergency Medical Services; Health Education; Humans; Incidence; International Cooperation; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pesticides; Refugees | 2004 |
Management of leishmanial osteolytic lesions in a hypothyroid dog by partial tarsal arthrodesis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Arthrodesis; Dog Diseases; Dogs; Hindlimb; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tarsal Joints; Treatment Outcome | 2004 |
Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Antimony Sodium Gluconate; Antiprotozoal Agents; Benzimidazoles; Bisbenzimidazole; Camptothecin; Cell Survival; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Leishmania donovani; Meglumine; Meglumine Antimoniate; Monocytes; Organometallic Compounds; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; U937 Cells | 2004 |
Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
Topics: Adolescent; Adult; Animals; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Tests | 2005 |
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Topics: Adolescent; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Greece; Humans; Infant; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2005 |
Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Topics: Administration, Topical; Animals; Antimony Sodium Gluconate; Cricetinae; Female; Gels; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Paromomycin; Random Allocation; Statistics, Nonparametric | 2005 |
Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Proliferation; Drug Evaluation, Preclinical; Fibroblasts; Humans; In Vitro Techniques; Indoles; Ketoconazole; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 2004 |
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2004 |
[Glucantime injection: benefit versus toxicity].
Topics: Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Exanthema; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Retrospective Studies | 2005 |
Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Brazil; Child; DNA, Protozoan; Female; Fluorescent Antibody Technique, Indirect; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Skin Tests | 2005 |
In vitro and in vivo cytotoxicities and antileishmanial activities of thymol and hemisynthetic derivatives.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Female; Humans; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Structure-Activity Relationship; Terpenes; Thymol; U937 Cells | 2005 |
Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antioxidants; Antiprotozoal Agents; Child; Child, Preschool; Female; Glutathione Peroxidase; Humans; Leishmaniasis, Cutaneous; Lipid Peroxidation; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase | 2005 |
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Hypotension; Immunocompromised Host; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive | 2005 |
Granulomatous lesion on a bitch's nipple caused by Leishmania infantum.
Topics: Allopurinol; Animals; Breast Diseases; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nipples; Organometallic Compounds | 2005 |
[Slowly progressing skin ulcers following a stay in Costa Rica].
Topics: Adult; Animals; Antiprotozoal Agents; Costa Rica; Disease Progression; DNA, Protozoan; Facial Dermatoses; Hand Dermatoses; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; RNA, Protozoan; RNA, Ribosomal; Skin Ulcer; Spain; Travel | 2005 |
Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
Topics: Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2005 |
[Spontaneous rupture of the spleen in a patient with visceral leishmaniasis].
Topics: Aged; Animals; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radiography; Rupture, Spontaneous; Spleen; Splenic Rupture; Treatment Outcome | 2005 |
Symmetrical cutaneous leishmaniasis.
Topics: Adult; Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Extremities; Female; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2005 |
The effect of Glucantime on the labeling of blood constituents with technetium-99m.
Topics: Animals; Blood Proteins; Erythrocytes; Isotope Labeling; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Statistics, Nonparametric; Technetium; Tin Compounds; Tissue Distribution | 2005 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |
Pancreatitis associated with N-methyl-glucamine therapy in a dog with leishmaniasis.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis | 2005 |
Developmental toxicity of meglumine antimoniate and transplacental transfer of antimony in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Antimony; Antiprotozoal Agents; Bone and Bones; Dose-Response Relationship, Drug; Female; Fetal Blood; Fetal Death; Fetal Development; Fetal Weight; Maternal-Fetal Exchange; Meglumine; Meglumine Antimoniate; No-Observed-Adverse-Effect Level; Organometallic Compounds; Placenta; Pregnancy; Rats; Rats, Wistar | 2006 |
Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Dog Diseases; Dogs; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spectrophotometry, Atomic | 2005 |
Childhood visceral leishmaniasis in Muzaffarabad, Azad Jammu and Kashmir: frequency and response to treatment in 61 cases.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Drug Resistance; Female; Hospitals, Military; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Treatment Outcome | 2005 |
Side effects of treatment with antimony salts.
Topics: Antiprotozoal Agents; Arrhythmias, Cardiac; Hepatomegaly; Humans; Hypokalemia; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 1989 |
Acute abdominal pain during therapy with glucantim: splenic infarct or excessive splenic enlargement?
Topics: Abdominal Pain; Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Fatal Outcome; Humans; Infarction; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spleen; Splenomegaly; Treatment Outcome | 1989 |
Our experiences in visceral leishmaniasis therapy.
Topics: Antiprotozoal Agents; Child; Hospitals, Pediatric; Humans; Italy; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sicily | 1989 |
Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Immunoglobulin G; Infant; Interferon-gamma; Interleukin-10; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organ Size; Organometallic Compounds; Prospective Studies; Spleen; Time Factors | 2005 |
[Functional status of haemostasis system in patients with visceral leishmaniasis].
Topics: Adolescent; Antiprotozoal Agents; Child; Hemostasis; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prothrombin Time; Thrombocytopenia | 2005 |
[The cutaneous leishmaniasis of the face in Gafsa area, Tunisia].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Incidence; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Necrosis; Nose Diseases; Organometallic Compounds; Prospective Studies; Skin Ulcer; Tunisia | 2005 |
Psoriasiform cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Diagnosis, Differential; Elbow; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Psoriasis | 2006 |
Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
Topics: Adolescent; Antimony; Antiprotozoal Agents; Blood Glucose; Diabetes Mellitus, Type 1; Female; Humans; Knee; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
Cutaneous lupoid leishmaniasis: a case report.
Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Face; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-12; Leishmania major; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thalidomide; Time Factors | 2006 |
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Topics: Animals; Antimony; Antiprotozoal Agents; Cations; Cell Line; Drug Resistance, Microbial; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Organometallic Compounds | 2006 |
Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size.
Topics: Animals; Antimony; Bone Marrow; Dogs; Drug Delivery Systems; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Particle Size; Tissue Distribution | 2006 |
[Adverse effects of intralesional Glucantime in the treatment of cutaneous leishmaniosis].
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Disease Susceptibility; Drug Eruptions; Facial Dermatoses; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Assessment; Sporotrichosis; Staphylococcal Skin Infections; Superinfection | 2006 |
Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
Topics: Adolescent; Adult; Animals; Antimony; Antiprotozoal Agents; Child; Drug Resistance; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Failure; U937 Cells | 2006 |
Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antiprotozoal Agents; Diagnosis, Differential; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
[Visceral leishmaniasis in an immunocompetent subject, acquired in the Pyrenees region].
Topics: Adult; Animals; Antiprotozoal Agents; Female; France; Hepatomegaly; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2006 |
Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children.
Topics: Adolescent; Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin | 2006 |
Mode of action of beta-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Circular Dichroism; Drug Stability; Female; Lipid Bilayers; Meglumine; Meglumine Antimoniate; Mice; Molecular Weight; Organometallic Compounds; Permeability; Skin; Skin Absorption; Solubility; Spectrometry, Mass, Electrospray Ionization; Temperature; Water | 2006 |
Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
Topics: Adult; Animals; Anti-Infective Agents; Antimony; Antiprotozoal Agents; Cartilage; Ciprofloxacin; Ear, External; Humans; Immunocompetence; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pseudomonas Infections; Rifampin | 2006 |
The therapeutic effect of combined cryotherapy, paramomycin, and intralesional meglumine antimoniate in treating lupoid leishmaniasis and chronic leishmaniasis.
Topics: Adolescent; Adult; Amebicides; Child; Child, Preschool; Chronic Disease; Combined Modality Therapy; Cryotherapy; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Paromomycin | 2006 |
Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH.
Topics: Animals; Antimony; Antiprotozoal Agents; Guanosine Monophosphate; Hydrogen-Ion Concentration; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Thermodynamics | 2006 |
Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia.
Topics: Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Bolivia; Drugs, Generic; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2006 |
Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Carrier State; Disease Reservoirs; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors; Treatment Outcome | 2007 |
Immunologic tests in patients after clinical cure of visceral leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Chromatography; Dogs; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunologic Tests; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Skin Tests; Time Factors | 2006 |
[Visceral leishmaniasis with cardiac affectation in an immunocompetent patient].
Topics: Adult; Animals; Antiprotozoal Agents; Echocardiography; Humans; Immunocompetence; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Myocarditis; Organometallic Compounds; Treatment Outcome | 2006 |
Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunity, Cellular; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2005 |
Canine leishmaniasis chemotherapy: dog's clinical condition and risk of Leishmania transmission.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Bone Marrow; Disease Transmission, Infectious; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Skin; Treatment Outcome; Trifluralin | 2006 |
Evaluation of renal and hepatic functions in dogs naturally infected by visceral leishmaniasis submitted to treatment with meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Kidney; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2007 |
Childhood cutaneous leishmaniasis: report of 117 cases from Iran.
Topics: Adolescent; Animals; Antiprotozoal Agents; Child; Endemic Diseases; Female; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence | 2006 |
Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.
Topics: Africa, Western; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Female; HIV Infections; Humans; Injections, Intramuscular; Leishmaniasis, Diffuse Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2007 |
Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.
Topics: Adult; Antimony; Area Under Curve; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metabolic Clearance Rate; Organometallic Compounds; Plasma | 2007 |
Visceral leishmaniasis: bone marrow biopsy findings.
Topics: Amphotericin B; Antiprotozoal Agents; Biopsy; Bone Marrow; Bone Marrow Examination; Child; Child, Preschool; Female; Fibrosis; Granuloma; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Necrosis; Organometallic Compounds; Prognosis; Retrospective Studies | 2007 |
Leishmania (Viannia) braziliensis infection in two Colombian dogs: a note on infectivity for sand flies and response to treatment.
Topics: Animals; Antiprotozoal Agents; Colombia; Dog Diseases; Dogs; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae | 2006 |
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Topics: Animals; Antigens, Protozoan; Antiprotozoal Agents; Cytokines; Drug Therapy, Combination; Immunoglobulin G; Immunologic Factors; Immunotherapy; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmania mexicana; Leishmaniasis, Cutaneous; Lipids; Mannans; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Organometallic Compounds; Polysaccharides | 2007 |
[Symptomatic hypokalemia caused by meglumine antimoniate].
Topics: Antiprotozoal Agents; Female; Humans; Hypokalemia; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2007 |
Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Geography; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Species Specificity; Treatment Failure | 2007 |
Kala-azar control, Uganda.
Topics: Adolescent; Agglutination Tests; Animals; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intramuscular; Isoptera; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reagent Kits, Diagnostic; Risk Factors; Seroepidemiologic Studies; Travel; Uganda | 2007 |
Real-time PCR assay in Leishmania-infected dogs treated with meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Protozoan; Dog Diseases; Dogs; Drug Therapy, Combination; Leishmania; Leishmaniasis; Lymph Nodes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin | 2008 |
Possible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiprotozoal Agents; Cardiotonic Agents; Cardiovascular Diseases; Drug Interactions; Electrocardiography; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Multivariate Analysis; Organometallic Compounds; Retrospective Studies | 2007 |
Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
Topics: Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2006 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing | 2007 |
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.
Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2007 |
Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses.
Topics: Animals; Antiprotozoal Agents; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Lymphadenitis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin | 2007 |
Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Treatment Outcome | 2007 |
The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Homeostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Prednisone; Random Allocation; Risk Assessment | 2008 |
Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Topics: Adolescent; Adult; Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Face; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome | 2007 |
Enhanced oral delivery of antimony from meglumine antimoniate/beta-cyclodextrin nanoassemblies.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; beta-Cyclodextrins; Circular Dichroism; Delayed-Action Preparations; Drug Carriers; Female; Freeze Drying; Hot Temperature; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Mice; Models, Biological; Nanoparticles; Organometallic Compounds; Particle Size; Spectrometry, Mass, Electrospray Ionization | 2008 |
Case report: Leishmaniasis of the upper lip.
Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Humans; Leishmaniasis, Cutaneous; Lip; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2007 |
[Clinical and histological study of lupoid cutaneous leishmaniasis (16 cases)].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Biopsy; Child; Disease Progression; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Skin; Time Factors; Treatment Outcome | 2007 |
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002].
Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia | 2007 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
Efficacy of the intralesional treatment with Chenopodium ambrosioides in the murine infection by Leishmania amazonensis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Chenopodium ambrosioides; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Lymph Nodes; Male; Medicine, Traditional; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C3H; Nitric Oxide; Organometallic Compounds; Plant Extracts; Plant Leaves | 2008 |
[Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report].
Topics: Antiprotozoal Agents; Child; Female; Heart Diseases; Humans; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2007 |
Short communication: The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004.
Topics: Antiprotozoal Agents; Colombia; Cost-Benefit Analysis; Disease Outbreaks; Hospital Costs; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2007 |
Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Treatment Outcome | 2008 |
Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Statistics as Topic; Treatment Outcome; Uganda | 2008 |
Mutilating lupoid leishmaniasis: twelve years to make the diagnosis!
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Biopsy; Chronic Disease; Diagnosis, Differential; Follow-Up Studies; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Remission Induction; Skin; Time Factors | 2008 |
In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Chitosan; Female; Inhibitory Concentration 50; Leishmania infantum; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Microspheres; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Immunotherapy; Leishmania infantum; Leishmaniasis Vaccines; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Survival Rate; T-Lymphocytes; Vaccines, Synthetic | 2008 |
A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
Topics: Aged; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2008 |
[An atypical presentation of visceral leshmaniasis in an immunocompetent patient].
Topics: Adolescent; Animals; Fatal Outcome; Female; Humans; Immunocompetence; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2008 |
[Sporotrichoid cutaneous leishmaniasis in Tunisia: a clinical and histological study].
Topics: Adult; Aged; Anti-Infective Agents; Antiprotozoal Agents; Female; Histiocytes; Humans; Leg Dermatoses; Leishmaniasis, Cutaneous; Lymphocytes; Male; Meglumine; Meglumine Antimoniate; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Sporotrichosis; Tunisia | 2008 |
A simple duplex-PCR protocol for routine diagnosis and follow up of canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; DNA, Kinetoplast; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Lymph Nodes; Lymphadenitis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity | 2007 |
[Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].
Topics: Aged; Antiprotozoal Agents; Fatal Outcome; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2008 |
Speciation of antimony (III) and antimony (V) using hydride generation for meglumine antimoniate pharmaceutical formulations quality control.
Topics: Antimony; Antiprotozoal Agents; Chemistry, Pharmaceutical; Flow Injection Analysis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quality Control; Spectrophotometry, Atomic | 2008 |
Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus | 2008 |
Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Hypoxia; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxygen; Phosphorylcholine | 2008 |
Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Iran; Leishmania donovani; Leishmaniasis, Visceral; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Seasons | 2008 |
In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Inhibitory Concentration 50; Leishmania braziliensis; Leishmania infantum; Leishmania mexicana; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Monocytes; Neutrophils; Nitric Oxide; Organometallic Compounds; Phagocytosis; Superoxides; Tumor Necrosis Factor-alpha | 2008 |
Activity of hydroxyurea against Leishmania mexicana.
Topics: Animals; Antiprotozoal Agents; Cell Cycle; Disease Models, Animal; Humans; Hydroxyurea; In Vitro Techniques; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests | 2008 |
Extranodal gammadelta-T-cell lymphoma in a dog with leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Leishmaniasis; Lymphoma, T-Cell; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2008 |
Detection of Leishmania kDNA in human serum samples for the diagnosis of visceral leishmaniasis.
Topics: Adolescent; Adult; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Brazil; Child; Child, Preschool; DNA, Kinetoplast; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Sensitivity and Specificity; Young Adult | 2009 |
Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran.
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Interferon-gamma; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2008 |
Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
Topics: Administration, Topical; Adult; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trichloroacetic Acid | 2008 |
[Outbreak of cutaneous leishmaniasis: about 213 cases in the province of Tizi-Ouzou].
Topics: Adolescent; Adult; Aged; Algeria; Antiprotozoal Agents; Child; Child, Preschool; Disease Outbreaks; Endemic Diseases; Facial Dermatoses; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2009 |
Cutaneous leishmaniasis imported from Colombia to Northcentral Venezuela: implications for travel advice.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Colombia; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Travel; Treatment Outcome; Venezuela; Young Adult | 2008 |
Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.
Topics: Animals; Antiprotozoal Agents; Blood Cell Count; Leishmania mexicana; Leishmaniasis, Cutaneous; Lymph Nodes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred CBA; Nitric Oxide; Organometallic Compounds; Structure-Activity Relationship; Thiadiazoles | 2009 |
Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil.
Topics: Acute Kidney Injury; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Ureohydrolases | 2008 |
The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Colombia; Female; Humans; Hyperthermia, Induced; Infant; Infant, Newborn; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
[Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Tunisia; Young Adult | 2008 |
Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime.
Topics: Administration, Oral; Adult; Animals; Antimony; Antiprotozoal Agents; Atrial Premature Complexes; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Prospective Studies; Ventricular Premature Complexes | 2008 |
Glibenclamide modulates glucantime activity and disposition in Leishmania major.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Cells, Cultured; Drug Synergism; Glyburide; Leishmania major; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Electron; Organometallic Compounds | 2009 |
Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment.
Topics: Animals; Antigens, Protozoan; Case-Control Studies; Concanavalin A; Female; Follow-Up Studies; Humans; Immunity, Cellular; Interferon-gamma; Interleukin-10; Leishmania braziliensis; Leishmaniasis, Cutaneous; Leukocytes, Mononuclear; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Statistics, Nonparametric; Treatment Outcome | 2009 |
Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Bone Marrow; Dog Diseases; Dogs; Female; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2009 |
Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
Topics: Achillea; Administration, Cutaneous; Animals; Antiprotozoal Agents; Female; Injections, Intraperitoneal; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phytotherapy; Plant Extracts; Propolis; Thymus Plant; Treatment Outcome | 2008 |
[Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us].
Topics: Animals; Antiprotozoal Agents; Comorbidity; Disease Reservoirs; Dog Diseases; Dogs; Drug Utilization; HIV Infections; Humans; Incidence; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 2009 |
Localized cutaneous leishmaniasis of the plantar region: a 40-year outcome.
Topics: Aged; Animals; Antiprotozoal Agents; DNA, Protozoan; Drug Administration Schedule; Foot; Gene Amplification; Humans; Injections, Intravenous; Leishmania; Leishmaniasis, Cutaneous; Male; Medical Records; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2008 |
Childhood cutaneous leishmaniasis: Experience of a Moroccan unit of dermatology.
Topics: Antiprotozoal Agents; Child; Dermatology; Face; Female; Hospitals, University; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Retrospective Studies; Sex Distribution; Treatment Outcome | 2008 |
[Cutaneous leishmaniasis in rheumatoid arthritis].
Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds; Prednisone | 2009 |
Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Flow Cytometry; Gene Expression; Green Fluorescent Proteins; Humans; Leishmania guyanensis; Luminescent Agents; Macrophages; Meglumine; Meglumine Antimoniate; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Organometallic Compounds; Transfection; U937 Cells | 2009 |
What is your diagnosis? Peritoneal effusion from a dog.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Ascitic Fluid; Dog Diseases; Dogs; Female; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2009 |
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult | 2009 |
Rhinophymous leishmaniasis: A new variant.
Topics: Aged; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rhinophyma | 2009 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine | 2009 |
Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrode.
Topics: Antimony; Chemistry, Pharmaceutical; Electrodes; Hydrogen-Ion Concentration; Meglumine; Meglumine Antimoniate; Nanotubes, Carbon; Organometallic Compounds; Osmolar Concentration; Potentiometry | 2009 |
Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Cardiovascular Abnormalities; Child; Child, Preschool; Electrocardiography; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2009 |
Drug hypersensitivity syndrome induced by meglumine antimoniate.
Topics: Adult; Antiprotozoal Agents; Drug Hypersensitivity; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Syndrome | 2009 |
Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Brazil; Facial Dermatoses; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult | 2009 |
Antileishmaniasis activity of flavonoids from Consolida oliveriana.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Flavonoids; Galactosides; Kaempferols; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Ranunculaceae; Rats; Rats, Inbred Strains; Turkey | 2009 |
Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Topics: Adolescent; Adult; Antiprotozoal Agents; Female; Heart; Humans; Leishmaniasis, Visceral; Liver Failure; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancreatitis; Renal Insufficiency | 2009 |
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
Topics: Amphotericin B; Amyloidosis; Anti-HIV Agents; Antiprotozoal Agents; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2009 |
[Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].
Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia | 2008 |
Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Asthenia; Bone Marrow; Brazil; CD4 Lymphocyte Count; Cough; Diarrhea; Female; Fever; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Splenomegaly; Time Factors; Weight Loss | 2009 |
The potential utility of green tea extract as a novel treatment for cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Camellia sinensis; Drug Resistance; Flavonoids; Humans; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Tea | 2009 |
Administration of miltefosine and meglumine antimoniate in healthy dogs: clinicopathological evaluation of the impact on the kidneys.
Topics: Animals; Antiprotozoal Agents; Body Weight; Dogs; Female; Fluorescent Antibody Technique; Histocytochemistry; Kidney; Kidney Diseases; Kidney Tubules; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Microscopy, Electron; Organometallic Compounds; Phosphorylcholine; Random Allocation; Toxicity Tests | 2009 |
[Mucosal complication of cutaneous leishmaniasis].
Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney Failure, Chronic; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds; Phosphorylcholine | 2009 |
Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta).
Topics: Animals; Antimony; Antiprotozoal Agents; Kidney; Leishmania braziliensis; Leishmaniasis, Cutaneous; Liver; Macaca mulatta; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen | 2010 |
In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests | 2010 |
Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
Topics: Antibodies, Monoclonal; Antiprotozoal Agents; Antirheumatic Agents; Humans; Infliximab; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha | 2010 |
Genotoxic effects of the antileishmanial drug Glucantime.
Topics: Animals; Antimony; Apoptosis; Bone Marrow Cells; Cells, Cultured; Comet Assay; DNA; DNA Damage; Female; Humans; Lymphocytes; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagens; Organometallic Compounds; Oxidation-Reduction; Trypanocidal Agents | 2010 |
Antimony in plasma and skin of patients with cutaneous leishmaniasis--relationship with side effects after treatment with meglumine antimoniate.
Topics: Adult; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Cutaneous; Male; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin; Treatment Outcome | 2009 |
Short report: Contribution of quantitative real-time polymerase chain reaction to follow-up of visceral leishmaniasis patients treated with meglumine antimoniate.
Topics: Antiprotozoal Agents; DNA, Protozoan; Follow-Up Studies; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction | 2009 |
Prolonged absorption of antimony(V) by the oral route from non-inclusion meglumine antimoniate-beta-cyclodextrin conjugates.
Topics: Absorption; Administration, Oral; Animals; Antimony; beta-Cyclodextrins; Circular Dichroism; Delayed-Action Preparations; Dogs; Female; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2010 |
Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
Topics: Allopurinol; Bone Marrow Examination; Humans; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Time Factors; Treatment Outcome; Trypanocidal Agents; Tunisia | 2010 |
Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Topics: Adolescent; Age Distribution; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome; Turkey | 2009 |
Some remarks about the LeishVet directions for the treatment of canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Guidelines as Topic; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
Cutaneous leishmaniasis of the lid: a report of nine cases.
Topics: Adolescent; Adult; Child; Eyelid Diseases; Eyelids; Female; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult | 2010 |
[Visceral leishmaniasis in immunocompetent adult with severe sepsis].
Topics: Antiprotozoal Agents; Echocardiography; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sepsis | 2010 |
Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; California; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Infusions, Intravenous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Referral and Consultation | 2010 |
[Visceral childhood leishmaniasis: diagnosis and treatment].
Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 2010 |
American tegumentary leishmaniasis in older adults: 44 cases treated with an intermittent low-dose antimonial schedule in Rio de Janeiro, Brazil.
Topics: Age Factors; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2010 |
[Side effects of meglumine antimoniate in cutaneous leishmaniasis: 15 cases].
Topics: Adolescent; Adult; Aged; Animals; Antiprotozoal Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome | 2010 |
Leishmanicidal activity of racemic +/- 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline.
Topics: Animals; Antiprotozoal Agents; Cell Survival; HeLa Cells; Humans; Leishmania mexicana; Lethal Dose 50; Meglumine; Meglumine Antimoniate; Motor Activity; Organometallic Compounds; Quinolines | 2010 |
A case with two unusual findings: cutaneous leishmaniasis presenting as panniculitis and pericarditis after antimony therapy.
Topics: Antiprotozoal Agents; Chest Pain; DNA, Protozoan; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Panniculitis; Pericarditis | 2010 |
Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes.
Topics: Animals; Antimony; Antiprotozoal Agents; Brazil; Drug Resistance; Gene Expression Profiling; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasites; Treatment Outcome | 2010 |
A 48-year-old man with laryngeal mass and vocal cord palsy.
Topics: Antiprotozoal Agents; HIV Infections; Humans; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Vocal Cord Paralysis | 2010 |
Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil.
Topics: Adolescent; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2010 |
Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006.
Topics: Adolescent; Allopurinol; Child; Face; Female; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence | 2010 |
Risk factors associated with dizziness during treatment of mucosal leishmaniasis with meglumine antimoniate: 16-year retrospective study of cases from Rio de Janeiro, Brazil.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Female; Humans; Leishmaniasis, Mucocutaneous; Lipase; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Odds Ratio; Organometallic Compounds; Retrospective Studies; Risk Factors; Sex Distribution; Young Adult | 2010 |
Long term follow-up of dogs diagnosed with leishmaniosis (clinical stage II) and treated with meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Follow-Up Studies; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Severity of Illness Index; Time Factors; Treatment Outcome | 2011 |
Childhood and adult cutaneous leishmaniasis in Tunisia.
Topics: Adolescent; Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Sex Distribution; Tunisia; Young Adult | 2010 |
Glucantime fever with parenteral meglumine antimonate in patients of cutaneous leishmaniasis.
Topics: Antimony; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2010 |
Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cricetinae; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Lizards; Macrophages; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; U937 Cells | 2010 |
Leishmania amazonensis META2 protein confers protection against heat shock and oxidative stress.
Topics: Animals; Antiprotozoal Agents; Blotting, Western; Fluorescent Antibody Technique; Gene Expression Regulation; Hot Temperature; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Mutation; Novobiocin; Nucleic Acid Synthesis Inhibitors; Organometallic Compounds; Oxidative Stress; Protozoan Proteins; Recombinant Proteins; RNA Interference; Trypanosoma brucei brucei | 2011 |
Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Biopsy; CD4 Lymphocyte Count; Humans; Immunocompromised Host; Iran; Leishmania tropica; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Substance Abuse, Intravenous; Travel | 2010 |
Lupoid leishmaniasis due to Leishmania major with remaining large scars: report of 2 cases.
Topics: Adolescent; Adult; Antiprotozoal Agents; Chronic Disease; Cicatrix; Diagnosis, Differential; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Lupus Vulgaris; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Outcome | 2010 |
HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Brazil; CD4 Lymphocyte Count; Endemic Diseases; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Viral Load; Young Adult | 2010 |
Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).
Topics: Adolescent; Albania; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Microscopy; Organometallic Compounds; Parasitology; Retrospective Studies; Serologic Tests | 2010 |
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Comorbidity; Ethiopia; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreatitis; Renal Insufficiency; Treatment Outcome; Young Adult | 2010 |
[Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Drug Therapy, Combination; Etoposide; Fatal Outcome; Glucocorticoids; Humans; Immunoglobulins; Infant; Leishmania; Leishmaniasis, Visceral; Lymphohistiocytosis, Hemophagocytic; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2010 |
[Mucocutaneous leishmaniasis in Morocco, evidence of the parasite's ecological evolution?].
Topics: Adolescent; Africa; Antiprotozoal Agents; Biological Evolution; Cheilitis; Host-Parasite Interactions; Humans; Immunocompetence; Latin America; Leishmania; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Species Specificity; Virulence | 2011 |
Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.
Topics: Adult; Antimony; Antiprotozoal Agents; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Leishmaniasis, Cutaneous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regeneration; Skin; Transforming Growth Factor beta; Treatment Failure | 2011 |
Risk factors for relapse of visceral leishmaniasis in Georgia.
Topics: Age Factors; Antiprotozoal Agents; Child; Child, Preschool; Delayed Diagnosis; Female; Georgia (Republic); Hemoglobins; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prognosis; Recurrence; Risk Factors | 2011 |
Unusual form of cutaneous leishmaniasis: erysipeloid form.
Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Erysipeloid; Facial Dermatoses; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Skin | 2011 |
Multidetector computed tomography aspects of tracheal mucosal leishmaniasis localization.
Topics: Aged; Antiprotozoal Agents; Bronchoscopy; Contrast Media; Humans; Imaging, Three-Dimensional; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Tracheal Diseases | 2011 |
[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
Topics: Adult; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antiprotozoal Agents; Antiviral Agents; Epstein-Barr Virus Infections; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Lymphoproliferative Disorders; Male; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Postoperative Complications; Remission Induction; Rituximab; Sirolimus | 2011 |
Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Imiquimod; Immunotherapy; Leishmania major; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome | 2011 |
Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Humans; Infectious Disease Transmission, Vertical; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Treatment Outcome | 2011 |
[Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].
Topics: Adolescent; Anti-Inflammatory Agents; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methylprednisolone; Organometallic Compounds; Panuveitis; Prednisone | 2011 |
Detection of Leishmania amastigotes in peripheral blood from four dogs--Short communication.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2011 |
Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Female; Humans; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2011 |
Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminoquinolines; Animals; Antigens, CD; Antigens, CD1; Antigens, CD20; Antigens, Differentiation, Myelomonocytic; Antiprotozoal Agents; B-Lymphocytes; CD3 Complex; Child; Dermis; Drug Therapy, Combination; Epidermis; Female; Humans; Imiquimod; Iran; Langerhans Cells; Leishmania tropica; Leishmaniasis, Cutaneous; Lymphocyte Count; Macrophages; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Parasite Load; Single-Blind Method; T-Lymphocytes; Young Adult | 2011 |
An experimental approach to studying the effectiveness and safety of meglumine antimoniate formulations.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Immunomodulation; In Vitro Techniques; Injections, Intramuscular; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Organometallic Compounds; Species Specificity; Toxicity Tests | 2011 |
Leishmania amazonensis: effects of oral treatment with copaiba oil in mice.
Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Cell Membrane; Cell Membrane Permeability; Cyclophosphamide; Erythrocytes; Fabaceae; Flow Cytometry; Humans; Injections, Subcutaneous; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Membrane Potentials; Mice; Mice, Inbred BALB C; Micronucleus Tests; Microscopy, Electron, Scanning; Mitochondria; Mutagens; Organometallic Compounds; Plant Oils | 2011 |
Cutaneous leishmaniasis with pseudoepitheliomatous hyperplasia simulating squamous cell carcinoma.
Topics: Antiprotozoal Agents; Carcinoma, Squamous Cell; Diagnosis, Differential; Epithelial Cells; Humans; Hyperplasia; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2011 |
Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Cholesterol; Dose-Response Relationship, Drug; Drug Compounding; Drug Delivery Systems; Excipients; Fluorescence; Humans; Indicators and Reagents; Leishmania major; Leishmaniasis; Liposomes; Macrophages; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Organometallic Compounds; Oxazines; Phosphatidylserines; Xanthenes | 2011 |
The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Calcium Channel Blockers; Colorimetry; Disease Models, Animal; Drug Synergism; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Verapamil | 2012 |
Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World.
Topics: Adolescent; Adult; Antiprotozoal Agents; Humans; Injections, Intralesional; Leishmaniasis, Mucocutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2012 |
The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Thiadiazoles; Treatment Outcome | 2012 |
Treatment of imported New World cutaneous leishmaniasis in Germany.
Topics: Adolescent; Adult; Aged; Amphotericin B; Animals; Antiprotozoal Agents; Female; Germany; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Travel; Young Adult | 2011 |
Disposition of antimony in rhesus monkeys infected with Leishmania braziliensis and treated with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Erythrocytes; Female; Half-Life; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macaca mulatta; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Oxidation-Reduction; Reproducibility of Results; Spectrophotometry, Atomic; Thyroid Gland; Tissue Distribution | 2012 |
Serological monitoring of paediatric visceral leishmaniasis By IFA and ELISA methods.
Topics: Adolescent; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; DNA, Protozoan; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Turkey | 2011 |
Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
Topics: Animals; Antiprotozoal Agents; Azure Stains; DNA, Protozoan; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Phosphorylcholine; Time Factors; Ulcer | 2012 |
Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
Topics: Antiprotozoal Agents; Child; Diagnosis, Differential; Facial Dermatoses; Humans; Leishmania; Leishmaniasis, Cutaneous; Lupus Erythematosus, Discoid; Lupus Vulgaris; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Treatment Outcome | 2012 |
In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure.
Topics: Algeria; Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dogs; Female; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation?
Topics: Adolescent; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Ethiopia; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leprosy, Tuberculoid; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2013 |
Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp.
Topics: Antiprotozoal Agents; Cell Line; Humans; Leishmania; Leishmaniasis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load; Parasitic Sensitivity Tests; Phosphorylcholine; Temperature | 2012 |
Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
Topics: Antiprotozoal Agents; Cells, Cultured; Drug Resistance, Microbial; Electrophoresis, Gel, Two-Dimensional; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics | 2012 |
Novel immunomodulatory function of 1,3,4-thiadiazole derivatives with leishmanicidal activity.
Topics: Animals; Antiprotozoal Agents; Cytokines; Disease Models, Animal; Histocytochemistry; Immunologic Factors; Injections, Intraperitoneal; Leishmaniasis; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Skin; Spleen; Thiadiazoles; Treatment Outcome | 2012 |
Possible links between sickle cell crisis and pentavalent antimony.
Topics: Anemia, Sickle Cell; Antimony; Child; Glutathione; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
Tongue nodules in canine leishmaniosis--a case report.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue; Tongue Diseases | 2012 |
Renal function evaluation in patients with American cutaneous leishmaniasis after specific treatment with pentavalent antimonial.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Kidney; Kidney Diseases; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Statistics, Nonparametric; Urban Population; Young Adult | 2012 |
Meglumine antimonate treatment enhances phagocytosis and TNF-α production by monocytes in human cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Brazil; Female; Humans; Hydrogen Peroxide; Interleukin-10; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Monocytes; Organometallic Compounds; Phagocytosis; Tumor Necrosis Factor-alpha | 2012 |
Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Antiprotozoal Agents; Child; Child, Preschool; Cross-Sectional Studies; Erythema; Female; Humans; Infant; Injections, Intralesional; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Pruritus; Treatment Outcome; Vomiting; Young Adult | 2012 |
Evaluation of the cardiac toxicity of N-methyl-glucamine antimoniate in dogs with naturally occurring leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Electrocardiography; Heart; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies; Troponin I | 2013 |
Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab.
Topics: Adalimumab; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds | 2012 |
Speciation of antimony in injectable drugs used for leishmaniasis treatment (Glucantime®) by HPLC-ICP-MS and DPP.
Topics: Antimony; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Humans; Leishmania; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pharmaceutical Preparations; Sensitivity and Specificity | 2012 |
Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis.
Topics: Adult; Aged; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin Tests | 2012 |
Quinolinic alkaloids from Galipea longiflora Krause suppress production of proinflammatory cytokines in vitro and control inflammation in vivo upon Leishmania infection in mice.
Topics: Alkaloids; Animals; Antigens, Protozoan; Antiprotozoal Agents; Cells, Cultured; Cytokines; Female; Immunosuppression Therapy; Inflammation Mediators; Leishmania braziliensis; Leishmaniasis; Lymphocyte Activation; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Organometallic Compounds; Parasite Load; Plant Extracts; Quinolines; Rutaceae; T-Lymphocytes | 2013 |
Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
Topics: Antigens, Protozoan; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Humans; Interferon-gamma; Interleukin-10; Interleukin-4; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tumor Necrosis Factor-alpha | 2012 |
Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Treatment Outcome | 2013 |
Early enlargement of an ulcerated area during leishmaniasis treatment with meglumine antimoniate in Brazil.
Topics: Antiprotozoal Agents; Brazil; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Outcome Assessment, Health Care; Skin Ulcer | 2013 |
Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis.
Topics: Antiprotozoal Agents; Child; Child, Preschool; DNA, Kinetoplast; Female; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Real-Time Polymerase Chain Reaction; Treatment Outcome | 2013 |
Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
Topics: Amino Acid Substitution; Animals; Antiprotozoal Agents; Base Sequence; Brazil; DNA, Protozoan; Drug Resistance; Genetic Markers; HSP70 Heat-Shock Proteins; Humans; Leishmania braziliensis; Leishmania guyanensis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Molecular Sequence Data; Mutation; Organometallic Compounds; Polymorphism, Genetic; Prognosis; Protozoan Proteins; Sequence Analysis, DNA; Treatment Outcome | 2013 |
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing | 2013 |
Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Intralesional; Injections, Intramuscular; Iran; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study.
Topics: Antiprotozoal Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Compounding; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Lactic Acid; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Microscopy, Electron, Scanning; Microspheres; Organometallic Compounds; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectrometry, X-Ray Emission; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2014 |
Unexpectedly high levels of antimony (III) in the pentavalent antimonial drug Glucantime: insights from a new voltammetric approach.
Topics: Antimony; Electrochemical Techniques; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osmolar Concentration | 2013 |
Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hypothyroidism; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Thyrotropin; Thyroxine | 2013 |
[Differential expression of proteins in Leishmania (Viannia) panamensis associated with mechanisms of resistance to meglumine antimoniate].
Topics: Antiprotozoal Agents; Drug Resistance; Electrophoresis, Gel, Two-Dimensional; Gene Expression Regulation; In Vitro Techniques; Leishmania guyanensis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics; Protozoan Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; RNA, Protozoan; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Subtraction Technique | 2012 |
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine | 2013 |
Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression.
Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Leishmania donovani; Meglumine; Meglumine Antimoniate; Membrane Proteins; Organometallic Compounds; Phosphorylcholine; Protozoan Proteins; Rhodamine 123 | 2013 |
Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Retrospective Studies; Species Specificity; Switzerland; Travel; Treatment Outcome; Young Adult | 2013 |
In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes.
Topics: Antiprotozoal Agents; Biuret; Colorimetry; Leishmania infantum; Leishmania major; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phylogeny | 2013 |
Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Apoptosis; Cytokines; DNA Fragmentation; Female; Immunologic Factors; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Lignans; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nitric Oxide; Organometallic Compounds | 2013 |
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Time Factors; Tissue Distribution | 2013 |
Cutaneous leishmaniasis "chiclero's ulcer" in subtropical Ecuador.
Topics: Administration, Topical; Adolescent; Antiprotozoal Agents; Ear; Ecuador; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Ulcer; Thimerosal | 2013 |
Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
Topics: Amplified Fragment Length Polymorphism Analysis; Antimony; Antiprotozoal Agents; Cell Line; DNA Fragmentation; DNA, Complementary; DNA, Protozoan; Drug Resistance; Genes, Protozoan; Inhibitory Concentration 50; Leishmania tropica; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Protozoan | 2013 |
Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.
Topics: Adult; Antiprotozoal Agents; Cell Survival; Female; Gene Expression Profiling; Host-Pathogen Interactions; Humans; Leishmania; Macrophages; Male; Meglumine; Meglumine Antimoniate; Membrane Transport Proteins; Middle Aged; Organometallic Compounds; Young Adult | 2014 |
Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman.
Topics: Aged, 80 and over; Antibodies, Protozoan; Antiprotozoal Agents; Erythema; Facial Dermatoses; False Negative Reactions; Female; Humans; Inclusion Bodies; Leishmania infantum; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Scalp Dermatoses; Staining and Labeling | 2013 |
Oxidative stress in mice treated with antileishmanial meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Brain; Brain Chemistry; Catalase; Glutathione; Heart; Kidney; Lipid Peroxidation; Liver; Meglumine; Meglumine Antimoniate; Mice; Myocardium; Organometallic Compounds; Oxidative Stress; Protein Carbonylation; Spleen; Superoxide Dismutase | 2013 |
Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine leishmaniasis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Aryldialkylphosphatase; Biomarkers; Case-Control Studies; Dog Diseases; Dogs; Drug Therapy, Combination; Enzyme Activation; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2014 |
Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid.
Topics: Animals; Ascorbic Acid; Female; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds | 2014 |
[Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis].
Topics: Antiprotozoal Agents; Child; Combined Modality Therapy; Cryotherapy; Facial Dermatoses; Female; France; Humans; Injections, Intralesional; Leishmania infantum; Leishmaniasis, Cutaneous; Mediterranean Region; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2013 |
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes.
Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles | 2014 |
Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate.
Topics: Adult; Antiprotozoal Agents; Antirheumatic Agents; Arthritis, Psoriatic; Combined Modality Therapy; Cryotherapy; Humans; Infliximab; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2014 |
Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Line; Drug Therapy, Combination; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Propolis; Spleen; Water | 2014 |
An atypical case of cutaneous leishmaniasis caused by Leishmania infantum in Portugal.
Topics: Aged; Antiprotozoal Agents; Humans; Leishmania infantum; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Portugal | 2013 |
Nonhealing ulcers: an infectious viewpoint.
Topics: Antiprotozoal Agents; Biopsy; Diagnosis, Differential; Female; Humans; Iran; Leg Ulcer; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Wound Healing | 2014 |
[Cutaneous leishmaniasis and multidermatomic herpes zoster].
Topics: Adult; Antiprotozoal Agents; Female; Herpes Zoster; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases, Viral | 2013 |
Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Topics: Animals; Drug Therapy, Combination; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Silymarin | 2015 |
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil.
Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult | 2015 |
Papular dermatitis due to Leishmania infantum infection in seventeen dogs: diagnostic features, extent of the infection and treatment outcome.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Dermatitis; DNA, Protozoan; DNA, Ribosomal Spacer; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Molecular Typing; Organometallic Compounds; Prognosis; Protozoan Proteins; Real-Time Polymerase Chain Reaction; Sequence Analysis, DNA; Skin Tests; Treatment Outcome | 2014 |
Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Cell Line; Female; Leishmania major; Leishmaniasis, Cutaneous; Liposomes; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Random Allocation; Skin; Spleen | 2014 |
Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs.
Topics: Administration, Oral; Animals; Antimony; Biological Availability; Carbohydrates; Circular Dichroism; Cyclodextrins; Humans; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds | 2014 |
Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.
Topics: Animals; Antiparasitic Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Lipase; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pancreas; Troponin I | 2014 |
Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.
Topics: Amphotericin B; Anemia; Antiprotozoal Agents; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Endemic Diseases; Fever; Humans; Infant; Iran; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2014 |
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Cohort Studies; Colombia; Drug Resistance; Humans; Infant; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Randomized Controlled Trials as Topic; Young Adult | 2014 |
Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran.
Topics: Antiprotozoal Agents; Antitubercular Agents; Child; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pleural Effusion; Polymerase Chain Reaction; Tomography, X-Ray Computed; Tuberculosis, Pulmonary | 2014 |
Cutaneous Leishmaniasis with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; HIV Infections; Humans; Immunocompromised Host; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2014 |
Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cheilitis; Combined Modality Therapy; Communicable Diseases, Emerging; Cryotherapy; Female; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Mucocutaneous; Lip; Lip Diseases; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Tunisia; Young Adult | 2015 |
Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area.
Topics: Algeria; Antiprotozoal Agents; Drug Resistance; France; Gene Expression Regulation; Genotype; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Metabolic Networks and Pathways; Organometallic Compounds; Parasitic Sensitivity Tests; Phenotype; Protozoan Proteins; Tunisia | 2014 |
Immune reconstitution-associated cutaneous sarcoid-like eruption in a patient with previous disseminated cutaneous leishmaniasis: a diagnostic challenge.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Drug Eruptions; Granuloma; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sarcoidosis | 2014 |
Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Chemistry, Pharmaceutical; Dog Diseases; Dogs; Drug Carriers; Drug Delivery Systems; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasite Load; Polyethylene Glycols; Spleen | 2014 |
In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis.
Topics: Animals; Antiprotozoal Agents; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Phosphorylcholine; Spleen | 2014 |
Tissue distribution of residual antimony in rats treated with multiple doses of meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Rats, Wistar; Time Factors; Tissue Distribution | 2014 |
Preliminary study on tubuloglomerular dysfunction and evidence of renal inflammation in patients with visceral leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Chemokine CCL2; Female; Humans; Inflammation; Kidney; Kidney Diseases; Leishmaniasis, Visceral; Male; Malondialdehyde; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2014 |
A 45 year old man with an ulcerated nodule on his right leg.
Topics: Antiprotozoal Agents; Humans; Injections, Intralesional; Leg Ulcer; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2014 |
Soy isoflavones have antimutagenic activity on DNA damage induced by the antileishmanial Glucantime (meglumine antimoniate).
Topics: Animals; Antimutagenic Agents; Antioxidants; Antiprotozoal Agents; Comet Assay; DNA Damage; Female; Glycine max; Isoflavones; Male; Meglumine; Meglumine Antimoniate; Mice; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutation; Organometallic Compounds; Oxidative Stress | 2015 |
Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Lebanon; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Refugees; Syria; Young Adult | 2014 |
[Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment].
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Diptera; DNA, Intergenic; DNA, Protozoan; Drug Resistance; Humans; Larva; Leishmania; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2014 |
[Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco].
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Cicatrix; Disease Progression; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Morocco; Nitrogen; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
Mucosal leishmaniasis of the tongue caused by Leishmania infantum in an immunocompetent woman.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Immunocompetence; Leishmania infantum; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tongue Diseases | 2015 |
Oral manifestations in the American tegumentary leishmaniasis.
Topics: Antiprotozoal Agents; Female; Humans; Larynx; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nose; Nose Diseases; Organometallic Compounds; Pharynx; Prognosis; Retrospective Studies | 2014 |
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds | 2015 |
Effects of in utero and lactational exposure to SbV on rat neurobehavioral development and fertility.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Estrus; Female; Fertility; Fetus; Lactation; Male; Meglumine; Meglumine Antimoniate; Milk; Motor Activity; Organometallic Compounds; Pregnancy; Rats; Rats, Wistar | 2014 |
Cutaneous leishmaniasis: 20 years' experience in a Spanish tertiary care hospital.
Topics: Adolescent; Adult; Africa, Northern; Aged; Antiprotozoal Agents; Comorbidity; Emigrants and Immigrants; Endemic Diseases; Female; HIV Infections; Humans; Immunocompromised Host; Latin America; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Spain; Tertiary Care Centers; Young Adult | 2015 |
The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
Topics: Adolescent; Adult; Antiprotozoal Agents; Cells, Cultured; Cytokines; Female; Humans; Interferon-gamma; Interleukin-10; Interleukin-17; Leishmaniasis, Visceral; Lymphocytes; Male; Meglumine; Meglumine Antimoniate; Monocytes; Nitric Oxide; Organometallic Compounds; Toll-Like Receptor 2; Toll-Like Receptor 4; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1.
Topics: 3' Untranslated Regions; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Aquaglyceroporins; Aquaporin 1; Cell Movement; Drug Resistance; Gene Expression Regulation; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; RNA, Messenger; RNA, Protozoan | 2015 |
In vitro sensitivity of paired Leishmania (Viannia) braziliensis samples isolated before meglumine antimoniate treatment and after treatment failure or reactivation of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Female; Humans; Leishmania braziliensis; Leishmaniasis; Lethal Dose 50; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Skin | 2015 |
[Facial inflammatory cutaneous leishmaniasis or "erysipeloid"].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiprotozoal Agents; Erysipeloid; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Postmenopause | 2015 |
Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient.
Topics: Antiprotozoal Agents; Biopsy; Carcinoma, Squamous Cell; Diagnosis, Differential; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Liver Transplantation; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth; Organometallic Compounds; Polymerase Chain Reaction | 2015 |
Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum.
Topics: Animals; Anthelmintics; Bibenzyls; Disease Models, Animal; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Phenols; Spleen | 2015 |
Apoptosis and frequency of total and effector CD8+ T lymphocytes from cutaneous leishmaniasis patients during antimonial therapy.
Topics: Adult; Antigens, Protozoan; Antiprotozoal Agents; Apoptosis; Brazil; CD8-Positive T-Lymphocytes; Cohort Studies; Female; Flow Cytometry; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Young Adult | 2015 |
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests | 2015 |
[Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
Topics: Administration, Intravenous; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Insect Bites and Stings; Insect Vectors; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus | 2015 |
[Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations].
Topics: Africa, Northern; Amphotericin B; Animals; Antiprotozoal Agents; Developing Countries; Disease Management; Disease Reservoirs; Dog Diseases; Dogs; Drug Substitution; Early Diagnosis; Humans; Immunologic Tests; Insect Control; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Zoonoses | 2015 |
Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
Topics: Adolescent; Animals; Antiprotozoal Agents; Female; Humans; Immunologic Factors; Interferon-alpha; Interleukin-10; Interleukin-13; Leishmania; Leishmaniasis; Leukocytes, Mononuclear; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Effectiveness of meglumine antimoniate against L. tropica in a recently emerged focus of cutaneous leishmaniasis in Birjand, eastern Islamic Republic of Iran.
Topics: Antiprotozoal Agents; Child; Female; Humans; Injections, Intralesional; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Outcome Assessment, Health Care; Surveys and Questionnaires; Treatment Outcome | 2015 |
[Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
Topics: Amphotericin B; Antiprotozoal Agents; Child, Preschool; Humans; Iran; Iraq; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Turkey | 2015 |
Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Young Adult | 2016 |
The pentavalent antimonial therapy against experimental Leishmania amazonensis infection is more effective under the inhibition of the NF-κB pathway.
Topics: Animals; Antiprotozoal Agents; Drug Therapy, Combination; Interleukin-10; Interleukin-12; Interleukin-1beta; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; NF-kappa B; Organometallic Compounds; Phenyl Ethers; Quinazolines; Signal Transduction | 2015 |
Can Intestinal Intussusception Complicate Visceral Leishmaniasis?
Topics: Antiprotozoal Agents; Child, Preschool; Humans; Ileal Diseases; Intussusception; Laparotomy; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly | 2016 |
Orofacial granulomatosis: do not forget leishmaniasis.
Topics: Antiprotozoal Agents; Diagnosis, Differential; Granulomatosis, Orofacial; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult | 2015 |
Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Topics: Animals; Antiprotozoal Agents; Chitosan; Female; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome | 2015 |
Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Appointments and Schedules; Disease Models, Animal; Drug Therapy, Combination; Injections, Intramuscular; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Paromomycin; Phosphorylcholine; Skin; Spleen; Treatment Outcome | 2015 |
[Erysipeloid cutaneous leishmaniasis: about a clinical observation].
Topics: Adult; Antiprotozoal Agents; Erysipeloid; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Nose Diseases; Organometallic Compounds | 2015 |
Cutaneous leishmaniasis mimicking granulomatous cheilitis and treated successfully with oral fluconazole in a boy.
Topics: Antiprotozoal Agents; Child; Diagnosis, Differential; Fluconazole; Humans; Leishmaniasis, Cutaneous; Lip; Male; Meglumine; Meglumine Antimoniate; Melkersson-Rosenthal Syndrome; Organometallic Compounds; Treatment Outcome | 2015 |
[Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases].
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Amphotericin B; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Bone Marrow; Female; Humans; Injections, Intramuscular; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2015 |
Propolis reduces Leishmania amazonensis-induced inflammation in the liver of BALB/c mice.
Topics: Animals; Cytokines; Inflammation; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Propolis | 2016 |
Antileishmanial Activities of Greek Juniper (Juniperus excelsa M.Bieb.) Against Leishmania major Promastigotes.
Topics: Antiprotozoal Agents; Fruit; Inhibitory Concentration 50; Juniperus; Leishmania major; Life Cycle Stages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Plant Extracts; Plant Leaves | 2017 |
Tumour Necrosis Factor-alpha (TNF-α) and its soluble receptor type 1 (sTNFR I) in human active and healed leishmaniases.
Topics: Adult; Antiprotozoal Agents; Case-Control Studies; Female; Humans; Interleukin-17; Interleukin-22; Interleukins; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Receptors, Tumor Necrosis Factor, Type I; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
In Vitro and In Vivo Antileishmanial Activities of Pistacia vera Essential Oil.
Topics: Animals; Antiprotozoal Agents; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Oils, Volatile; Organometallic Compounds; Pistacia | 2016 |
Cutaneous Leishmaniasis: An Overlooked Etiology of Midfacial Destructive Lesions.
Topics: Adolescent; Adult; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nose; Nose Diseases; Organometallic Compounds; Polymerase Chain Reaction; Young Adult | 2016 |
In vivo antileishmanial activity and chemical profile of polar extract from Selaginella sellowii.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Biflavonoids; Chromatography, High Pressure Liquid; Cricetinae; Drainage; Foot; Glycosides; Infusions, Intralesional; Leishmania; Leukocytes, Mononuclear; Macrophages; Male; Meglumine; Meglumine Antimoniate; Nitric Oxide; Organometallic Compounds; Parasite Load; Plant Extracts; Selaginellaceae; Solvents; Tandem Mass Spectrometry | 2016 |
Cytotoxic cell involvement in human cutaneous leishmaniasis: assessments in active disease, under therapy and after clinical cure.
Topics: Adult; Antiprotozoal Agents; CD4 Lymphocyte Count; Cell Degranulation; Cells, Cultured; Cytotoxicity, Immunologic; Female; Humans; Killer Cells, Natural; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Natural Killer T-Cells; Organometallic Compounds; Young Adult | 2016 |
Visceral Leishmaniasis in Southwestern Iran: A Retrospective Clinico-Hematological Analysis of 380 Consecutive Hospitalized Cases (1999-2014).
Topics: Adolescent; Adult; Aged; Amphotericin B; Bone Marrow Cells; C-Reactive Protein; Child; Child, Preschool; Female; Hospitalization; Humans; Infant; Iran; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Thrombocytopenia; Young Adult | 2016 |
Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology.
Topics: Algeria; Animals; Disease Models, Animal; Humans; Leishmania infantum; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Spleen | 2016 |
AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT.
Topics: Amphotericin B; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2016 |
Two small yellowish papules in a 1 year-old boy: cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Facial Dermatoses; Humans; Infant; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin | 2016 |
Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; DNA, Protozoan; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Real-Time Polymerase Chain Reaction | 2016 |
In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
Topics: Adult; Aged; Animals; Antiprotozoal Agents; Brazil; Complement System Proteins; Cytokines; DNA, Protozoan; Female; Guinea Pigs; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Male; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Middle Aged; Nitric Oxide; Organometallic Compounds; Random Amplified Polymorphic DNA Technique | 2016 |
Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cricetinae; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania infantum; Liposomes; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphatidylserines | 2016 |
Hair parasite load as a new biomarker for monitoring treatment response in canine leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Hair; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load | 2016 |
Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis.
Topics: Adult; Drug Hypersensitivity; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2017 |
Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Brazil; Fatal Outcome; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Mucosa; Organometallic Compounds; Polymerase Chain Reaction; Skin Tests | 2016 |
Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
Topics: Adult; Antiprotozoal Agents; Cohort Studies; Cross-Sectional Studies; Humans; Inhibitory Concentration 50; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Treatment Failure; U937 Cells; Young Adult | 2016 |
Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
Topics: Antiprotozoal Agents; Child; Child, Preschool; Cost of Illness; Female; Health Care Costs; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Morocco; Neglected Diseases; Organometallic Compounds | 2016 |
Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Drug Carriers; Female; Hydrophobic and Hydrophilic Interactions; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Microscopy, Atomic Force; Nanoparticles; Organometallic Compounds; Scattering, Small Angle; Solvents; Treatment Outcome; X-Ray Diffraction | 2016 |
Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Aquaglyceroporins; Dog Diseases; Dogs; Drug Resistance; Gene Expression; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Sulfhydryl Compounds | 2016 |
Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
Topics: Antiprotozoal Agents; Cross-Sectional Studies; Down-Regulation; Drug Resistance; Gene Expression; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protein Kinase C; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction | 2016 |
Leishmaniasis with Femoral Bone Involvement.
Topics: Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Bone Marrow; Femur; Humans; Knee; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
[Polymorphic lesions of cutaneous leishmaniasis revealing human immunodeficiency virus infection].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Endemic Diseases; Female; Fluconazole; Herpes Zoster; Humans; Immunocompromised Host; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Morocco; Organometallic Compounds; Recurrence; Viremia; Young Adult | 2016 |
LEISHMANIA INFANTUM INFECTION IN BENNETT'S WALLABIES (MACROPUS RUFOGRISEUS RUFOGRISEUS) IN A SPANISH WILDLIFE PARK.
Topics: Allopurinol; Animals; Animals, Zoo; Female; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Macropodidae; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Psychodidae; Spain | 2016 |
Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre.
Topics: Adult; Aged; Aged, 80 and over; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Long-standing Erythematous Plaque in a Perianal Skin Fold.
Topics: Aged, 80 and over; Antiprotozoal Agents; Buttocks; Erythema; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2017 |
Topical Treatment of Leishmania tropica Infection Using (-)-α-Bisabolol Ointment in a Hamster Model: Effectiveness and Safety Assessment.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Cricetinae; Cytochrome P-450 CYP2D6 Inhibitors; Disease Models, Animal; Injections, Intralesional; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Molecular Structure; Monocyclic Sesquiterpenes; Organometallic Compounds; Sesquiterpenes; Skin; Stereoisomerism | 2016 |
An 8-Year Retrospective Study of Human Visceral Leishmaniasis.
Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Sex Distribution; Young Adult | 2016 |
TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Follow-Up Studies; Leishmania infantum; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasite Load; Parasitemia; Toll-Like Receptor 2; Toll-Like Receptor 4; Up-Regulation | 2016 |
Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children in Southwestern China: A Retrospective Analysis From 2001 to 2015.
Topics: Antiprotozoal Agents; Biopsy; Bone Marrow; Child; Child, Preschool; China; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies | 2017 |
Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Apolipoprotein A-I; Biomarkers; Dogs; Electrophoresis, Gel, Two-Dimensional; Leishmaniasis; Mass Spectrometry; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteome | 2016 |
DETC-based bacterial cellulose bio-curatives for topical treatment of cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Animals; Antiprotozoal Agents; Cellulose; Cytokines; Ditiocarb; Drug Therapy, Combination; Female; Gluconacetobacter; Humans; Injections, Intraperitoneal; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Primary Cell Culture; Superoxide Dismutase-1; Superoxides | 2016 |
The pulsed dye laser is more effective and rapidly acting than intralesional meglumine antimoniate therapy for cutaneous leishmaniasis.
Topics: Adult; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Lasers, Dye; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome | 2017 |
Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.
Topics: Adolescent; Adult; Aged; Audiometry, Pure-Tone; Auditory Threshold; Brazil; Cochlea; Female; Hearing; Humans; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Otoacoustic Emissions, Spontaneous; Prospective Studies; Young Adult | 2017 |
Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
Topics: Animals; Antiprotozoal Agents; Cell Line; Leishmania tropica; Leishmaniasis; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nanoparticles; Organometallic Compounds; Titanium | 2017 |
Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment.
Topics: Allopurinol; Animals; Antimetabolites; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Drug Therapy, Combination; Kidney Diseases; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteinuria | 2017 |
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles | 2017 |
Coinfection of
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Cytochromes b; Fatal Outcome; HIV; HIV Infections; Humans; Leishmania guyanensis; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins; Sequence Analysis, DNA; Shock, Septic; Skin; Treatment Failure | 2017 |
Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Aged; Amphotericin B; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Kidney Transplantation; Leishmaniasis, Cutaneous; Male; Mediterranean Region; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Tumor Necrosis Factor-alpha | 2017 |
Library of Seleno-Compounds as Novel Agents against Leishmania Species.
Topics: Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmania infantum; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Selenium; Superoxide Dismutase | 2017 |
Laryngeal leishmaniasis, a rare manifestation of an emerging disease.
Topics: Animals; Antiprotozoal Agents; Communicable Diseases, Emerging; Emergencies; Hoarseness; Humans; Laryngeal Diseases; Leishmania braziliensis; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Nasal Obstruction; Organometallic Compounds; Psychodidae; Tracheostomy; Treatment Outcome | 2017 |
Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Colombia; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Risk Factors; Treatment Failure; Young Adult | 2017 |
Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
Topics: Administration, Oral; Antiprotozoal Agents; Caregivers; Child; Child, Preschool; Cost-Benefit Analysis; Directly Observed Therapy; Drug Costs; Female; Humans; Injections, Intramuscular; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Monte Carlo Method; Organometallic Compounds; Phosphorylcholine; Sensitivity and Specificity; Treatment Outcome; United States | 2017 |
In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.
Topics: Animals; Arginase; Biosynthetic Pathways; Flavonoids; Flavonols; Glutathione; Inhibitory Concentration 50; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; RAW 264.7 Cells | 2017 |
Knockdown of Host Antioxidant Defense Genes Enhances the Effect of Glucantime on Intracellular Leishmania braziliensis in Human Macrophages.
Topics: Antioxidants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Glutamate-Cysteine Ligase; Glutathione Reductase; Glutathione S-Transferase pi; Glutathione Synthase; Host-Pathogen Interactions; Humans; Leishmania braziliensis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction | 2017 |
Leishmaniasis of the Feet Sole: A Case Report.
Topics: Adult; Antiprotozoal Agents; Female; Foot Dermatoses; Forefoot, Human; Humans; Injections, Intramuscular; Iran; Leishmania; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2017 |
Leishmanial dactylitis: an unusual clinical presentation.
Topics: Aged; Antiprotozoal Agents; Diagnosis, Differential; Endemic Diseases; Female; Fingers; Humans; Iran; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Travel-Related Illness | 2017 |
Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
Topics: Antiprotozoal Agents; Brazil; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2017 |
Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis.
Topics: Amiodarone; Animals; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Hindlimb; Histocytochemistry; Itraconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction; Skin; Treatment Outcome | 2017 |
Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).
Topics: Animals; Antiprotozoal Agents; Asteraceae; Female; Leishmania; Leishmania mexicana; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Oils, Volatile; Organometallic Compounds; Plant Leaves | 2017 |
Identification of novel biomarkers for treatment monitoring in canine leishmaniosis by high-resolution quantitative proteomic analysis.
Topics: Acute-Phase Proteins; Allopurinol; Animals; Antiprotozoal Agents; Biomarkers; Dog Diseases; Dogs; Female; Ferritins; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Proteomics; Serum Globulins | 2017 |
Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
Topics: Age Distribution; Ambulatory Care Facilities; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Incidence; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Sex Distribution; Somalia | 2017 |
Genotypic profiles of Leishmania (Viannia) braziliensis strains from cutaneous leishmaniasis patients and their relationship with the response to meglumine antimoniate treatment: a pilot study.
Topics: Adolescent; Adult; Age Factors; Antiprotozoal Agents; Brazil; Child; Cluster Analysis; Cohort Studies; DNA, Kinetoplast; Electrophoresis, Agar Gel; Female; Genotype; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phenotype; Pilot Projects; Polymerase Chain Reaction; Polymorphism, Genetic; Young Adult | 2017 |
Intralesional Infiltration with Meglumine Antimoniate for the Treatment of Leishmaniasis Recidiva Cutis in Ecuador.
Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Child; Ecuador; Female; Follow-Up Studies; Humans; Injections, Intralesional; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Young Adult | 2017 |
Leishmania infantum exerts immunomodulation in canine Kupffer cells reverted by meglumine antimoniate.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Kupffer Cells; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2017 |
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties | 2018 |
Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.
Topics: Allopurinol; Animals; Dog Diseases; Dogs; Female; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Trypanocidal Agents | 2017 |
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).
Topics: Adult; Antiprotozoal Agents; Cohort Studies; Female; Humans; Incidence; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome | 2017 |
In vivo studies of the effectiveness of novel N-halomethylated and non-halomethylated quaternary ammonium salts in the topical treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Body Weight; Cricetinae; Disease Models, Animal; Female; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Salts; Skin; Toxicity Tests | 2018 |
Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment.
Topics: Antiprotozoal Agents; Clinical Protocols; Humans; Injections, Intralesional; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Reproducibility of Results | 2018 |
Antimonial susceptibility and in vivo behaviour of Leishmania major isolates collected in Algeria before and after treatment.
Topics: Adult; Algeria; Animals; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Middle Aged; Organometallic Compounds; Treatment Failure; Young Adult | 2018 |
Cutaneous Leishmaniasis in Pediatric Patients in a Single Tertiary Hospital in Ankara.
Topics: Antiprotozoal Agents; Child; Child Health Services; Child, Preschool; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Male; Medical Records; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Tertiary Care Centers; Turkey | 2017 |
Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Gene Expression Regulation; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Liver Cirrhosis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Random Allocation; Transforming Growth Factor beta; Vimentin | 2018 |
Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia.
Topics: Colombia; Cost-Benefit Analysis; Disabled Persons; Humans; Hyperthermia, Induced; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quality-Adjusted Life Years; Treatment Outcome | 2018 |
Epidemiological Aspects of Cutaneous Leishmaniasis during 2009-2016 in Kashan City, Central Iran.
Topics: Adolescent; Adult; Age Factors; Animals; Child; Child, Preschool; Disease Reservoirs; Disease Vectors; Female; Health Education; Humans; Incidence; Infant; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Seasons; Time Factors; Young Adult | 2018 |
Glucantime reduces mechanical hyperalgesia in cutaneous leishmaniasis and complete Freund's adjuvant models of chronic inflammatory pain.
Topics: Acetylglucosaminidase; Animals; Chronic Pain; Cytokines; Freund's Adjuvant; Inflammation; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Peroxidase; Skin | 2018 |
Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Enzyme-Linked Immunosorbent Assay; Fluoroimmunoassay; Immunoglobulin A; Immunoglobulin G; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2018 |
Sinergism between alkaloids piperine and capsaicin with meglumine antimoniate against Leishmania infantum.
Topics: Alkaloids; Antiprotozoal Agents; Benzodioxoles; Capsaicin; Chromatography, High Pressure Liquid; Drug Synergism; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Magnetic Resonance Spectroscopy; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Piperidines; Polyunsaturated Alkamides; Spectrophotometry, Ultraviolet | 2018 |
Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Saliva | 2018 |
Evaluation of In vitro and In vivo Drug Efficacy Over Leishmania tropica: A Pilot Study.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Mice; Microbial Sensitivity Tests; Organometallic Compounds; Pilot Projects; Practice Guidelines as Topic; Turkey | 2018 |
Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain.
Topics: Adolescent; Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Blood; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Spain | 2018 |
Embryonic toxico-pathological effects of meglumine antimoniate using a chick embryo model.
Topics: Abnormalities, Drug-Induced; Animals; Antiprotozoal Agents; Avian Proteins; Blood Vessels; Chick Embryo; Drug Evaluation, Preclinical; Female; Gene Expression; Meglumine; Meglumine Antimoniate; Models, Animal; Neovascularization, Physiologic; Organometallic Compounds; RNA, Messenger; Teratogens; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cell Death; Disease Models, Animal; Drug Compounding; Drug Liberation; Female; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Phosphatidylserines; Tissue Distribution | 2018 |
Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.
Topics: Animals; Antimony Potassium Tartrate; Antiparasitic Agents; Bone Marrow; Disease Models, Animal; Dogs; Female; Gene Expression Profiling; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liver; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; MicroRNAs; Organometallic Compounds; Parasite Load; Spleen | 2018 |
Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area.
Topics: Amphotericin B; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Child; Child, Preschool; Dietary Supplements; Endemic Diseases; Female; Humans; Infant; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen; Zinc | 2018 |
Treatment of Localized Cutaneous Leishmaniasis With Intralesional Meglumine Antimoniate and Photodynamic Therapy.
Topics: Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Photochemotherapy | 2020 |
Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Ulcer | 2021 |
Evaluating the effect of oral clarithromycin on acute cutaneous leishmaniasis lesions compared with systemic glucantime.
Topics: Antiprotozoal Agents; Clarithromycin; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2022 |
Unusual manifestation of genital cutaneous leishmaniasis in an immunocompetent patient from São Paulo, Brazil: A case report.
Topics: Adult; Antiprotozoal Agents; Brazil; Genitalia; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Polymerase Chain Reaction | 2021 |
Meglumine Antimoniate-Loaded Aqueous-Core PLA Nanocapsules: Old Drug, New Formulation against Leishmania-Related Diseases.
Topics: Animals; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nanocapsules; Organometallic Compounds; Polyesters; Tissue Distribution | 2021 |
Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report.
Topics: Antiprotozoal Agents; Humans; Injections, Intralesional; Leishmania infantum; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain; Treatment Outcome | 2022 |
Antiproliferative properties of Turmerone on Leishmania major: Modes of action confirmed by antioxidative and immunomodulatory roles.
Topics: Animals; Antioxidants; Antiprotozoal Agents; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Molecular Docking Simulation; Organometallic Compounds | 2022 |
Systemic meglumine antimoniate-induced severe dilated cardiomyopathy.
Topics: Antiprotozoal Agents; Cardiomyopathy, Dilated; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2022 |
"It's not all about the disease": do treatment and socioeconomic status affect perceived impact and satisfaction of patients treated for cutaneous leishmaniasis?
Topics: Antiprotozoal Agents; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Satisfaction; Social Class | 2023 |
Treatment of Cutaneous Leishmaniasis with Allopurinol Plus Itraconazole in Iran.
Topics: Allopurinol; Antiprotozoal Agents; Humans; Iran; Itraconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome | 2023 |